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Abstract 
 
Introduction  
Fetal ventriculomegaly is the most common detectable central nervous system abnormality 
affecting 1% of fetuses and is associated with abnormal neurodevelopment in childhood. 
Neurodevelopmental outcome is partially predictable by the 2D size of the ventricles in the 
absence of other abnormalities while the aetiology of the dilatation remains unknown. The main 
aim of this study was to investigate brain development in the presence of isolated 
ventriculomegaly during fetal and neonatal life. 
 
Methods 
Fetal brain MRI (1.5T) was performed in 60 normal fetuses and 65 with isolated 
ventriculomegaly from 22-38 gestational weeks. Volumetric analysis of the ventricles and 
supratentorial brain structures was performed on 3D reconstructed datasets while cortical 
maturation was assessed using a detailed cortical scoring system. The metabolic profile of the 
fetal brain was assessed using magnetic resonance spectroscopy. During neonatal life, volumetric 
analysis of ventricular and supratentorial brain tissue was performed while white matter 
microstructure was assessed using Diffusion Tensor Imaging. The neurodevelopmental outcome 
of these children was evaluated at 1 and 2 years of age. 
 
Results 
Fetuses with isolated ventriculomegaly had significantly increased cortical volumes when 
compared to controls while cortical maturation of the calcarine sulcus and parieto-occipital 
fissure was delayed. NAA:Cho, MI:Cho and MI:Cr ratios were lower whilst Cho:Cr ratios were 
higher in fetuses with ventriculomegaly. Neonates with prenatally diagnosed ventriculomegaly 
had increased ventricular and supratentorial brain tissue volumes and reduced FA values in the 
splenium of the corpus callosum, sagittal striatum and corona radiata. At year 2 of age, only 
37.5% of the children assessed had a normal neurodevelopment. 
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Conclusions 
The presence of relative cortical overgrowth, delayed cortical maturation and aberrant white 
matter development in fetuses with ventriculomegaly may represent the neurobiological substrate 
for cognitive, language and behavioural deficits in these children.  
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1 Introduction 
1.1 Fetal Ventriculomegaly 
1.1.1 Ventriculomegaly overview 
Fetal ventriculomegaly is the most common central nervous system (CNS) abnormality 
occurring in 1% of the fetal population. Despite being the most frequent abnormal brain finding, 
counselling the parents with affected fetuses is challenging as the aetiology and 
neurodevelopmental outcome is variable (Gaglioti et al., 2009; Garel et al., 2003b; Mehta and 
Levine, 2005; Wyldes and Watkinson, 2004). 50% of ventriculomegaly cases have no additional 
CNS abnormalities (isolated ventriculomegaly) and the aetiology of the dilatation for these cases 
remains unknown (Kelly et al., 2001). The neurodevelopmental outcome in children with 
isolated fetal ventriculomegaly is variable and includes predominantly cognitive, language and 
behaviour deficits (Leitner et al., 2009; Sadan et al., 2007). The reasons for this variability are 
not understood. Most published research into fetal ventriculomegaly has focused on the 
correlation of later neurodevelopmental outcome with ventricular 2D size but the results have 
been variable and inconclusive (Gaglioti et al., 2009; Garel et al., 2003b; Lyall et al., 2012; 
Mehta and Levine, 2005; Wyldes and Watkinson, 2004). To date there is no detailed prospective 
study looking at whether fetal brain development is altered in the presence of isolated 
ventriculomegaly. The main aim of this study is to investigate changes in brain development at a 
macro- and micro-structural level and characterise in detail the brain phenotype of the fetus with 
isolated ventriculomegaly.  
 
1.1.2 Definition and prevalence 
The size of the lateral ventricles remains stable from 14 gestational weeks until birth as evaluated 
on ultrasound with a single linear measurement (atrial diameter) at the posterior part of the 
lateral ventricles (Figure 1) (Snijders and Nicolaides, 1994). Mean atrial diameter between 20 
and 40 weeks as measured on ultrasound is 6.4 mm (±1.2 mm) (Almog et al., 2003). The atria of 
the ventricles are routinely measured during the fetal anomaly ultrasound scan, offered to all 
pregnant women and performed around 20 weeks gestation. Antenatal diagnosis of 
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ventriculomegaly is defined when the atrial diameter of one or both lateral ventricles is equal to 
or exceeds 10 mm (corresponding to 4 standard deviations above the mean) from 14 gestational 
weeks until term (Cardoza et al., 1988) (Figure 2). Atrial diameter is measured on ultrasound and 
MR images according to the International Society of Ultrasound in Obstetrics and Gynaecology 
(ISUOG) guidelines (ISUOG, 2007). Measurements between the two modalities correlate well 
(Griffiths et al., 2010; Leijser et al., 2007; Morris et al., 2007). According to the guidelines for 
performing the 'basic examination' of the fetal CNS by ISUOG, 'the ventricular atrial diameter is 
measured in a transverse plane at the level of the atrium perpendicular to the ventricular cavity, 
positioning the calipers inside the echoes of the ventricular walls' (Figure 1). The anterior aspect 
of the lateral ventricles is not routinely measured on ultrasound on MRI. 
 
 
Figure 1. Measurement of the atrium of the lateral ventricles  
(A) Ultrasound image of a fetal brain in a transverse plane illustrating correct positioning of callipers for the 
measurement of the ventricular atrial diameter (B) T2-weighted MR image of a fetal brain (30
+5
 weeks) in a 
transverse plane illustrating the measurement of the ventricular atrial diameter. The atrial diameter measurement is 
performed at the posterior part of the lateral ventricles, at the level of the low basal ganglia and perpendicular to the 
ventricular axis. Atrial diameter measurement is shown in pink. The calipers are placed in the low signal intensity of 
the ventricular wall, touching the inner edge of the ventricle and perpendicular of the long axis of the ventricle. The 
subependymal lining of the ventricular wall (low signal intensity) is not included. Image (A) has been reproduced 
from the ISUOG guidelines (ISUOG, 2007). 
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Ventriculomegaly is more common in boys than girls and previous studies have reported a range 
of male/female ratios of 1.31 to 2 (Falip et al., 2007; Ouahba et al., 2006). Ultrasound biometry 
studies have shown that boys have larger atrial and biparietal diameter measurements than girls 
(Kramer et al., 1997; Nadel and Benacerraf, 1995; Patel et al., 1995; Smulian et al., 1995), 
however the differences are of small magnitude. Studies have argued as to whether the 10 mm 
cut-off should be extended to 11 mm for male fetuses however at the present time an atrial 
diameter of 10 mm is the cut-off value applied to both sexes (Hilpert et al., 1995; Pretorius et al., 
1986).  
 
Ventriculomegaly is classified as isolated when there are no other CNS abnormalities detected. 
Depending on the degree of enlargement ventriculomegaly is classified into borderline (10 mm), 
mild (10.1-12 mm), moderate (12.1-15 mm) and severe (>15 mm). The current diagnosis of 
isolated ventriculomegaly does not require a normal karyotype or negative infection status. The 
prevalence of ventriculomegaly has been calculated by previous studies between 0.08% and 1% 
(Salomon et al., 2007; Sethna et al., 2011; Vergani et al., 1998; Weichert et al., 2010). The 
prevalence of isolated ventriculomegaly has been estimated at a range of 0.03% to 0.4% (Sethna 
et al., 2011; Vergani et al., 1998). The large discrepancy may be due to differences in imaging 
modality, diagnostic criteria or gestational age at diagnosis. 
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Figure 2. Fetal ventriculomegaly  
T2-weighted MR image in a transverse plane of (A) a normal control fetus aged 31
+5
 weeks and (B) a fetus aged 30 
weeks with ventriculomegaly. Fetal ventriculomegaly is diagnosed when the atrial diameter is equal to or exceeds 10 
mm. Atrial diameter measurements are shown in yellow. It should be noted that at this level the dilatation involves 
only the posterior aspect of the lateral ventricles. 
 
1.1.3 Causes of ventriculomegaly  
Ventriculomegaly is a descriptive term indicating an enlargement of the lateral ventricle(s) in the 
developing brain.  
 
1.1.3.1 Abnormal cerebro-spinal fluid turnover 
While ventriculomegaly is a descriptive term not referring to the underlying aetiology, the term 
hydrocephalus has been used in the past to describe an abnormal accumulation of cerebro-spinal 
fluid (CSF) within the ventricles. Increase in pressure may occur due to an obstruction in the 
ventricular system (D'Addario et al., 2007). The reasons for the formation of an obstruction can 
be numerous, such as a congenital aqueduct stenosis, an inflammatory process subsequent to 
infection or haemorrhage, a tumour, or a CNS malformation such as Dandy-Walker (Gaglioti et 
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al., 2009). Most commonly seen causes postnatally are dilation secondary to haemorrhage or 
infection.  In some rare cases increased pressure may result from overproduction of CSF as in 
cases of choroid plexus papilloma (Nejat et al., 2008). Although it is not possible to measure 
intraventricular pressure in-utero, there are specific brain features visible on MR images that 
would be indicative of increased pressure. Obstruction may be associated with a large or 
increasing occipito-frontal circumference and brain imaging appearance of ballooned ventricles 
with a decreased extra-cerebral space, suggestive of raised pressure within the ventricles and 
intracranial cavity (Figure 3). Structural obstructions may occasionally be directly visible such as 
a large cyst, haemorrhage or indirectly such as secondary enlargement of the 3
rd
 ventricle due to 
aqueduct stenosis. In addition, alteration in the signal intensity of the adjacent white matter may 
be detected resulting from oedema due to the increased pressure, presumed secondary to 
impaired venous drainage (Del Bigio, 1993). The term hydrocephalus was extensively used in 
the past to describe any ventricular enlargement however it has now been replaced by the term 
obstructive ventricular dilatation.  
 
 
Figure 3. Fetal ventriculomegaly secondary to obstruction at the foramen of monro 
T2-weighted MR images of a 39
+6 
weeks old fetus with ventriculomegaly. Lateral ventricles appear "ballooned" 
(asterisk). There is evidence of structural obstruction (cyst present) at the foramen of monro (arrowhead) and also 
decreased extra-cerebral space (arrow).  
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1.1.3.2 Association with other abnormalities  
Presence of ventriculomegaly has been associated with a high risk of detecting additional CNS 
abnormalities (Gaglioti et al., 2009). Fetal MRI has been proven to be a valuable adjunct to 
antenatal ultrasound for the detection of additional CNS abnormalities. The risk of associated 
abnormalities (ventriculomegaly 10-15 mm)  reported in previous studies varies from 10% to 
76% (Breeze et al., 2005; Bromley et al., 1991; Gaglioti et al., 2005; Goldstein et al., 1990; 
Mercier et al., 2001; Morris et al., 2007; Patel et al., 1994; Pilu et al., 1999; Vergani et al., 1998). 
Cases with measurements above 12 mm are more likely to be associated with additional brain 
abnormalities (Gaglioti et al., 2005). Brain abnormalities that have been associated with 
ventriculomegaly are presented in Table 1 (Breeze et al., 2007; Gaglioti et al., 2005; Gaglioti et 
al., 2009; Gomez-Arriaga et al., 2012; Joo et al., 2008; Madazli et al., 2011; Ouahba et al., 2006; 
Senat et al., 1999; Sethna et al., 2011; Weichert et al., 2010; Wilhelm et al., 1998). The most 
commonly detected CNS abnormality associated with fetal ventriculomegaly is agenesis of the 
corpus callosum (Figure 4). The ventricles have a characteristic parallel pattern and appear 
shaped as a tear-drop posteriorly (Manfredi et al., 2010). This relative posterior dilation is termed 
colpocephaly. This appearance has been attributed to the fact that callosal fibres that normally 
cross the brain midline fail to cross the midline and form ectopic thick bundles running anterior-
posteriorly (Probst bundles). 
 
CNS malformations associated with fetal ventriculomegaly 
Agenesis of the corpus callosum 
Spina bifida 
Holoprosencephaly 
Agenesis of the cerebellar vermis 
Absent septum pellucidum 
Cerebral haemorrhage 
Subependymal heterotopia 
Schizencephaly 
Arnold-Chiari malformation 
Dandy-Walker syndrome 
Miller-Dieker syndrome 
Table 1. CNS malformation associated with fetal ventriculomegaly 
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Figure 4. Agenesis of the corpus callosum 
(A-B) Ventriculomegaly and agenesis of the corpus callosum in a 31 week old fetus. The intrahemispheric fissure 
appears wide due to agenesis of the corpus callosum (arrowhead in A). The ventricles have a characteristic parallel 
orientation (arrows in A) and are enlarged posteriorly (asterisk in B) and third ventricle is elevated (arrowhead in B). 
(C) fibres from the hemispheres fail to cross the midline and form fibre bundles running anteroposteriorly (Probst 
bundles-arrows) as shown in a diffusion tensor image of a 18 month old infant. 
 
1.1.3.3 Neuronal migration disorders 
Neuronal migration disorders accompanied by ventriculomegaly include periventricular 
subependymal heterotopia. A brain abnormality caused by defective neuronal migration with a 
MR appearance of ectopic neuronal "nodules" lining the lateral ventricles (Figure 5). 
Pathogenesis may arise due to a disruption of the radial glia scaffolding organisation and 
neuronal orientation (Carabalona et al., 2012). Studies in adults and children have linked 
subependymal heterotopia to epilepsy and impaired cognition  (Raymond et al., 1994; Srour et 
al., 2011).  Genetic mutations such as in the FilaminA gene may be present (Liu, 2011). 
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Figure 5. Subependymal heterotopia 
Fetus aged 32
+5
 gestational weeks with subependymal heterotopia and superior ventricular dilatation. Characteristic 
ectopic neuronal nodular lining the ventricular walls (arrows). Ventricular enlargement also present posteriorly 
(asterisk). 
 
1.1.3.4 Infection 
As mentioned, ventriculomegaly may indicate the presence of an infection therefore TORCH 
infection screening is offered to all pregnant women with a diagnosis of ventriculomegaly. 
TORCH screening which is performed on maternal blood includes testing for Toxoplasmosis, 
Other (syphilis, parvovirus, hepatitits B, varicella-zoster, Epstein-Barr), Rubella, 
Cytomegalovirus and Herpes (Kriebs, 2008). Testing can be performed on a current blood 
sample or on the stored booking bloods acquired in the first 12 weeks of pregnancy. A 
comparison of the two samples is usually needed to confirm a recent infection. Infection 
screening using polymerase chain reaction (PCR) on a sample of amniotic fluid obtained through 
amniocentesis is also offered. The incidence of infection in ventriculomegaly has been estimated 
in previous studies between 0.6-2.9% (Gomez-Arriaga et al., 2012; Pier et al., 2011). According 
to a systematic review by Devaseelan et al., (2010) the risk of positive infection in isolated mild 
ventriculomegaly is 0.4% whilst in isolated mild to moderate ventriculomegaly the average rate 
is 1.5%. It is quite common however that the presence of infection is associated with additional 
abnormalities and suspicious signs on antenatal ultrasound imaging may include calcification, 
increased periventricular echogenicity, microcephaly, cerebellar abnormalities, abnormal signal 
intensity in the white matter, cortical abnormalities and periventricular pseudocysts (Figure 6) 
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(Malinger et al., 2003). Even in cases where antenatal brain MR imaging may only indicate 
isolated ventriculomegaly the progression of an infection may result in severe brain damage 
(Pistorius et al., 2008). The clinical outcome of these cases seems to be correlated to the extent of 
brain damage and can range from normal development to cognitive impairment and behavioural 
abnormalities, and in the severe cases to fetal or neonatal death (Malinger et al., 2011b).  
 
 
Figure 6. Ventriculomegaly secondary to congenital infection 
Fetus aged 30
+1
 weeks presenting with severe ventriculomegaly (asterisk) and cerebellar haemorrhage, seen as low 
signal intensity around the hemisphere (arrow) secondary to parvovirus infection. 
 
1.1.3.5 Chromosomal abnormalities 
The risk of aneuploidies is higher in non-isolated ventriculomegaly regardless of the degree of 
dilatation (Bromley et al., 1991; Gaglioti et al., 2005; Mercier et al., 2001; Pilu et al., 1999; 
Vergani et al., 1998). However, the incidence is lower in severe isolated ventriculomegaly 
compared to mild to moderate (Nicolaides et al., 1990). In isolated cases the risk of an abnormal 
karyotype ranges from 3% to 14% (Bromley et al., 1991; Gaglioti et al., 2005; Graham et al., 
2001; Mercier et al., 2001; Patel et al., 1994; Pilu et al., 1999; Vergani et al., 1998). In a 
systematic review by Devaseelan et al., (2010) it was reported that in isolated ventriculomegaly 
(10.1-15 mm) the risk for a chromosomal abnormality is 5% (41/923 cases). In mild isolated 
ventriculomegaly the risk is smaller at 3% (12/319). A recent ultrasound study measured the area 
of the lateral ventricles and choroid plexuses in euploid fetuses and fetuses with trisomy 21, 18 
and 13 and showed that most fetuses with trisomy 13 and one third of fetuses with trisomy 18 
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had evidence of ventriculomegaly (Loureiro et al., 2012). The only reliable screening test for the 
detection of chromosomal abnormalities is karyotyping on amniotic fluid, however 
amniocentesis carries an approximate 1% risk of miscarriage that parents may be unwilling to 
take.   
 
1.1.3.6 Germinal matrix haemorrhage 
Fetal ventriculomegaly may be secondary to germinal matrix haemorrhage although this is a rare 
cause in a singleton fetus. As discussed haemorrhage may complicate congenital infections such 
as parvovirus and cytomegalovirus. In twin pregnancies complicated by twin-to-twin transfusion 
syndrome, haemorrhage may be seen particularly following an interventional procedure such as 
laser ablation of placental vessels (Figure 7). Thrombophilia screening may be indicated in fetal 
haemorrhage cases. Mutations in the genes for thrombotic proteins Factor-V and Factor-II and 
the MTHFR gene have been associated with thrombophilia. Patients of Mediterranean origin are 
a high risk group as studies have shown a high incidence of these mutations in this population 
(Hatzaki et al., 2003; Zoossmann-Diskin et al., 2008). Mutations in the Col4A1 genes have also 
been associated with perinatal cerebral haemorrhage and porencephaly (Breedveld et al., 2006; 
Gould et al., 2005).  
 
 
Figure 7. Ventriculomegaly secondary to haemorrhage 
(A-B) Fetus aged 27
+1
 weeks showing marked ventricular dilatation and a large germinal matrix haemorrhage 
(arrow). Fetus shown is a twin from a diamniotic monochorionic pregnancy complicated by twin-to-twin transfusion 
syndrome.  Laser ablation of the placental vessels was performed at 24 weeks. * = ventricular dilatation. 
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1.1.3.7 Brain atrophy 
Rarely during fetal life and more commonly during neonatal life, ventricular enlargement may 
develop secondary to atrophy of the surrounding brain tissue as a consequence of  brain injury 
(Figure 8), arising from ischemia, haemorrhage or infection  (Rutherford et al., 2006). Brain 
tissue atrophy is evident on fetal MRI and features may include a normal or small occipito-
frontal centile, decreased white matter volume and enlargement of the extra-cerebral space. 
Overt lesions or evidence of injury and distortion of the tissue may also be present (Leviton and 
Gilles, 1996).  
 
 
Figure 8. Ventriculomegaly secondary to brain tissue atrophy 
Fetus aged 30
+5
 gestational weeks presenting with ventriculomegaly (asterisk) secondary to brain tissue atrophy. 
Characteristic features include increased extra-cerebral space (arrow) and distorted brain appearance and white 
matter loss (arrowhead). Brain size is small for gestational age while the cortex posteriorly is markedly abnormal 
consistent with polymicrogyria. These findings may represent an early insult to the brain. 
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1.1.4 Isolated ventriculomegaly 
Half of the cases of ventriculomegaly however have no associated abnormality and are classified 
as isolated ventriculomegaly (Figure 9) (Kelly et al., 2001). In the absence of infection or 
chromosomal abnormality the cause of isolated ventriculomegaly is obscure. As described in 
future work (chapter 5.5) we are currently exploring the relationship of maternal vitamin D 
deficiency and fetal ventriculomegaly. The outcome of isolated ventriculomegaly is variable 
which poses a challenging case for consultation for clinicians and great stress to the prospective 
parents. For these reasons the main focus of this project is to improve our understanding of brain 
development in the fetuses with isolated ventriculomegaly in order to better predict outcome. 
 
 
Figure 9. Isolated ventriculomegaly 
Isolated ventriculomegaly presenting in three different fetal cases aged (A) 24
+5
 gestational weeks (B) 32
+2
 
gestational weeks (C) 37
+1
 gestational weeks. Enlargement of the lateral ventricles is the only brain abnormality 
(asterisk).  
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1.1.5 Outcome 
Prediction of the outcome of fetal ventriculomegaly is challenging partly because the aetiology 
of the dilation is unknown and also due to the variability of neurodevelopmental outcome. The 
reasons behind this spectrum in outcomes are unclear and improved understanding of the 
underlying causative mechanisms leading to ventriculomegaly together with an improved 
description of the imaging phenotype will aid outcome prediction and counselling. 
 
Diagnosis on ultrasound is usually followed by a course of investigations which include 
screening for the presence of a congenital infection, karyotyping for exclusion of chromosomal 
abnormalities, and if available, MRI scan for the exclusion of additional brain abnormalities. 
Sequential ultrasound scans are recommended to monitor the size and document the progression 
of the dilatation. Correct differentiation between the various aetiologies of ventriculomegaly is 
essential to predict outcome and counselling is heavily dependent on the results of the above 
investigations. Numerous studies have assessed the outcome of fetuses with ventriculomegaly 
and variation between studies has been attributed to inhomogeneity in the cohorts assessed. We 
have reviewed the current literature and have extrapolated, were possible, the outcome of the 
isolated cases (Table 2). 
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Study 
Imaging 
modality 
No. 
cases  
Ventriculomegaly 
size Cohort 
Assessment 
modality 
Developmental 
areas assessed 
Mean 
age  
GA 
range % abnormal Specific deficits 
G
ag
lio
ti
 2
0
0
5
 
US 59 
Group 1:              
10-12mm          
Group 2:                
12.1-14.9mm   
Group 3:       
>15mm  
isolated VM          
-ve TORCH 
euploid. 
Questionnaires 
Locomotor, eye 
and hand co-
ordination, 
hearing and 
speech, learning 
performance. 
≥ 24 m 2-12 y 
Group 1: 7%        
Group 2: 25%     
Group 3: 
37.5% 
Language problems, nystagmus, 
mild intellective impairment, 
mild strabismus, mild 
neurodevelopmental delay, 
severe handicap.  2 cases 
required ventroperitoneal 
shunt. 
V
er
ga
n
i 1
9
9
8
 
US 45 10-15mm 
isolated VM 
euploid. 
Prechtl scoring 
system, Milani-
Comparetti, 
Gidoni. 
Cognition, 
motor. 
28 m 3-72 m 
<12mm: 3%    
≥12mm: 23% 
N/A 
B
ee
gh
ly
 2
0
1
0
 
MRI 98 
Group 1:              
10-12mm     
Group 2:      
>12mm  
isolated VM          
-ve TORCH 
euploid.     
BSID-II, 
Vineland 
Behaviour 
Scales, standard 
neurological 
exam. 
Cognitive, 
motor, adaptive 
behaviour. 
24.4 m N/A 
Group 1: 
mental status 
(8%), cranial 
nerves (3%), 
hearing/vision 
(0%), strength 
(0%), posture 
and tone (6%), 
gait (3%). 
Group 2: mental status (0%), 
cranial nerves (8%), 
hearing/vision (0%), strength 
(0%), posture and tone (0%), 
gait (0%). 
Le
it
n
er
2
0
0
9
 
MRI 28 10-12mm 
isolated VM          
-ve TORCH 
euploid.    
Unilateral vs 
bilateral         
(K-ABC), 
neurological 
examination 
and parental 
questionnaires 
Neurodevelopm
ent                    
co-ordination, 
skills, speech 
and language, 
cognitive, 
memory, 
attention 
visuomotor. 
4.4 y 3-5.9 y 
unilateral: 
12.5%   
bilateral: 33% 
Cerebral palsy-left hemiparesis, 
deficits requiring 
physiotherapy, speech/ 
language therapy and 
occupational therapy. Lower 
scores in working memory, 
attention and Kaufman 
achievement scale. 
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Study 
Imaging 
modality 
No. 
cases  
Ventriculomegaly 
size Cohort 
Assessment 
modality 
Developmental 
areas assessed 
Mean 
age  
GA 
range % abnormal Specific deficits 
G
o
m
ez
-A
rr
ia
ga
 2
0
1
2
 
US 18 10-12mm 
isolated 
VM,           
-ve 
infection, 
euploid.          
Battelle 
Developmental 
Inventory 
Screening Test 
Personal-social, 
adaptive behaviour, 
gross/fine motor, 
communication, 
cognition. 
4.9 y 1-8 y 
personal/social 
64%, adaptive 
behaviour 39%, 
gross motor 
57%, fine motor 
28%, receptive 
communication 
39%, expressive 
communication 
23%, cognition 
17%. 
Language impairment, 
intellectual retardation, left 
hemiparesis. Delayed scores 
in: social-personal, gross 
motor, adaptive behaviour 
(attention), communication, 
cognition. 
Ta
tl
i 2
0
1
2
 
US 
(+postna
tal US) 
31 10-15mm 
isolated 
VM 
BSID-III 
Cognition, 
expressive/receptive 
language, gross/fine 
motor. 
16.7 m 8-33 m 
Cognitive: 16%  
Language: 13%   
Motor: 29% 
Down's syndrome, tuberous 
sclerosis, equivarous foot 
deformity, cognitive/ 
language/ motor delay. 
P
ilu
 1
9
9
9
 
US 31 10-15mm 
non-
isolated/ 
isolated 
VM  
Parental and 
paediatrician 
interviews. 
N/A 33 m 
21-72 
m 
11.5% 
isolated cases all normal, 
non-isolated cases cognitive 
and motor 
delay/retardation. 
Si
gn
o
re
lli
  2
0
0
4
 
US 60 10-12mm 
isolated 
VM,           
-ve 
TORCH, 
euploid. 
Retrospective: 
38 children: 
Parental and 
paediatrician 
interviews.                 
Prospective: 
22 children: 
GMDS 
Cognitive, motor. 
Retr.      
5.4 y 
Prosp.   
18 m 
Retr.       
3-10 y 
Prosp.  
18 m 
0% - 
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Study 
Imaging 
modality 
No. 
cases  
Ventriculomegaly 
size Cohort 
Assessment 
modality 
Developmental 
areas assessed 
Mean 
age  
GA 
range 
% 
abnormal Specific deficits 
O
u
ah
b
a 
2
0
0
6
 
US  
(+MRI at 
2 months 
and 2 
years) 
101 10-15mm 
isolated 
VM             
-ve TORCH, 
euploid.       
Questionnaires 
in 36 children. 
Brunet-Lezine 
psychomotor 
scale, MSCA, 
WPPSI-III in 65 
children. 
Gross/fine 
motor, 
language, 
social skills, 
memory. 
54.7 m 
19-127 
m 
11.8% 
PVL+encephalopathy, 
encephalopathy and mental 
retardation, hydrocephalus, epilepsy, 
dyslexia, language delay, upper limb 
monoparia, cerebral palsy. 
Sa
d
an
 
2
0
0
7
 
US 21 10-15mm 
isolated 
VM 
BSID-II, VABS. 
Mental, motor, 
behaviour. 
23.1 m 24-42 m 25% 
Global developmental delay, 
language/communication delay, 
hypotonia. 
Fa
lip
 2
0
0
7
 
US 
(+postnat
al US and 
MRI) 
101 10-15mm 
isolated 
VM             
-ve TORCH, 
euploid.       
Brunet-Lezine 
psychomotor 
scale, MSCA, 
WPPSI-III 
Gross/fine 
motor, 
language, 
social skills, 
memory. 
24.5 m 8 m-6.5 y 9% 
Neurological abnormalities, language 
delay, autism, behaviour disorders, 
severe encephalopathy, cerebral 
diplegia, oculomotor apraxia, 
language and graphic delay, seizures. 
Li
p
it
z 
1
9
9
8
 
US 25 11-15mm 
isolated 
unilateral 
VM,            
-ve TORCH, 
euploid. 
neonatal 
evaluation at 
birth 
N/A 13 m 6-32 m 1 case Petit mal seizures. 
B
lo
o
m
 1
9
9
7
 
US 22 10-15mm 
isolated 
VM 
BSID-II, VABS. 
Cognitive, 
motor, 
adaptive 
behaviour. 
21.6 m N/A 36.4% 
Lower scores in mental and motor 
scales, ventriculoperitoneal shunt. 
Table 2. Neurodevelopmental outcome in isolated ventriculomegaly: review of the literature 
VM: ventriculomegaly, m:months, y:years, -ve: negative,  MacCarthy scales of children's abilities, WPPSI: Wechsler Preschool and Primary Scale of 
Intelligence, K-ABC: Kaufman Assessment Battery for Children, VABS: Vineland Behaviour Scales, BSID: Bayley Scales of Infant Development, GMDS: 
Griffiths Mental Development Scales. No. of cases represented the number of cases that were participated in the follow-up.
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1.1.5.1 Ventricular size and outcome 
In non-isolated ventriculomegaly the outcome is defined by the abnormality detected. In isolated 
ventriculomegaly the sole predictor of outcome is the degree of enlargement (atrial diameter 
measurement). Other aspects that affect outcome are the evolution of ventriculomegaly with a 
decrease in ventricular size associated with a better outcome, whilst further enlargement has a 
worse prognosis (Arora et al., 1998; Gaglioti et al., 2005; Ouahba et al., 2006). Devaseelan et al., 
(2010) reported that the risk of neurological abnormality in isolated ventriculomegaly 10.1-15 
mm and in the absence of infection or chromosomal abnormality is 12%. In mild isolated 
ventriculomegaly (10-12 mm) the overall risk of abnormality decreases to 4%.  
 
In a study in 76 fetuses with isolated ventriculomegaly Gaglioti et al., (2005) divided cases into 3 
groups according to atrial diameter (10-12 mm, 12.1-14.9 mm, ≥15 mm) and showed that an 
atrial diameter above 12 mm is less frequently associated with a normal outcome. In a study by 
Vergani et al., (1998) on 45 euploid fetuses with isolated ventriculomegaly it was reported that 
male fetuses and those with atrial measurements below 12 mm had a better prognosis. Tatli et al. 
(2012) studied the neurodevelopmental outcome of 31 children with antenatal borderline 
ventriculomegaly and reported that risk factors for an abnormal outcome included an atrial 
diameter >12 mm and persistence of the enlargement after birth. The study included a case 
diagnosed with Down's syndrome and one case with tuberous sclerosis. When excluding these 
cases their results showed cognitive delay (n=3), language delay (n=2) and motor delay (n=5). 
 
Probably one of the most comprehensive imaging follow-up studies is the study by Falip et al., 
(2007) in a series of 101 fetuses with isolated ventriculomegaly (10-15 mm). Antenatal 
ultrasound and MRI were performed during the fetal period whilst brain development was 
followed up postnatally using cranial ultrasound at birth and MRI at 1 year, between 1 and 3 
years and after the age of 3. Neurodevelopmental follow up was also performed. According to 
the study and as previously shown, outcome was more favourable in mild (12-11.9 mm) 
compared to moderate (12-15 mm) ventriculomegaly with 94% and 85% of infants with a normal 
outcome respectively. An interesting observation was that at the neonatal cranial ultrasound, 
ventriculomegaly was found in only 24 out of 64 neonates scanned. However postnatal MRI 
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which was performed in 76 infants, showed persisting ventriculomegaly in 58 cases. The authors 
suggested that the lateral ventricles were decreased as a result of vaginal delivery and decided to 
stop performing cranial ultrasound examinations shortly after birth as it was underestimating the 
progression of the dilatation.  
 
Ouahba et al., (2006) followed 101 of children with antenatal isolated ventriculomegaly (10-15 
mm) with a normal TORCH screening and a normal karyotype. Paediatric follow up included a 
cranial ultrasound at 3 days and a brain MRI at 2 months and at 2 years. Neurodevelopmental 
assessments were performed at a mean age of 54.7 months (range 19-127 months) using 
questionnaires (36 children) or a complete paediatric follow up including detailed developmental 
assessments at short time intervals (46 children) or one or more neurological and developmental 
assessments (19 children). Transcranial ultrasound revealed persisting ventriculomegaly in 61% 
of cases. Out of the 101 cases, 89 had a normal psychomotor development whilst 12 had 
neurological or developmental delay. Poor neurological outcome was more often associated with 
atrial diameter >12 mm, asymmetrical ventriculomegaly (>2 mm) and progression of the 
dilatation prenatally (more than 3 mm). The 12 children with abnormal outcome included cases 
with periventricular leucomalacia, encepahlopathy, heterotopia and hydrocephalus as diagnosed 
antenatally.  
 
The group of Melchiorre et al., (2009b) evaluated the outcome of 20 children with non-
progressive isolated ventriculomegaly (10-12 mm) diagnosed on antenatal ultrasound. Postnatal 
follow-up was performed at a mean age of 42.7 months (range 13 to 95 months) and found that 4 
children had a mildly impaired neurological outcome. All children were entered into 
rehabilitation programs for their specific needs and 2 later recovered. Interestingly, the 2 cases 
that did not recover had exhibited a normal ventricular measurement on postnatal ultrasound.  
 
1.1.5.2 Fetal ventriculomegaly and normal outcome 
Signorelli et al., (2004), retrospectively assessed the neurodevelopment (range 3-10 years) of 38 
children which were diagnosed with antenatal mild isolated ventriculomegaly (10-12 mm) and 
found no cases with an abnormal outcome. Prospectively they followed-up 22 infants with 
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antenatal mild isolated ventriculomegaly and found no abnormal outcome at 18 months. They 
suggested that mild isolated ventriculomegaly is a normal variant. Similarly Lipitz et al., (1998) 
evaluated the development of children with antenatal ventriculomegaly and found that all the 
isolated cases had a normal outcome at a mean age of 13 months. 
 
1.1.5.3 Cognitive and behavioural delay 
Sadan et al., (2007) studied 20 children with antenatal unilateral ventriculomegaly at a mean age 
of 32 months and found a significant difference between the ventriculomegaly and control 
cohorts in the mental and behaviour scale but not in the motor scale. In more detail, 20% of the 
ventriculomegaly group performed two SDs below average classified as significant 
developmental delay and another 25% had some developmental delay that required intervention. 
They reported that girls did better than boys in the ventriculomegaly group but there was no 
difference between sexes in the control group. When looking at ventriculomegaly laterality and 
developmental scores they reported a significant difference in the mental scale between left and 
right ventriculomegaly with the latter associated with a higher score in the mental scale only. As 
part of their study they also examined children with antenatal asymmetric ventricles (>2mm 
asymmetry) but below 10 mm. They reported that having ventricular asymmetry was associated 
with behaviour deficits but no difference was found in the mental or motor scales.  
 
The group of Gomez-Arriaga et al., (2012) followed up 18 children with antenatal isolated 
ventriculomegaly (≤12mm) using parental filled questionnaires during telephone interviews at a 
mean age of 4.9 years (range 1-8). 64% showed a delay in social-personal skills, 56% in gross 
motor skills (majority were minor deviations from normality), 39% in adaptive behaviour and 
28% in fine motor skills and 22% in cognitive skills.  
 
Bloom et al. (1997) compared the development of 22 children with isolated antenatal 
ventriculomegaly (10-15mm) as diagnosed on ultrasound and in comparison with a control 
group. Children in the ventriculomegaly group scored significantly lower in the mental 
development index, a generalised score of development and in the motor development index. 
Atrial diameter and mental developmental index score correlated negatively (r=-0.5, p=0.001). 
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Eight children in the ventriculomegaly group and one from the control group were classified as 
developmentally delayed. Interestingly there was no difference in the children’s behaviour.  
 
Pilu et al., (1999) looked at the outcome of 31 fetuses with isolated ventriculomegaly (diagnosed 
on ultrasound, 10-15mm). Mild to moderate cognitive and motor delay was present in 11.5% of 
cases. However, the cohort selected included cases with chromosomal abnormalities and 
additional brain abnormalities diagnosed after birth.  
 
Leitner et al., (2009) used ultrasound and MRI to diagnose isolated ventriculomegaly (10-15 
mm) in 28 fetuses and followed up their cohort until a mean age of 4.4 years. Whilst most 
children with ventriculomegaly were within the normal range in most measurements, they 
reported significantly reduced attention span and working memory scores compared to controls 
and suggested that these specific difficulties could later influence academic performance at 
school. Two children had motor impairments. One child had a fixed motor deficit (cerebral 
palsy-left hemiparesis) and another child had multiple development difficulties requiring 
physiotherapy and speech and language therapy.  
 
Beeghly et al., (2010) performed a study looking at the relationship between atrial diameter and 
neurodevelopmental outcome in 78 fetuses with isolated ventriculomegaly. Assessments were 
performed at year 1 and year 2 and evaluated the cognitive, motor and behaviour of these 
children. They showed no association between atrial diameter and abnormal outcome and atrial 
diameter did not correlate with any of the neurodevelopmental scores. They reported that while 
the average scores in mental, motor and behaviour development were within normal limits, 
individual scores in either sub-scale varied from severely or mildly delayed to within normal 
limits. However the majority of  cases were a motor abnormality of uncertain functional 
significance as commented by the authors.  
 
Falip et al., reported that 1 case with isolated antenatal ventriculomegaly was diagnosed with 
autism at 1.5 years of age. There are currently no studies on children with antenatal 
ventriculomegaly performing diagnostic assessments for autistic spectrum disorders. 
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1.1.5.4 Conclusions 
The limitation of outcome studies using ultrasound as the sole imaging modality is that some 
brain abnormalities may not be detected prenatally. Several studies have shown that MRI will 
add information in 17% (Griffiths et al., 2010; Ouahba et al., 2006; Salomon et al., 2006) of 
cases after diagnosis of isolated ventriculomegaly on ultrasound. Therefore the outcome severity 
in "isolated" ventriculomegaly may be overestimated in these studies. In addition inclusion of 
cases with chromosomal abnormalities and a positive infection screen make previous studies 
inconclusive. There have been only 2 studies that have used MRI to confirm no additional 
abnormalities after an ultrasound referral of ventriculomegaly and have excluded cases with 
chromosomal abnormalities and positive infection screening (Beeghly et al., 2010; Leitner et al., 
2009).  
 
The variation between studies on developmental outcome can be attributed to selection of 
different and non-standardised developmental assessment examinations, evaluation at different 
and wide range of ages, follow-up rate and limited sample size. Additional bias may also be 
introduced due to study design with retrospective studies introducing selection and recall bias.  
Despite variability in outcome studies, it is apparent that developmental outcome in isolated 
ventriculomegaly predominantly includes language (Falip et al., 2007; Sadan et al., 2007) 
cognitive (Bloom et al., 1997; Gomez-Arriaga et al., 2012; Leitner et al., 2009; Sadan et al., 
2007) and behavioural deficits (Falip et al., 2007; Gomez-Arriaga et al., 2012; Leitner et al., 
2009; Sadan et al., 2007). Behavioural and cognitive impairments may not be obvious at 2 years 
of age therefore longer follow-up is essential while developmental assessment tools need to be 
sensitive to the impairments anticipated.  
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1.1.6 Ventriculomegaly in childhood and adulthood 
Ventricular enlargement in adult life has been observed in many neurologic and psychiatric 
disorders including schizophrenia (Wright et al., 2000), epilepsy (Jackson et al., 2011), autism 
spectrum disorders (Palmen et al., 2005) and attention-deficit hyperactivity disorders (Lyoo et 
al., 1996). It is still uncertain whether these adults have always had ventriculomegaly and 
whether the dilatation had its origins in fetal life. It is also unknown whether fetal 
ventriculomegaly persists into adulthood and is a predisposing factor for adult psychiatric 
disorders.  
 
1.1.6.1 Schizophrenia 
Probably the most common structural brain abnormality associated with schizophrenia is 
ventricular enlargement and a large number of studies support a neurodevelopmental basis for 
this disorder (Fatemi and Folsom, 2009; Lewis and Levitt, 2002; Owen et al., 2011). A detailed 
meta-analysis (Wright et al., 2000) of 18 volumetric studies of patients with schizophrenia 
compared to controls showed increased volume of the lateral, third and fourth ventricles in 
patients with schizophrenia while whole brain volumes were decreased. The question arises as to 
whether fetal ventriculomegaly is a risk factor or a marker of increased risk of schizophrenia. 
Despite the association between schizophrenia and ventriculomegaly it is unclear as to when the 
enlargement occurs. A brain morphology study in first-episode schizophrenics revealed that 
ventricular enlargement was present in this population indicating that brain changes are present 
very early in the onset of symptoms and may not be due to medication or disease chronicity 
(Nopoulos et al., 1997). There is therefore no clear link between fetal ventriculomegaly and adult 
schizophrenia. There are no published prospective studies looking at the progression of fetal 
ventriculomegaly or mental status of children after school age and into adulthood and there are 
no retrospective studies reviewing the antenatal ultrasounds of adults with schizophrenia. 
Antenatal and perinatal complications have been associated with an increased risk for 
schizophrenia however these do not mention cases diagnosed with antenatal ventriculomegaly 
(Buka and Fan, 1999).  
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1.1.6.2 Epilepsy 
Ventriculomegaly has also been observed in epileptic children. An imaging study by Kalnin et 
al., (2009) in 281 children with newly diagnosed seizures revealed that 87 had at least one brain 
abnormality. Ventricular enlargement was the most common finding present in 51% of the 
patients and in the majority of those cases this was an isolated finding. Similarly, Jackson et al., 
(2011) performed a MRI volumetric analysis of the lateral ventricles in children with new-onset 
paediatric epilepsy and showed a significant increase in volume compared to controls with 
enlargement most prominent in the frontal horns. The authors of both studies hypothesised that 
ventricular enlargement may be secondary to atrophy. However they did not measure brain 
volumes. Herman et al., (2010) performed a MRI volumetric analysis of cortical gray matter and 
white matter in 38 children with new-onset epilepsy and demonstrated a decrease in cortical 
volume and delayed growth of white matter in the epilepsy cohort (Hermann et al., 2010).  
 
1.1.6.3 Autism 
Palmen et al., (2005) performed MR volumetric analysis in 21 medication-naive high-
functioning autistic children and compared the results to a healthy control group. They showed 
that autistic children had significantly larger total brain and lateral ventricle volumes (more than 
40%) and the ventricular enlargement persisted even when correcting for cerebral volume. 
Enlargement was also reported in cerebral gray matter and the cerebellum. Subsequent studies 
have not however replicated these data. However studies investigating brain development and 
size in autism have been contradicting and factors that account for this variation include age at 
imaging, IQ, gender and medication (Courchesne et al., 2011a). The conflicting results between 
studies on autism are attributed to the fact that autism is not a single disorder but encompasses a 
wide spectrum of symptoms and may include Asperger’s and pervasive developmental disorder 
(Johnson and Myers, 2007). The age of imaging seems to play the most important role in 
validation of results. The changes that are occurring in the autistic brain are evolving and age 
specific, therefore different brain phenotypes are observed at different ages. There are currently 
no studies using serial imaging in children with autism due to the difficulty in collecting MRI 
scans across a wide age range in autistic and healthy children. Age-related changes are 
statistically inferred from meta-analyses studies. The feature of the autistic brain that most 
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studies highlight is increased brain size. According to the study by Courchesne et al. (2011a) 
looking at brain growth across the life span in autism, early brain overgrowth (2-4 years) is 
observed in autism. This is followed by a decreased growth rate during childhood with brain 
volumes decreasing in autism at a faster rate than normal leading to brain sizes slightly smaller 
than average by 6 years of age. Retrospective studies have collected data of head circumference 
at birth and showed that enlargement was not present at birth. However, these are retrospectively 
collected data and head circumference measured after birth may not be the most reliable method 
of evaluating brain enlargement. At a cellular level, an excess of cerebral cortical neurons (by 
67%) has been found at autopsy in a small group (n=7) of autistic patients compared to controls 
(Courchesne et al., 2011b). The authors suggested that such an increase in neuronal numbers can 
only have occurred during fetal life as there is no other time during brain development during 
which such a large excess of cortical neurons is generated.  
 
1.1.6.4 Attention-deficit hyperactivity disorder  
Studies looking at brain volumetry in attention-deficit hyperactivity disorder (ADHD) have also 
been contradictory. A MR volumetric study performed in 51 children (mean age 11.7 years and 
range 5-17 years) with ADHD showed increased lateral ventricles and decreased area of the 
splenium of the corpus callosum (Lyoo et al., 1996). In contrast, Castellanos et al., (1996) 
analysed brain MRIs from 57 boys with ADHD (mean age 12 years and range 5-18 years) and 
showed no difference in ventricular volume but reversal of normal left>right ventricular 
asymmetry. In addition total cerebral volumes were decreased by 4.7%. Interestingly they 
speculated that a fetal event affecting normal development of ventricular asymmetry might 
underlie their findings. IQ, medication, dyslexia and heterogeneity in the groups must all 
contribute to the heterogeneity in study results.  
 
1.1.6.5 Hemimegalencephaly 
Hemimegalencephaly is a congenital CNS abnormality which is characterised by enlargement of 
one cerebral hemisphere and its associated lateral ventricle with additional abnormal cortical 
gyrification (Kalifa et al., 1987) (Figure 10). Patients have intractable seizures and mental 
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retardation. Although the aetiology of hemimegalencephaly remains unknown, studies have 
shown abnormal neuronal migration and presence of giant neurons throughout the cortex and 
subcortical white matter (Bosman et al., 1996; Manoranjan and Provias, 2010). Post-mortem 
evidence demonstrates that neurons do not differentiate completely during proliferation and 
migration from the germinal matrix leading to a disordered arrangement of neurons in the gray 
and white matter (Bosman et al., 1996). Hemispheric enlargement is a result of an increased 
number of neurons and glia due to overproduction of neuroblasts and glioblasts or from a 
reduction in apoptosis. Abnormally increased levels of the neurotrophic, nerve growth factor 
(NGF) and brain-derived neurotrophic factor (BDNF) have been detected in brain samples from 
infants with hemimegalencephaly (Antonelli et al., 2004). 
 
 
Figure 10. Ventriculomegaly and hemimegalencephaly 
Fetus aged 28
+3
 gestational weeks presenting with hemimegalencephaly and ventricular enlargemnt. MR images 
show enlrargment of one hemisphere (arrow) and the assosciated ventricle (asterisk).  
 
1.1.6.6 Soto’s syndrome 
Soto's syndrome also known as cerebral gigantism is characterised by brain and somatic 
overgrowth. More specifically it is characterised by macrocephaly (being the most distinctive 
characteristic), tall stature, advanced bone age, typical facial anomalies and mental retardation 
(Leventopoulos et al., 2009). Mild ventricular enlargement is a common imaging finding in 
patients with Soto's syndrome as indicated in imaging studies in children and fetuses with 
macrocephaly (Leventopoulos et al., 2009; Malinger et al., 2011a; Melo, 1999). Mutations in the 
NSD1 gene are the principal cause of Soto's syndrome affecting the regulation of transcription 
through histone modification (Douglas et al., 2003). 
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1.1.7 Animal models of ventriculomegaly 
The cause and underlying mechanism of isolated ventriculomegaly is unknown, thus there are no 
animal models engineered specifically for the condition. The literature describes an animal 
model of ventriculomegaly caused by mechanically increased intraventricular pressure inside the 
cranium of rats representing hydrocephalus (McAllister et al., 1985; Park et al., 2011). However 
as mentioned previously increased intraventricular pressure is not a common feature in the fetus 
and such fetuses are not part of this study.  
 
A brain phenotype of isolated ventriculomegaly has been described in a newborn rat model of 
gestational Vitamin D deficiency. This model was designed to create adult rats with a 
“schizophrenia phenotype” based on epidemiological studies showing links between low 
antenatal vitamin D and enhanced risk of schizophrenia. The study examined the effect of serum 
maternal Vitamin D deficiency throughout pregnancy on the newborn pup and showed that there 
were profound changes on the fetal brain (Eyles et al., 2003). The newborn pups exhibited 
enlarged ventricles, larger brains and an increased cortical volume whilst having a thinner cortex. 
Maternal deficiency altered brain gene and protein expression and disrupted the balance between 
neuronal stem cell proliferation and programmed cell death in the offspring (Eyles et al., 2003; 
Feron et al., 2005). There was no change in Vitamin D receptor expression. After re-introduction 
of Vitamin D to pups postnatally the brain size normalised but not the ventricular size, 
suggesting persisting changes in the adult brain (Feron et al., 2005). Microscopically there was a 
decrease in neurotrophic proteins and in proteins involved in neurotransmission and cytoskeleton 
maintenance (Eyles et al., 2003; Feron et al., 2005). When the rats reached adulthood they 
exhibited abnormal behaviour and hyperlocomotion (Burne et al., 2004; Fernandes de Abreu et 
al., 2010). 
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1.2 Development of the brain and ventricular system  
Intrauterine development comprises 3 stages; the blastocyst implantation period during the first 3 
gestational weeks, the embryonic period from week 4 until day 57 and lastly the fetal period 
ending at birth.  
 
At 3 weeks post fertilisation the sides of the neural plate, a sheet of elongated neuroectodermal 
cells that will give rise to the central nervous system, start to rise up and fold inwards.  By 3½ 
post fertilisation weeks the major subdivision of the nervous system appear. The primary vesicles 
of the embryonic brain consist of the prosencephalon (forebrain), mesencephalon (midbrain) and 
rhombencephalon (hindbrain) (Figure 11) (O'Rahilly and Muller, 2008).  By week 4 the neural 
groove folds begin to fuse to form the neural tube which constitutes the primitive brain. The ends 
of the neural tube fuse and it goes through a series of folds, bends, constrictions and rotations to 
shape the future brain, with the anterior becoming the expanded brain, the posterior the spinal 
cord and the cavity of the neural tube the primitive ventricular system (Greene and Copp, 2009; 
O'Rahilly and Muller, 2008). These changes in shape are achieved through the continuous 
generation of neuroblasts and neuronal divisions from the neuroepithelium (cells lining the 
neural tube), to form the future forebrain, midbrain and hindbrain.  
 
At week 6 of development, five secondary vesicles are established. Figure 12 illustrates the later 
subdivision of the forebrain, midbrain and hindbrain into the brain structures present in the adult 
brain. The prosencephalon consists of the telencephalon and diencephalon which are the 
precursors of the future cerebrum including the cerebral cortex, white matter and basal nuclei. 
The mesencephalon will become the adult midbrain region. The hindbrain consisting of the 
metencephalon and myelencephalon will form the cerebellum/pons and the medulla oblonganta 
respectively (Nichols et al., 2001). By week 8, the lateral ventricles have become c-shaped and 
the anterior and inferior horns are clearly established while the posterior horns have not yet been 
formed although their location can be determined (Blaas et al., 1998; O'Rahilly and Muller, 
1990). The posterior horns become visible around week 11 of gestation and become more 
elongated in an anterior posterior fashion as gestation progresses (Kinoshita et al., 2001; Levene 
and Chervenak, 2009). Ultrasound studies have shown that the atrial diameter remains relatively 
stable in the second and third trimesters although an increase in absolute values is observed 
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(Almog et al., 2003; Snijders and Nicolaides, 1994). Fetal MRI volumetric studies have been 
inconclusive as to whether the volume of the lateral ventricles increases (Scott et al., 2011), 
decreases (Clouchoux et al., 2011) or remains stable (Kazan-Tannus et al., 2007) from 22 to 40 
weeks of gestation. 
 
Brain shaping and ventricular formation are regulated by regional cell proliferation, apoptosis 
and cytoskeletal rearrangements in the neuroepithelium inside the neural tube (Buss and 
Oppenheim, 2004; Kolega, 1986; Lecuit and Lenne, 2007). The manner in which the neural tube 
folds is regulated by distinct gene expression domains that control early tissue specification and 
therefore influence the position of the ventricles (Lumsden and Krumlauf, 1996). Regional 
specification of neural tissue is determined and influenced by the pattern of gene expression of 
neurons in each region. Hox genes, first described in Drosophila, coordinate the expression of a 
number of other genes in order to form a specific structure of each region in the embryo. 
Throughout the developing CNS, anterior-posterior and dorsoventral gradients of transcription 
factors determine regional specification (Nichols et al., 2001).  
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Figure 11. Early embryonic brain morphogenesis   
Schematic representation of how the neural tube folds to form the embryonic brain.  F, forebrain; M, midbrain; H, 
hindbrain; MHBC, midbrain hindbrain boundary constriction. (Image taken from Lowery and Sive 2009). 
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Figure 12. Embryonic brain regions and equivalent adult structures 
The forebrain consists of the telencephalon and diencephalon which are the precursors of the future cerebrum 
including the cerebral cortex, white matter and basal nuclei. The midbrain will form the adult midbrain region. The 
hindbrain comprises of the metencephalon and myelencephalon which is the precursors of the pons/cerebellum and 
medulla oblongata respectively. 
 
1.2.1 The ventricular system 
The ventricular system consists of a series of connected cavities filled with CSF extending 
through all the major divisions of the central nervous system (Figure 13). The two lateral 
ventricles in the cerebrum, which are c-shaped, are connected to the third ventricle in the 
diencephalon which is in turn connected to the fourth ventricle (via the cerebral aqueduct) 
located between the cerebellum and the pons (Davson and Segal, 1996; Millen and Woollam, 
1962). The fourth ventricle is then connected to the spinal cord canal and the subarachnoid space 
that surrounds the brain. During development, ultrasound studies have shown that the atrial 
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diameter remains relatively stable in the second and third trimester although an increase in 
absolute values is observed (Almog et al., 2003). The width of the third ventricle remains 
relatively stable from 12 until 27 gestational weeks and increases thereafter (Sari et al., 2005; 
Snijders and Nicolaides, 1994). As shown on ultrasound the configuration of the third ventricle 
also varies during gestation, starting as a single line and evolving to two parallel lines and 
eventually to a v-shaped configuration. MRI data indicate that the width of the third ventricle is 
relatively stable throughout gestation despite some fluctuation in values. When corrected for 
brain growth the third ventricle decreases with gestation in proportion to the fetal brain (Garel, 
2004). The anterio-posterior diameter of the fourth ventricle increases through gestation however 
this growth is proportional to the fetal brain (Garel, 2004). 
 
Figure 13. Adult brain ventricular system and CSF flow 
CSF is produced by the choroid plexuses present in the lateral, 3
rd
 and 4
th
 ventricles. CSF flows from the lateral 
ventricles through the foramen of monro to the 3
rd
 ventricle and then through the cerebral aqueduct into the 4
th
 
ventricle. LV, Lateral ventricles, 3V, third ventricle, 4V, fourth ventricle. (Image adapted from from Lowery and 
Sive 2009 and Oresković and Klarica 2010). 
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In adults, CSF flows from the lateral ventricles to the third and fourth ventricles and then enters 
the subarachnoid space at the base of the brain, it then ascends surrounding the brain 
hemispheres and eventually flows into the space surrounding the spinal cord. CSF drains away 
mainly through the arachnoid villi into the dural venous system (Davson and Segal, 1996; 
Nicholson, 1999) (Figure 13). The flow of CSF is a result of pressure gradients which are 
generated by pulsatile arterial blood flow and by gradients generated by the continuous 
absorption and production of CSF. The CSF dynamics during fetal life have received little 
attention but it is suggested that arachnoid villi are not present before birth and CSF clearance is 
a function of the lymphatic system (Mollanji et al., 2012). Although the central nervous system 
parenchyma does not contain lymphatic vessels, drainage may occur through the cribiform plate 
(located at the roofs of the nasal cavity) into extracranial lymphatic vessels (Mollanji et al., 
2012).  
 
1.2.2 The role of embryonic CSF 
The role of CSF was rather interestingly described by  C. Nicolson (1999): " CSF is to the brain 
what the Great Lakes and waterways are to North America: a system of interconnected fluid 
spaces that influence the local climate and the environment of the territory that encloses them, 
while providing a conduit for traffic in goods and services". 
 
CSF appears to interact with the neuroepithelium in an interdependent and co-operative way to 
promote brain growth, morphogenesis and histiogenesis (Gato and Desmond, 2009). As the 
neural plate invaginates to form the neural tube and the neuropores fuse, amniotic fluid is trapped 
inside the primitive ventricular lumen (Johansson et al., 2008). From then on, there are a number 
of processes taking place that lead to the production of the embryonic CSF (Gato and Desmond, 
2009). Production of embryonic CSF begins when fluid starts to accumulate into the ventricular 
lumen as it enters via an osmotic gradient. This fluid influx is thought to be controlled by 
Na
+
K
+
ATPase pumps (Na
+ 
influx) as well as proteoglycan secretion from the neuroepithilium. 
Alfonso et al., (1998)  demonstrated in an animal model that an increase in Na
+
 influx leads to 
expansion of the ventricles and expansion of the whole brain while Lowery and Sive (2005) 
showed that Na
+
K
+
ATPase mutants where unable to inflate their ventricles and supported that 
ion transport is essential for inflation of the ventricles during development. They also suggested 
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that ventricular morphogenesis requires an intact polarised neuroepithelium for the formation of 
the neural tube, efficient activity of the Na
+
K
+
ATPase pumps for inflation of the ventricles and 
localised cell proliferation. Gato et al., (1993) demonstrated that osmosis which is created by 
accumulation of osmotic molecules such as proteoglycans and Na
+
 is responsible for regulation 
of CSF pressure and that these molecules enter the lumen by either crossing through the 
epithelium or are secreted by the neuroepithium cells. 
 
It should be noted that the choroid plexus is formed around the end of the embryonic period (6-9 
weeks), well after the accumulation of embryonic CSF, so it does not appear to be involved in 
CSF production at these early developmental stages (O'Rahilly and Muller, 1990). This 
accumulation of fluid leads to an increase in pressure inside the ventricular lumen which 
promotes brain growth. Desmond et al., (2005) used chick embryos and demonstrated that 
intraluminar pressure increases 10% at each developmental stage as the embryo develops. In 
addition they showed that an increase in intraluminar pressure leads to increased mitotic activity 
of the neuroepithelium cells, while a decrease in pressure leads to a reduction in brain volume 
(Desmond and Jacobson, 1977). Also, the pressure applied on the neuroepithilum stimulates cell 
proliferation possibly through tension receptors thus promoting brain growth (Gato and 
Desmond, 2009).  Gilmore et al. (2008) in a study in neonates with ventriculomegaly suggested 
that changes in ventricular size may lead to changes in CSF flow and subsequently leading to an 
increase in neuroepithilium.  
 
Moreover, embryonic CSF is able to alter neuroepithelial cell behaviour by means of biologically 
active components. While in the adult brain, there are only traces of proteins contained in the 
CSF, embryonic and fetal CSF contain high concentrations of proteins including signalling, 
growth factors, enzymes and proteases (Dziegielewska et al., 2001; Parada et al., 2006; 
Zappaterra et al., 2007). It appears that this protein rich environment is essential in brain 
ventricle development as neuroepithelial proliferation occurs primarily at the ventricular surface. 
CSF is essential for brain development as indicated by the groups of Gato et al., (2005) and 
Miyan et al., (2006) who showed that chick and rat cell lines are unable to proliferate or undergo 
neurogenesis in a chemically defined medium while when CSF is added, cell survival, 
replication and neurogenesis were stimulated. CSF may also regulate gene expression through 
different stages of development thus affecting brain growth (Parada et al., 2006). CSF contains 
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multiple factors expressed at different stages of development such as NGF, BDNF, neurotrophin-
3 (NT-3) and insulin-like factor (IGF-1). These neurotrophins have an important role in the 
regulation of survival, differentiation and synaptogenesis of neurons in the developing brain 
(Cohen et al., 1996; Salehi and Mashayekhi, 2006). Transfer of molecules from blood to brain 
and CSF occurs via intercellullar junctions in the brain barrier interface which are known to be 
present from early stages of brain development for a wide range of metabolically essential 
molecules such as glucose, amino acids and hormones (Saunders et al., 2012). 
 
1.2.3 Cavum septum pellucidum 
The 'maverick' of brain CSF spaces is the cavum septum pellucidum (CSP) (Figure 14). The CSP 
is the fluid-filled cavity found between the lateral ventricles in almost all developing human 
fetuses (Mott et al., 1992). In the 1950s it was termed the fifth ventricle however this term has 
proven inaccurate as the CSP is not part of the ventricular system. The CSP is not a ventricle as it 
does not contain choroid plexus, does not communicate directly with the ventricular system and 
does not have ependymal lining (Alonso et al., 1989). It is anatomically, functionally and 
developmentally closely related to the corpus callosum. The CSP comprises the anterior 
pellucidum and the cavum vergae (Figure 14) (Raybaud, 2010). Due to its central location it is a 
marker of normal brain midline development and its absence or enlargement is associated with 
various CNS malformations such as agenesis of the corpus callosum, holoprosencephaly and 
septo-optic dysplasia. It is easily recognised and routinely imaged in fetal and neonatal scans 
(Callen et al., 2008).  
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Figure 14. Cavum septum pellucidum 
(A) T2-weighted MRI scan of a 28
+1
 week old fetus showing the outline of the CSP in the sagittal view (B) 3D 
volume representation of the CSP components, the anterior pellucidum and cavum vergae. 
 
 
By 6 months of age it is generally closed, while patency in has been reported in 2.4% of normal 
adults (Bodensteiner et al., 1998). An increase in patency rates has been reported in 
schizophrenia, epilepsy, chromosomal disorders, Tourette’s syndrome, obsessive compulsive 
disorder, in boxers as a result of head trauma and in infants as a result of vigorous shaking. It 
remains unclear whether CSPs that are patent in late childhood and adulthood have closed and 
reopened or have remained patent from fetal life. It is also unclear whether cava that are 
excessively wide during fetal and early neonatal life remain patent into adult life.  
 
Studies on the fetal CSP have followed its development through linear measurements, showing a 
pattern of increase in size in early gestation and then decrease in late gestation: the CSP forms 
and disappears (Falco et al., 2000; Jou et al., 1998; Serhatlioglu et al., 2003). It first appears 
around 12 to 14 weeks, it increases until 28 weeks of gestation and decreases thereafter and 
closes by term or early in neonatal life. It is generally said to close from posterior to anterior 
(Winter et al., 2010). Hypotheses as to the means by which it closes vary (Winter et al., 2010). 
 
Animal studies have shown that early in gestation (week 12), cells of the subventricular zone 
proliferate and form wedge-shape groups that extend continuously across the brain midline 
forming a glial sling which serves as a guide for developing callosal axons (Hankin et al., 1988; 
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Raybaud, 2010; Shu et al., 2003). Crossing the midline, the glial sling cells begin to die and a 
large serous-filled cavity appears. This space is the beginning of the CSP. The relationship 
between formation of the CSP and the ventricular system and whether the septal leaves are CSF 
permeable is unclear. Some pressure or osmotic gradient within ventricular CSF may cause the 
cavum to increase in size. It is difficult to understand the development of the cavum in abnormal 
cases as there are no previous studies looking at 3D CSP evolution in normal fetuses. The 
ventricles start to form well before the CSP and it is hypothesised that aberrant formation of the 
ventricular system may affect normal CSP development. 
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1.2.4 Cortical development  
The cerebral cortex is a complex structure organised in a laminar and radial fashion. 
Development of the cortex is a dynamic process and defects underlie many developmental 
disorders of higher brain function. Unlike most organs where cells are produced near their final 
location, neurons designated to form the cortex are generated at a distance from the cortex. The 
cortex is formed in an inside-out manner with neurons born in the ventricular zone adjacent to 
the cerebral ventricles (Rakic, 2006; Rakic and Lombroso, 1998). Cortical development and 
organisation is regulated by the basic coordinated morphogenetic processes of proliferation, 
apoptosis, migration and differentiation of both neurons and glia (Chan et al., 2002). At week 6 
of human gestation, the neopallium lining the lateral ventricles consists of 2 zones, the 
neuroepithelium and the preplate (Zecevic, 1993). The majority of neuroepithilial progenitor 
cells (conventionally called radial glia) go through several mitotic cycles thus expanding the pool 
of neural precursor cells and ultimately give rise to several types of cells within the cerebral 
cortex (Bystron et al., 2008). Post-mitotic nuclei re-enter the cell cycle resulting in two daughter 
cells which both remain attached to the ventricular surface (symmetric division) and extend to 
the cortical plate to guide migrating neurons (Chenn and McConnell, 1995; Lui et al., 2011). 
Asymmetric division generates a replacement radial glial cell and either a mature cortical neuron 
that migrates to the appropriate cortical layer or an intermediate progenitor cell that migrates to 
the subventricular zone (Molnar, 2011). The intermediate progenitor cell undergoes 1-3 
symmetric divisions to amplify neurogenesis. At week 7, the subventricular zone appears just 
above the ventricular zone which gives rise to circuit neurons and glia (Zecevic, 1993). 
Elongated GFAP (glial fibrillary acidic protein) positive radial glial cells dominate the cerebral 
wall in the human fetus and serve as guides for migrating neurons by extending from the 
neuroepithilium to the cortical plate. Immature neurons migrate from the ventricular zone to the 
overlying cortical plate by using the scaffolding of the radial glial cells as a substrate (Rakic, 
1971; Rakic and Lombroso, 1998). Neurons migrate in an inside out gradient formation of the 
cortical layers and distinct zones start to arise. The zones from the ventricular surface to the 
cortex include the ventricular zone, subventricular zone, intermediate zone, cortical plate (within 
the preplate) and marginal zone (Bystron et al., 2008; Kostovic and Jovanov-Milosevic, 2006) 
(Figure 15).  
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Figure 15. Formation of layers in the human cerebral wall 
(A) T2-weighted image of a normal fetus aged 28
+1
 weeks (B) Layers of the cerebral tissue as seen on an 
amplification of image (A). (C) Layers of the cerebral tissue as seen on human embryonic tissue E56. Nuclei are 
shown in blue using Bisbenzimide staining while mitotic cells are shown in pink using Phosphohistone-H3 staining. 
(Image C reproduced from Bystron 2008). 
Ventricle (asterisk), ventricular zone (VZ), subventricular zone (SVZ), intermediate zone and subplate (IZ/SP), 
cortical plate (CP) and marginal zone (MZ). 
 
The location of a neuron in the cortical layers depends on the position of the precursor cell in the 
ventricular zone thus the cytoarchitecture and topographic maps depend on the spatial 
distribution of the progenitor cells in the ventricular zone (Rakic, 2006). The laminar position 
and phenotype of the cortical neurons is dependent on the time of their origin. At about week 10, 
the intermediate zone and cortical plate expand due to symmetric division (Choi, 1988; Kostovic 
and Vasung, 2009) while weeks 12-15 represent the peak of proliferation in the ventricular zone 
and preplate (Simonati et al., 1999). Neurons continue to migrate from the ventricular and 
subventricular zones towards the cortical plate and congregate above it (Ayoub and Kostovic, 
2009). Earliest-born neurons migrate and settle in the deepest cortical layers while later 
generated neurons occupy more superficial layers and the cortex is formed in an inside-out 
manner (Rakic, 2006; Rakic and Lombroso, 1998). By week 15, the ventricular zone is no longer 
increasing indicating that migration of young neurons and cell proliferation are balanced. By 
week 16, the size of the ventricular zone starts to decrease as germinal matrix cells have started 
to migrate (Simonati et al., 1999). The subplate begins to form at around 13-15 weeks of 
gestation and starts to disappear from gestational week 35 and until the end of the second 
56 
 
postnatal month (Kendler and Golden, 1996; Kostovic and Judas, 2010; Kostovic and Rakic, 
1990). On MRI the hypointense zone of the subplate starts to disappear from 28 gestational 
weeks (Perkins et al., 2008). It is a distinct transient layer located directly beneath the cortical 
plate with a functional role in normal development of cerebral cortical structure and connectivity 
(McQuillen et al., 2003). The subplate consists of migratory and postmigratory neurons, growth 
cones, axons, dendrites, synapses and glial cells (Kostovic and Rakic, 1990). While the cortical 
plate contains no synapses during the mid-fetal period the subplate contains presynaptic and 
postsynaptic elements and synapses from the thalamus, basal forebrain, brainstem and 
glutamatergic subplate neurons and is therefore a major site for synaptic interactions (Kostovic 
and Judas, 2010). 
 
By week 24 the size of the ventricular and subventricular zones has reduced further. Proliferation 
in the ventricular/subventricular areas has been reduced while mitotic activity has increased in 
the intermediate zones and subplate. Progenitor cell proliferation in the intermediate and subplate 
zones starts to increase from week 20, peaks around 23-25 weeks, and decreases in the third 
trimester (Kendler and Golden, 1996). By the end of the fetal period the subventricular zone has 
almost disappeared. Proliferation follows a latero-medial gradient in the neocortex. Coinciding 
with proliferation, migration and differentiation is apoptosis which has an important role in 
adjusting the initial progenitor size and for CNS morphogenesis (Chan et al., 2002). Early in 
gestation apoptosis is involved in the development and morphogenesis of the neural tube 
supporting the role of apoptosis in adjusting the initial progenitor pool size (Kuan et al., 2000). 
At around 4.5 weeks apoptotic activity is seen in the ventricular zone but is very low. By week 6-
7 apoptosis in the ventricular zone increases five-fold and there is evidence of apoptosis in the 
preplate (Zecevic and Rakic, 2001). By week 11 apoptosis has commenced in all cortical layers 
although it is most prominent in the proliferative zones. Between 12 and 22 weeks, apoptosis 
increases significantly throughout the telencephalon. After 32 weeks, apoptosis continues in all 
cortical layers. It is suggested that apoptosis during the embryonic period coincides with the 
process of proliferation and early migration and has a role in regulating the size of neuronal 
population while during fetal life it is synchronous with differentiation and synaptogenesis and 
probably involved in the establishment of neuronal circuitry (Rakic and Zecevic, 2000). An 
excess of neurons is produced during brain development many of which are discreetly removed 
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through normal developmental apoptosis, a process via which the developing brain is “sculpted” 
(Kalinichenko and Matveeva, 2008). This process by which exuberant neuronal branches and 
connections are removed is essential for establishing the functional organisation of circuitry. 
Delayed apoptosis may result in atypical patterns of connectivity which would be associated with 
cognitive dysfunction (Tau and Peterson, 2010).  
 
1.2.4.1 Cortical folding 
The surface of the fetal brain is initially smooth (lissencephalic) and as gestation progresses it 
becomes highly convoluted (gyrencephalic). Gyral elevations and sulcal indentations appear in 
different brain regions at separate gestational time points and develop at dissimilar rates creating 
complex patterns. Cortical folding involves a dynamic interaction between several 
developmental processes including neuronal proliferation, migration and differentiation, glial 
cell proliferation, apoptosis, axonal development and synaptogenesis (Grove and Fukuchi-
Shimogori, 2003; Monuki and Walsh, 2001; O'Leary and Nakagawa, 2002; Rakic, 2006; Sur and 
Rubenstein, 2005).  
 
The most widely accepted theory describing the underlying mechanisms of cortical folding is the 
VanEssen (1997) tension-based theory of gyral morphogenesis. Neurites exhibit a number of 
mechanical properties allowing them to adjust their length and maintain a steady tension. As 
immature neurites grow and extend they generate substantial mechanical tension (stress) and 
stretch to a length proportional to the tension exerted (Dennerll et al., 1988). When the tension is 
released then the neurite will shorten slightly while if stretched further it will become wavy like a 
rubber band. Elongation occurs when the tension overcomes a certain threshold whilst retraction 
occurs when the tension is released. During development the fetal brain undergoes significant 
changes in size and shape, at a time when neurons are establishing long-distance connections and 
must therefore continuously adjust their size. In order for the brain to form a rigid structural 
framework this tension is counterbalanced by hydrostatic pressure exerted by intrinsic pressure 
differential across the cellular plasma membrane (VanEssen, 1997). Cortical convolutions occur 
at specific spatial patterns. Previous studies have suggested that differential growth of cortical 
layers may explain cortical folding patterns however lesions in preterm infants affecting long-
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distance connections alter cortical folding (Dehay et al., 1996; Toro and Burnod, 2005). 
According to the tension-based theory, folding is tension mediated. Mechanical tension created 
by populations of white matter axons "pull" together the pliable cortical sheet. A gyrus is formed 
when the crease is directed towards the exterior and the length of the axons within the gyrus is 
reduced (VanEssen, 1997). Cortical regions that are strongly interconnected are pulled together 
forming a gyrus. When tension directs the crease towards the interior sulci are formed.  
 
However, neuroimaging data using diffusion tensor imaging (DTI) to visualise axonal fibre 
connections in humans, chimpanzees and macaque monkeys support an axonal "pushing" theory 
of cortical folding. The group of Nie et al., (2011) showed that fibre endings concentrate on gyral 
regions with 5.2 times higher axonal fibre density than in sulcal regions. In addition, gyral-gyral 
connections were highly dominant followed by gyral-sulcal. According to the axonal pushing 
theory, in early brain development thalamocortical, callosal and cortico-cortical axons grow 
guided by signalling molecules (O'Leary et al., 2007) and constantly "push" the cortical plate 
such that cortical layers expand in tangential directions. Mechanical constraint due to the fact 
that cortical area is almost three times larger than the cranial area causes cortical regions to fold 
inwards leading to the formation of sulci (Nie et al., 2010). 
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1.3 Aims and Hypothesis 
The main aim of this thesis is to investigate brain development and characterise the volumetric, 
maturational and micro-structural changes in the fetal and neonatal brain in the presence of 
isolated ventriculomegaly. We hypothesise that isolated fetal ventriculomegaly is a marker of 
altered brain development characterised by relative overgrowth and aberrant white matter 
development. 
 
Specific aims 
1. Establish whether there is evidence of relative overgrowth and/ or aberrant development 
in multiple intracranial structures in fetuses with ventriculomegaly and how these relate 
to ventricular volume.  
2. Design a detailed protocol for the evaluation of cortical development and establish 
whether ventriculomegaly is associated with delayed or abnormal cortical maturation. 
3. Assess differences in brain metabolite ratios between fetuses with isolated 
ventriculomegaly and normal fetuses. 
4. Assess white matter development in neonates with antenatally diagnosed 
ventriculomegaly.  
5. Assess the neurodevelopmental outcome of children with antenatal isolated 
ventriculomegaly at 1 and 2 years of age and correlate developmental scores with MR 
measurements. 
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1.4 Magnetic Resonance Imaging 
Magnetic resonance imaging is a non-invasive imaging technique that has been increasingly used 
for imaging the developing fetus due to its safety profile, high resolution and soft tissue contrast. 
MRI provides a unique opportunity to study in vivo brain development and provide additional 
information in clinical cases of congenital abnormalities. 
 
1.4.1 Physics of Magnetic Resonance Imaging 
1.4.1.1 Precession 
The most abundant atom in the human body is Hydrogen (
1
H) with a nucleus comprising of a 
single proton. The single positively charged hydrogen proton spins very fast around an axis 
producing a small magnetic field. 
 
Each hydrogen nucleus is spinning on a given axis and when there is no external magnetic field 
the nuclei are randomly orientated (Figure 16A). When an external magnetic field (B0) is applied 
though they align with the magnetic field parallel or anti-parallel (Figure 16B). Aligned protons 
also "wobble" around their axis. This type of movement is termed precession. During precession 
the axis of the spinning proton spins forming a cone shape. The frequency of the precession is 
proportional to the magnetic field strength and is defined by the Larmor equation: 
 
ω0 = γ Β0 
 
Where ω0   = Precessional or Larmor frequency (MHz) 
 γ    = Gyro magnetic Ratio (MHz/T) 
 Β0   = Magnetic field strength (T)  
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Figure 16. Precession 
(A) When no external magnetic field is applied, hydrogen atoms are randomly orientated. (B) When an external 
magnetic field B0 is applied the hydrogen atoms align parallel or anti-parallel with the magnetic field. During 
alignment the atoms spin around their own axis (precess). 
 
1.4.1.2 The Zeeman effect 
The two alignments (parallel or anti-parallel) are on different energy levels. Nuclei that align 
parallel to the magnetic field are in a low energy state and are termed spin up nuclei whilst nuclei 
that are aligned anti-parallel are in a high energy state and are termed spin down. This is the 
Zeeman effect. Nuclei are continually oscillating between the two states although the preferred 
state of alignment is the one that needs less energy. To favour a low energy state, there are more 
protons aligned parallel or low energy state than anti-parallel or high energy state. The excess 
amount of protons aligned parallel within a magnetic field are proportional to B0 and the total 
magnetic field for the excess protons is known as the net magnetisation vector or M0. Therefore 
the larger the B0 the greater the difference in energy levels and the greater the excess number of 
protons aligned parallel to the magnetic field. The net magnetisation vector is in a direction 
along/longitudinal to the external magnetic field therefore it is called longitudinal magnetisation. 
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1.4.1.3 Excitation 
A radiofrequency (RF) pulse is applied and the protons absorb that energy and resonate moving 
to a higher energy state. The frequency of the RF pulse is equal to the Larmor frequency in order 
to excite the protons (resonance). The addition of this RF pulse is termed excitation and it leads 
to an increase in the number of nuclei in the high energy state. This results in the movement of 
the net magnetisation vector out of alignment from the B0 and pointing in the direction which the 
precessing protons point (transverse magnetisation). The angle to which this occurs is termed the 
flip angle and its amplitude depends on the amplitude of the radio-frequency pulse, normally 90°
. 
 
1.4.1.4 Signal detection 
The constant changing in the magnetic vector induces an electric current which is the MRI signal 
detected by an antenna. After the application of the radiofrequency pulse, the hydrogen protons 
lose the energy they absorbed and return from a high energy state to their lower energy state, 
realigning with B0. The established transverse magnetisation starts to disappear (transverse 
relaxation) while the longitudinal magnetisation increases to the original state (longitudinal 
relaxation). The net magnetisation vector realigns with B0 and some of the absorbed 
radiofrequency energy is being retransmitted to the surroundings. Part of the energy induces an 
increase in temperature of the surrounding tissue referred to as lattice. The process in which the 
excited protons release the absorbed energy back into the surrounding lattice and re-establishing 
the thermal equilibrium is known as T1 Relaxation or longitudinal relaxation. The time course 
whereby the system returns to equilibrium is described by an exponential curve. As protons 
move together, their magnetic field begins to interact (spin-spin interaction). The temporary and 
random interaction between 2 spins leads to a loss of phase and a loss of signal known as T2 
Relaxation or transverse relaxation. The signal decay due to T2 relaxation is denoted by an 
exponential curve. The image is not generated directly from the signal received. The signal is 
encoded in an intermediate form, the k-space. The data in k-space are transformed into the final 
image using Fourier transformation. 
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1.4.1.5 Pulse Timing Parameters 
The RF pulses can be described using pulse sequences, indicating frequency and repetition. The 
time between each pulse is termed as the repetition time (TR). Echo time (TE) is the time 
between the peak of the 90° RF pulse to the peak of the signal induced in the coil or how long 
the magnetisation remains in the transverse plane before being refocused. Images with different 
contrasts are produced by altering the TE and by choosing the appropriate repetition time. In 
certain tissues the transverse magnetisation may decay faster compared to other regions. When 
the signal is delayed then less signal is detected from this region which therefore appears darker.  
 
1.4.2 MR safety 
MRI is considered a safe imaging modality for assessing the developing fetus and currently there 
is no evidence suggesting a harmful effect to the mother or the fetus. Guidelines are given by the 
National Radiological Protection Board (NRPB) (1991), the International Non-Ionizing 
Radiation Committee of the International Radiation Protection Association (ICNIRP) and the 
National Radiological Protection Board (NRPB). Establishing the risk from MRI to the fetus is 
complex as there is variation of magnet field strengths, gradient strengths and RF pulse 
sequences used but most importantly we do not understand what reaches the fetus and what the 
effect is at the different gestational ages. Current guidelines recommend that MRI is avoided 
during the first trimester except in cases with compelling maternal reasons. 
 
1.4.2.1 Animal studies  
Animal research regarding MR safety during pregnancy has been reported in numerous studies. 
Heinrichs et al., (1988) exposed pregnant mice in a 0.35T MR scanner at mid-gestation and 
found no gross effects but found some evidence of reduced crown-rump length. The study by 
Yip et al., (1994b) investigated exposure of chick embryos to 1.5T magnet for 6 hours at 
different developmental time points and observed an increase in abnormalities and mortality after 
birth. In a further study by the same group looking at effects at the molecular level, there was no 
difference in cell proliferation, migration or axonal outgrowth (Yip et al., 1994a; Yip et al., 
1994b). Exposure of pregnant mice to 4T MRI did not show any alteration in fetal or postnatal 
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growth after long term exposure (9 hours) during day 9 (neural tube growth) and day 12 
(reproductive system development) (Magin et al., 2000). 
  
1.4.2.2 Human studies  
Myers et al. (1998) compared fetal growth in a group of 74 normal fetuses (recruited as healthy 
volunteers) exposed to 0.5T MRI and a control group of 148 fetuses that did not undergo fetal 
MRI. There was no difference in fetal growth between the groups. Three studies (Michel et al., 
2002; Poutamo et al., 1998; Vadeyar et al., 2000) have monitored fetal heart rate during MRI and 
did not detect any variance in heart rate during the scan.  
 
1.4.2.3 Static Magnetic Field 
Review of the literature on the safety of strong static magnetic field suggests there is no firm or 
established evidence of any adverse effect on human health (Schenck, 2000). Studies on cell 
cultures exposed to a static magnetic field ranging from 0.49T to 8T showed no effect on cell 
viability, growth or ability to differentiate (Kula and Drozdz, 1996; Sato et al., 1992; Ueno et al., 
1994). Mevissen et al. (1994) exposed pregnant rats to a static magnetic field of 30mT 
throughout their gestation and reported increased risk of fetal loss. Additional studies exposing 
embryos from different species at a static magnetic field early in gestation have shown evidence 
of altered early embryonic development with duration of exposure being a significant factor. A 
large study on human pregnant MRI workers revealed no significant association between 
fertility, length of gestation, birthweight, pregnancy outcome and offspring gender with working 
with MRI (Kanal et al., 1993). 
 
1.4.2.4 Time-varying magnetic gradient fields 
The concerns for the fetus regarding the pulsed electromagnetic gradient fields are biological and 
acoustic noise. In terms of biological effects, it has been questioned whether low frequency 
electromagnetic fields are associated with an increased risk of spontaneous abortion (Li et al., 
2002). However in vitro and in vivo animal and human studies have revealed no measurable 
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effects (De Wilde et al., 2005). More studies are needed to establish whether there is any effect 
from time-varying gradients used in MRI. A major concern has been acoustic noise which is 
produced by the rapid switching of the currents within the gradient coils in the presence of a 
strong magnetic field. This leads to the generation of Lorentz forces which make the coils vibrate 
and produce the characteristic knocking noise. Acoustic noise and the effect on the fetus has 
been of great concern to the MRI community as the mother's hearing is protected with 
headphones and it is unclear how much sound is attenuated as it passes though the abdomen and 
amniotic fluid to the fetus. Studies however have been inconclusive. The levels of acoustic noise 
measured during a MR examination are high and range from 80 to 120dB with a 30dB 
attenuation for the fetus (Glover et al., 1995; Price et al., 2001). However transition of sound in-
utero occurs in a complex way with sound being attenuated and frequency being increased 
(Lecanuet et al., 1998). A report for the American Academy of Paediatric concluded that there 
was evidence of high frequency hearing loss, reduced gestation length and a decrease in birth 
weight in exposure over 90dB (Etzel et al., 1997). However, Reeves et al. (2010) assessed the 
cochlear function of 96 neonates that had undergone fetal MRI and did not show an increase in 
hearing impairment. In the study by Kok et al. (2004) 41 children that had undergone fetal MRI 
(1.5T) during the third trimester were followed up between 1 and 3 years and no harmful effects 
on neurodevelopment related to antenatal MRI were observed. More research is required to 
ascertain the effect of acoustic noise on the developing fetus. 
 
1.4.2.5 RF pulse and heating 
The risk associated with RF energy is an increase in maternal and subsequently fetal 
temperature. An elevation in temperature can be hazardous for the developing fetus (Edwards et 
al., 2003). A raised temperature may occur in humans through fever or other forms of heating. 
Although a specific temperature threshold has not been established it is accepted that a 
temperature rise of 2-2.5 °C in humans above the normal body temperature for over 24 hours 
may have an adverse effect on the developing fetus including abortion, growth restriction and 
developmental defect (Chambers et al., 1998; Edwards et al., 2003; Kline et al., 1985). The stage 
of gestation in human studies has been broad. Abnormalities are induced as elevated 
temperatures can affect cell proliferation, migration, differentiation and normal developmental 
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apoptosis. The nature of defect is dependent on the elevation, the duration of increased 
temperature and the developmental stage when this occurred. The sensitivity of the fetus to heat 
varies and depends on the state of development with various "windows" during fetal life where 
the risk is high and the fetus is especially vulnerable (Edwards et al., 1995). Sensitivity of 
different organs to heat is dependent on the stage of development with the susceptibility period 
being just before and after the commencement of cell proliferation. Therefore fetal organs are 
most susceptible while they are forming and are relatively resistant to heat once they have 
formed making the brain most sensitive during the embryonic and mid gestation period. The 
fetus has no homeostatic mechanisms to control its own temperature and is therefore dependent 
on regulation by the maternal temperature and placental blood flow. The fetus has a temperature 
of  +0.5 °C above the maternal temperature (Schroder and Power, 1997). Manufactures design 
MRI systems in accordance to an international standard  (IEC_60601-2-33, 2002) and must 
establish the specific absorption rates (SAR) for each pulse sequence conforming to guidelines. 
The ICNIRP guidelines (2004)
  
state: 'It seems reasonable to assume that adverse developmental 
effects will be avoided with a margin of safety if the body temperature of pregnant women does 
not rise by more than 0.5 °C and the temperature of the fetus is less than 38 °C’. In a study by 
Hand et al. (2010) a mathematical model was used to estimate the regional heat absorption 
during fetal scanning in both 1.5T and 3T and showed that maximum heat absorption was in the 
mother and levels in the fetus appeared safe. 
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1.4.3 Imaging the fetus using ultrasound and MRI 
Since the first application of MRI to study the fetal brain in 1983 (Smith et al., 1983), its clinical 
use has increased dramatically and significant progress and great advances have been made in 
the acquisition and post-processing of images (Figure 17). 
 
Figure 17. Fetal MR imaging through the years 
(A) T1 -weighted MR image of a 32 week old fetus performed in 1984 (b:brain, image reproduced from Smith et al. 
(1984), (B) T2-weighted MR image of a 30
+5
 weeks old fetus performed in 2012. 
 
However it wasn't until the early 1990s that fetal MRI was revolutionised with the development 
of the single-shot rapid acquisition sequence during which each slice is acquired in less than a 
second providing good quality images in the presence of fetal motion.  
MRI is an excellent complimentary imaging modality to ultrasound and is used when 
confirmation or additional information is requested for a diagnosed or suspected abnormality or 
in pathological cases where brain changes may not be detectable by ultrasound. MRI has a large 
field of view allowing visualisation of the whole uterus and fetal body and is not limited by fetal 
position. Great soft tissue contrast renders it excellent for visualising the different intracranial 
structures whilst image quality is not largely affected by the presence of excessive adipose tissue. 
Visualisation is also not affected in clinical conditions with low volume of amniotic fluid 
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(oligohydramnios). It also provides good visualisation of the posterior fossa an area difficult to 
visualise on ultrasound after 33 weeks, allows direct visualisation of both sides of the fetal brain 
and is an excellent modality for visualisation and assessment of cortical folding (Coakley et al., 
2004; Glenn, 2006). However MRI is expensive and time-consuming. Maternal claustrophobia 
and discomfort during the scan are common complaints compared to ultrasonography whilst the 
small diameter of the bore may not allow imaging of patients with a high BMI. In addition, MRI 
is contraindicated in patients that have ferrous metal inside their body. Fetal motion affecting 
image acquisition and degrading quality has been a major limitation however this can be 
overcome with more recent advances in image acquisition and post-processing techniques (Jiang 
et al., 2007). Lastly, ultrasound may be superior to MRI for visualisation of some cysts and for 
calcification.  
 
1.4.4 Fetal CNS assessment 
T2-weighted images are the mainstay in antenatal MRI to assess normal and pathological brain 
anatomy as they provide excellent delineation between fluid and tissue. The fetal brain is 
assessed for the presence of structural abnormalities on T2-weighted single shot fast spin echo 
(ssFSE) sequences obtained in transverse, coronal and sagittal planes. ssFSE sequences are used 
as they provide good quality images even in the presence of fetal motion due to the fast 
acquisition time of each slice. The T2 time of fat is shorter compared to water, therefore the 
transverse component of magnetisation of fat decays faster and the magnitude of transverse 
magnetisation of fat is small while the magnitude of transverse magnetization in water is large. 
Consequently, water has a high signal and appears bright while fat has a low signal and appears 
dark on T2-weighted images. CSF fluid around the brain provides excellent contrast of the 
cerebral surface and developing gyration. 
 
1.4.4.1 Fetal brain volumetry 
Fetal MRI studies have successfully measured brain parenchyma and volumes of intracranial 
structures across gestational age in order to establish normative growth trajectories (Clouchoux 
et al., 2011; Corbett-Detig et al., 2011; Gong, 1998; Grossman et al., 2006; Hu et al., 2009; 
Limperopoulos et al., 2010; Rajagopalan et al., 2011a; Scott et al., 2011). However the majority 
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of studies have produced brain volumes using non-reconstructed data, sensitive to fetal motion 
(Clouchoux et al., 2011; Gong, 1998; Grossman et al., 2006; Hu et al., 2009). Critical limitations 
of fetal brain MRI include fetal and maternal motion, which lead to incomplete brain volumes, 
creation of artefacts and degraded image quality. Measurement errors may occur due to thick 
slice acquisitions and inter-slice motion induced differences in out-of-plane views. Maternal 
sedation is used in some centres outside the UK to minimise maternal and fetal motion however 
motion still exists due to diaphragmatic movement from maternal breathing. These data would be 
inappropriate for reliable quantification of the developing intracranial structures and comparison 
with high-risk groups or normal controls as they may not be accurate enough for ascertaining 
small but significant differences between groups. As described later, to overcome this issue in 
the current project we have used the Snapshot MRI with Volume Reconstruction (SVR) 
technique (Jiang et al., 2007), developed in our department, which provides image datasets of 
high resolution, high signal-to-noise ratio and full brain coverage essential for reliable 
volumetric analysis (Figure 18). 
 
Figure 18. Example of fetal dataset before and after reconstruction 
Before reconstruction (T2-weighted image prior to reconstruction) slices are corrupted due to fetal motion with lines 
of low signal intensity representing missing data while after registration of multiple acquisitions and reconstruction 
(3D reconstructed brain) there is no missing data and image quality has improved. 
T2-weighted image prior to reconstruction   
3D reconstructed brain 
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Segmentation of brain structures may be performed manually or using automated software.  
Manual segmentation of brain structures involves the examiner tracing around the structure of 
interest on each slice delineating the region of interest. The delineated area is multiplied by the 
voxel thickness to produce volumetric values. Whilst manual segmentation provides accurate 
data and is considered the 'gold standard' it is time-consuming and a laborious method of 
volumetric analysis thus impeding the analysis of large amount of data. While automatic 
methods have been successfully used for segmentation of intracranial structures, fetal brain 
volumetry is a new field that has emerged in the past decade with a number of studies developing 
automated methods for quantifying the fetal brain (Gholipour et al., 2011; Gong, 1998; Scott et 
al., 2011). Automatic techniques may be intensity-based, driven by differences in signal intensity 
between brain structures. However, reliable automatic segmentation in the fetal brain is hindered 
by the low contrast between the different brain structures because of image degradation due to 
fetal motion, increased water content throughout the cerebrum and presence of unmyelinated 
white matter. Whilst the contrast between CSF and cortical gray matter is adequate for 
delineation between the two, the gray matter/white matter boundary may not be easy to 
distinguish and mislabelling due to partial volume may result in incorrect tissue classifications. 
Another approach is the atlas-based approach. This relies on the construction of a probabilistic 
atlas generated from manually segmented brains at the age of interest. Any new case can be 
aligned on the constructed atlas to generate structural segmentations based on established 
algorithms using prior knowledge (Aljabar et al., 2009; Gousias et al., 2008; Kuklisova-
Murgasova et al., 2011). 
 
1.4.4.2 Methods for assessing cortical folding 
Folding of the cerebral cortex during development follows a highly orchestrated sequence of 
gyral and sulcal formation. A number of studies have attempted to quantify the maturation of the 
cerebral cortex using different techniques. The majority of studies use an observational approach 
for the study of cortical maturation. This approach generates a timeline of appearance of 
different cortical landmarks and has been performed on post-mortem and MR studies (Afif et al., 
2007), on fetuses (Garel et al., 2003a; Levine and Barnes, 1999; Toi et al., 2004) and neonates 
(Childs et al., 2001; van der Knaap et al., 1996). The gyrification index which is an overall 
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measurement of cortical maturation has also been used in previous studies, and calculated as the 
ratio of whole gyral contour length to their outer exposed surface (Armstrong et al., 1995; Kesler 
et al., 2006; Zilles et al., 1988). Recent advances in post-processing techniques have also allowed 
for the use of computational methods with the use of algorithms for the delineation of the sulcal 
patterns during development (Clouchoux et al., 2012; Mangin et al., 2004; Scott et al., 2011). 
 
1.4.4.3 
1
H magnetic resonance spectroscopy 
In addition to structural data, advances in MR techniques allow us to assess the function of the 
developing brain using 
1
H magnetic resonance spectroscopy (
1
HMRS). 
1
HMRS has been 
commonly used to assess the neonatal brain and less frequently the fetal brain. It provides data in 
the output form of a chemical spectrum of metabolites. It can assess the metabolic profile of 
different brain tissue by measuring small molecular weight amino acids, carbohydrates, fatty 
acids and lipids. This technique was used to assess and compare the metabolic profile of normal 
fetuses and those with isolated ventriculomegaly. The frequency at which a proton generates a 
signal depends on the tissue in which it is incorporated therefore the metabolic fingerprint of a 
tissue varies according to the brain region studied and can be altered in structural damage, 
biochemical and genetic conditions. This is known as chemical shift and is expressed in terms of 
parts per million (ppm) (Gilles and Nelson, 2012).  
 
As mentioned previously, the MR signal to create anatomical images is generated by the 
1
H 
protons in water. In 
1
HMRS, the signal is generated by the protons attached to other molecules 
and is visualised as a spectrum of peaks at different radiofrequencies representing protons in 
different chemical environments. Therefore the chemical shift provides information regarding 
the molecular group containing the hydrogen atoms. The RF pulses used in 
1
HMRS are known as 
'pulse Fourier transform spectroscopy'. The signal is recorded as a function of voltage against 
time, which for a single RF pulse is denoted as the free induction decay (FID). The FID is 
analysed using the Fourier transformation mathematical process to produce a spectrum with the 
constituent frequencies.  
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Although the area under the peak is proportional to the number of protons producing the signal 
there are additional factors that influence the MR signal such as relaxation time, coupling of the 
sample to the coil, pulse sequence used and acquisition method. Therefore absolute 
concentrations cannot be established without controlling all confounding factors. Consequently, 
relative concentrations of metabolite ratios are often used for quantification and are more robust 
than absolute quantification. These are expressed as ratios to a peak with a known concentration 
or to a stable metabolite in the spectrum. A limitation is the certainty that a metabolite is stable 
particularly in the developing or injured brain.  Metabolites that are mobile and not incorporated 
into cell membranes or myelin can be measured with 
1
HMRS.  
 
Peaks in the spectra represent different metabolites and are identified by their frequency in parts 
per million (ppm) relative to a standard. The area below the peak represents the metabolite 
concentration in a given voxel. The height and width of the peaks is also influenced by the spin 
lattice and spin-spin relaxation and the exponential decay times. Mobile molecules generate 
narrow peaks while molecules attached to other structures produce short and broad resonances. 
Metabolites that have been successfully measured in the fetus are myo-inositol (MI), choline 
(Cho), creatine (Cr), N-acetylaspartate (NAA), lactate (Lac) (Figure 19). 
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Figure 19. 
1
HMRS fetal spectrum 
1
HMRS spectrum from a normal control 24
+6
 weeks old fetus. The resonance peaks for myo-inositol (3.5 ppm), 
choline (3.2 ppm), creatine (3 ppm), NAA (2 ppm), lactate (1.3 ppm, bifid inverted peak) are indicated. 
 
1.4.4.3.1 N-acetylaspartate 
The NAA signal is detected at 2.0ppm and reflects both NAA and NAAG. In the normal brain 
NAA is synthesised in neuronal mitochondria from acetyl-CoA and N-acetyltransferase. It then 
diffuses along axons and is transferred to oligodendrocytes (Ariyannur et al., 2008; Gilles and 
Nelson, 2012; Moffett et al., 2007; Patel and Clark, 1979) where it is used for myelin and protein 
synthesis and energy production. NAA increases as the brain matures (Brighina et al., 2009). 
NAA is clinically important as a reduction may indicate altered mitochondrial function or 
neuronal/axonal damage or loss (Gilles and Nelson, 2012; Roelants-van Rijn et al., 2004). 
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1.4.4.3.2 Creatine 
Creatine peak is detected at 3.0ppm and reflects both creatine and phosphocreatine. These 
molecules are in rapid chemical exchange in order to replenish ATP levels and are involved in 
energy metabolism. Cell cultures indicate that creatine is concentrated in astrocytes and 
oligodendrocytes (Urenjak et al., 1993). In autopsy studies in preterm and term infants creatine 
concentrations have shown regional variation with higher levels measured in the basal ganglia 
and thalami (Brighina et al., 2009; Huppi et al., 1995). It is probably required  for energy 
production during myelination as the basal ganglia and thalami are highly metabolically active 
during myelination (Hegde et al., 2011). During gestation creatine is assumed to be relatively 
stable within a specific brain region and has been used by previous studies as a reference 
metabolite (Kok et al., 2002; Story et al., 2011a; Story et al., 2011b). 
 
1.4.4.3.3 Choline 
Choline is a complex peak comprised of several Cho-containing metabolites and detected at 
3.2ppm. This peak is representative of only 10% of the choline present in a tissue as the majority 
of choline is incorporated in substances such as myelin and is not detectable using 
1
HMRS. Cho-
compounds are involved in the synthesis and breakdown of phospholipids and therefore cell 
membrane formation. It is found in high levels in glial cells but is also involved in acetylcholine 
synthesis therefore in neuronal uptake (Katz-Brull et al., 2002). Choline is of interest in tumour 
spectroscopy as cancer cells have abnormal membrane metabolism and abnormal choline. 
During normal development choline levels have been shown to decrease with progressive 
myelination due to the high levels of substrate needed for the formation of cell membranes 
(Girard et al., 2006a; Kok et al., 2002; Story et al., 2011b). 
 
1.4.4.3.4 Myo-inositol 
Myo-inositol is detected at 3.5ppm and is a pentose sugar synthesised from glucose-6-phosphate. 
It is an essential constituent of living cells and is involved in maintaining osmolyte homeostasis 
via the sodium/myo-inositol transporter (Brighina et al., 2009). It is important for neuronal 
plasticity and regulation of cell growth and is found in high concentrations in the CNS. While 
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initially thought that inositol was predominantly localised in glia and was an astrocyte marker, 
higher concentrations have also been found in neuronal populations (Novak et al., 1999). In 
adults an increase in MI is seen in gliomas and multiple sclerosis reactional gliosis whilst 
reduced levels are present in herpetic encephalitis. MI is also increased after acute perinatal brain 
injury due to an increase of osmolytes after hypoxia-ischaemia and in chronic cases of perinatal 
white matter injury in preterms (Robertson et al., 2000; Robertson et al., 2001). 
 
1.4.4.3.5 Lactate 
Lactate is detected at 1.33ppm and is not detected in the normal adult brain. It is a product of 
anaerobic glycolysis and increased levels have been detected in human neonates after a hypoxic 
insult, the higher the levels the worse the neurological outcome (Roelants-Van Rijn et al., 2001). 
However, animal studies have shown that the developing brain, in contrast to the adult brain, has 
the ability to metabolise lactate (Hernandez et al., 1980). Studies suggest a role for lactate as a 
fuel source in the developing brain and low levels have been detected in preterm infants and in 
term newborns with a normal brain appearance. These levels subsequently decrease (Cady et al., 
1996; Tabernero et al., 1996; Tyson et al., 2003). 
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1.4.5 Imaging the neonate 
MR imaging although a relatively new technique has been extensively used to visualise the 
neonatal brain and allows clinicians to assess normal development, to detect lesions and to 
predict outcome. Advances in imaging techniques extend the role of MR imaging beyond visual 
confirmation of normality and pathology and allow for objective volumetric measurement of 
intracranial structures, measurement of specific MR properties such as T1 and T2 and diffusion 
coefficients, quantification of white matter tract properties, quantification of metabolites and 
functional information (Arichi, 2012; Ball et al., 2010; Malamateniou et al., 2012; Ramenghi et 
al., 2009; Rutherford et al., 2010; Rutherford, 2002b; Varela et al., 2012; Xue et al., 2007). The 
purpose of this study extends beyond understanding brain development during fetal life. In a 
cohort of fetuses brain development was assessed during the neonatal period using volumetric 
analysis to assess intracranial volumetric changes after birth and also DTI to assess the 
microstructure of white matter tracts. 
 
1.4.5.1 Diffusion Tensor Imaging 
Diffusion Tensor Imaging has been extensively used in the neonatal and adult brain to provide 
information regarding tissue microstructure by quantifying the 3D micromovements of water 
molecules and providing voxelwise, scalar measures of water diffusion in different brain tissue. 
In CSF, the movement of water is isotropic, meaning that it is equivalent in all directions as 
water diffuses freely. In white matter water movement is strongly anisotropic (directional) with 
the majority of diffusion occurring parallel to the direction of the white matter tracts. Water 
motion is restricted along the axis of the tracts due to the structured and coherent formation and 
myelination of white matter bundles. Two basic properties are measured using the overall 
amount of water diffusion and the directionality (anisotropy) of diffusion. These properties are 
measured at each voxel. Therefore, DTI can indirectly identify and characterise white matter 
pathways and provide information regarding brain connectivity.  
 
In addition to providing information on white matter fibre tracking it can assess tissue 
microstructure and maturation status of different brain regions. Anisotropic diffusion is an effect 
of the tissue microstructure and changes in anisotropy can reflect changes in tissue 
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microstructure. High values of diffusion in white matter may indicate poorly developed, 
immature or structurally compromised white matter (Smith et al., 2006). 
 
1.4.5.1.1 Quantification 
A measure of the molecular diffusion of water is the apparent diffusion coefficient (ADC) which 
depicts all forms of water motion including diffusion, perfusion and flow. Therefore ADC 
represents intracellular, extracellular and intravascular diffusion environments. In white matter 
however, the motion of water is highly anisotropic and in order to depict the directions and 
degree of anisotropy it is necessary to consider diffusion as a tensor (3x3 matrix) (Nucifora et al., 
2007; Roberts and Schwartz, 2007). The tensor is described in terms of three coordinate axes 
with the main axis representing the preferred direction of diffusion (Figure 20). This eigenvector 
indicates the direction of greatest diffusion within a voxel. For convenience, diffusivity is 
represented in the form of a three-dimensional ellipsoid. Equal to all directions diffusion would 
be represented by a sphere. While the eigenvectors define the diffusion orientation of the 
ellipsoid, the eigenvalues (λ1, λ2, λ3) represent the degree of directional preference. The sum 
of the principle diffusivities is represented by the Fractional Anisotropy (FA) which is an index 
ranging from 0 (isotropic) to 1 (fully anisotropic). FA quantifies the strength of directionality of 
a tract structure. An example of an ADC and an FA map in a normal neonate is shown in Figure 
21. 
 
Figure 20. Diffusion ellipsoids 
Diffusivity is represented as a 3D ellipsoid. The eigenvalues (λ1, λ2,λ3) represent the degree of directional preference.  
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Figure 21. DTI Imaging: ADC and FA maps 
DTI of a normal neonatal brain (A) ADC map; bright areas indicate isotropic water diffusion while darker areas 
indicate restricted water diffusion. (B) FA map; bright areas indicate high FA values and increased directionality of 
water diffusion. 
 
Many studies of neonatal DTI have used regions of interest to obtain diffusion measurements 
directly from diffusion tensor images. However this approach is subjective and laborious and 
does not allow for comparison of large number of subjects. In addition, in order to analyse data 
from multiple subjects, FA images must be aligned in order to draw valid conclusion from the 
subsequent voxelwise analysis. These problems are addressed with the use of Tract-Based 
Spatial Statistics (TBSS), a powerful technique for analysis of DTI data that allows for multi-
subject analysis with increased sensitivity and reduced subjectivity (Smith et al., 2006). The 
TBSS protocol includes tuned nonlinear registration and projection into an alignment-invariant 
tract representation (mean FA skeleton) and is described in detail in chapter 2.4.3. TBSS is a 
reproducible and objective voxelwise assessment of the white matter allowing the detection of 
changes consistent across subjects while avoiding the bias of location selection. 
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2 Materials and Methods 
2.1 Ethics 
Ethical approval for the study entitled “Quantification of fetal brain growth and development 
using magnetic resonance imaging” was granted by the Hammersmith Hospital Ethics 
Committee (ethics No. 07/H0707/105) and written informed consent obtained from all 
participants. Fetuses were referred to our department from antenatal ultrasound departments in 
hospitals across London, in order to further assess brain development. The reasons for referral 
are summarised in Table 3. Healthy volunteers were recruited from the antenatal clinic in Queen 
Charlotte’s and Chelsea Hospital and through voluntary enrolment through patients and 
colleagues. As part of the research study all participants were offered neurodevelopmental follow 
up of their children. In summary, the follow up program included a brain scan and neurological 
examination during the neonatal period or at term equivalent after birth and a 
neurodevelopmental assessment at 1 and 2 years of age. 
 
Reasons for referral for performance of an MRI fetal scan 
Brain abnormality detected on ultrasound 
Non-CNS abnormality detected on ultrasound 
Maternal infection 
Previous sibling with CNS abnormality 
Complications during twin pregnancy 
Table 3. Reasons for referral for a fetal MRI scan 
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2.2 Study population  
2.2.1 Normal control cohort 
Normal control fetuses were carefully selected from the total cohort of fetuses referred to our 
department from women who were either healthy pregnant volunteers, who had had a previous 
child with a confirmed abnormality, or who had had a suspected fetal abnormality on ultrasound 
not detected on MRI. The inclusion criterion was normal brain appearance on fetal MR 
examination as established by an experienced neuroradiologist. The clinical MR examination 
consisted of evaluation of the extra-cerebral space, ventricular system, cortex, white matter, 
corpus callosum, basal ganglia and thalami, internal capsule, cerebellum and brainstem. A 
normal appearance on fetal MRI however may not exclude subtle brain changes or 
developmental delay later in childhood thus it was considered important to follow-up these 
children ensuring their later neuro-development was within the normal range.  Exclusion criteria 
for participation as a normal control were: poor MR image quality, delivery complications with 
abnormal neurological signs, birth-weight below the 3
rd
 centile, congenital malformations or 
infection, chromosomal abnormality, twin pregnancy, premature delivery (<36 weeks), abnormal 
clinical neonatal examination, abnormal findings on neonatal MR examination, and abnormal 
neurodevelopmental examination at either one or two years of age.  
 
2.2.2 Isolated ventriculomegaly cohort 
Fetuses presenting with ventricular dilatation on clinical antenatal ultrasound were referred to 
our department for further assessment of the developing brain. Fetuses diagnosed with isolated 
ventriculomegaly were included in the ventriculomegaly group. Exclusion criteria were: 
additional brain abnormalities, positive infection or chromosomal abnormality screening, 
maternal drug use, twin pregnancy, intra-utero growth restriction, birth-weight below the 3
rd
 
centile or poor image quality. Upon diagnosis of fetal ventriculomegaly all pregnant women 
were advised by their obstetrician to undertake a TORCH screening test performed on maternal 
blood. Amniocentesis was recommended to exclude the presence of chromosomal abnormalities 
and fetal infections. To ascertain a negative infection status all TORCH results were reviewed. 
To exclude genetic syndromes all delivery summaries were reviewed for any indication of 
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dysmorphic facial features or additional undiagnosed congenital malformations which could 
indicate an underlying genetic syndrome. Clinical notes were also collected during the neonatal 
MRI and neurological examination and during the assessments at year 1 and 2 were reviewed. 
Maternal drug use was checked through review of the maternal medical notes. Birth weight and 
delivery history was recorded as indicated on the delivery summary for each newborn. Intra-
utero growth restriction was defined as an estimated fetal weight below the 5th centile in 
association with ultrasound Doppler abnormalities (Damodaram et al., 2012). 
 
2.3 Fetal Imaging 
Expectant mothers were provided with an information sheet entailing the study information and 
details about the procedure prior to the scan date. Information sheets provided to patients and 
healthy volunteers are available in the Appendix 1 and 2. A video of the fetal MRI procedure for 
the parents has been produced in the department and is available online via the following link 
http://vimeo.com/37368763 Upon the day of examination, written informed consent was 
obtained from all participants and a detailed metal check questionnaire was completed to 
establish suitability for entering a strong magnetic field. Informed consent was obtained for a 
conventional clinical scan, acquisition, storage and use of research images, and permission to 
contact parents after delivery. Mothers were asked to lie in a lateral tilt to avoid compression of 
the inferior vena cava by the enlarged uterus which could lead to dizziness and loss of 
consciousness. A 32-channel coil was placed around the maternal abdomen and proximal to the 
fetal head. Scanning duration did not exceed 60 minutes; image acquisition was not continuous 
but was intermittent with small time frames of geometry setting of the next scan.  Core body 
temperature was measured prior to and after the scan using an electronic ear thermometer. After 
the scan, all parents were provided with a questionnaire regarding their experience for later 
completion (Appendix 3) 
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2.3.1 MR safety 
2.3.1.1 Temperature 
Although maternal temperature is not routinely measured in other imaging departments and there 
are no national guidelines regarding maternal core body temperature and fetal imaging 
procedures, we have established a set of local rules based on review of the current literature and 
experience. Temperature was recorded in all participants prior to and after the scan. In 
accordance to the IRCNIP guidelines (2004) described earlier we have set an upper threshold for 
maternal temperature of 37.5 °C (equivalent to a fetal temperature of 38 °C). Therefore if the 
recorded maternal temperature prior to the scan was equal or above 37.5 °C the scan was not 
performed and was rescheduled for another day. Hospital scrubs were provided to ensure metal 
free clothing was worn and to avoid any increase in temperature due to personal clothing. 
Traditional clothing such as burkas were removed. Air conditioning inside the bore of the 
magnet was turned on to provide additional cooling. Placement of hands on the abdomen was 
discouraged. Heat absorption by the fetus was reduced further by interchanging low and high 
SAR sequences in addition to having short breaks for geometry setting between sequences. 
Room temperature was set to 18 °C and periodically monitored. 
 
2.3.1.2 Noise  
Headphones were provided to protect maternal hearing, provide music during the scan and to 
communicate with the mother. 
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2.3.2 Imaging 
2.3.2.1 Data acquisition 
A full clinical assessment was performed using an optimised protocol of different sequences for 
assessment of brain anatomy as described below.  
 
Parameters T2dyn T2ssTSE SNAPIR T2* 
PRESS 
42 
PRESS 
136 
PRESS 
270 
TE (ms) 160 127 9.5 80 45 136 270 
TR (ms) 15000 1011 23000 3600 1500 1500 1500 
Flip angle (deg) 90 90 180 90 - - - 
Acquisition Voxel size (mm) 1.25x1.25x2.5 1.08x1.98x4 1.00x1.01x4 1.2x1.2x2 - - - 
Slice gap (mm) -1.25 0.4 0 -1.2 - - - 
Reconstructed voxel size 
(mm) 1.18x1.18x2.5 0.84x0.84x4 0.96x0.97x4 0.63x0.63x2 - - - 
FOV (mm) 320x340x95 430x352x114 320x340x88 400x400x65 - - - 
SAR (W/Kg) 1.7 2 1 0.4 0.4 0.4 0.4 
Table 4. Fetal imaging parameters 
Structural scans included T2dyn, T2ss and SNAPIR. T2* was used for improved visualisation of haemorrhage. 
Spectroscopy sequences at echo times 42ms, 136ms and 270ms included PRESS 42, PRESS 136 and PRESS 270.  
T2dyn: T2 T2-weighted dynamic Single Shot Turbo Spin Echo, T2ss: T2-weighted Single Shot Turbo Spin Echo, 
SNAPIR: T1-weighted Snapshot Inversion-Recovery T2*:T2*-weighted Gradient Echo, PRESS: Point Resolved 
Spectroscopy. 
 
2.3.2.1.1 T2-weighted Single Shot Turbo Spin Echo (ssTSE) 
A rapidly acquired sequence in which the brain parenchyma appears hypointense and CSF 
appears hyperintense (Figure 22). T2-weighted ssFSE sequences were acquired in the transverse, 
coronal and sagittal planes with the parameters detailed in Table 4. 
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Figure 22. T2-weighted Single Shot Turbo Spin Echo  
T2-weighted Single Shot Turbo Spin Echo sequences imaging a normal control 30
+5
 weeks old fetus in (A) sagittal 
(B) coronal and (C) transverse plane. 
 
2.3.2.1.2 T2-weighted dynamic Single Shot Turbo Spin Echo (ssTSE)  
This optimised sequence was designed in our department (Jiang et al., 2007) to overcome the 
issue of fetal motion and to enable the acquisition of complete datasets suitable for volumetric 
measurement (Figure 23). Multiple T2-weighted dynamic ssTSE overlapping slices (4 
transverse, 2 coronal and 2 sagittal acquisitions) were obtained using the parameters detailed in 
Table 4 which were later post-processed offline for the production of 3D datasets. 
 
Figure 23. T2-weighted dynamic Single Shot Turbo Spin 
T2-weighted dynamic Single Shot Turbo Spin sequences imaging a normal control 30
+5
 weeks old fetus in (A) 
sagittal (B) coronal (C) transverse plane. 
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2.3.2.1.3 T1-weighted Snapshot Inversion-Recovery 
Conventional T1-weighted image sequences are long and therefore subject to artefact, even when 
combined with a maternal breath hold. A T1-weighted Snapshot Inversion-Recovery (SNAPIR) 
sequence, designed in our department (Malamateniou et al., 2011) was acquired as described in 
Table 4. This single shot sequence allows for confirmation of the normal or abnormal anatomy 
and visualising haemorrhage, fat and myelination near term. In contrast to conventional T1-
weighted gradient echo sequences it is more robust to fetal motion thus providing better 
delineation of fetal brain anatomy (Figure 24).  
 
Figure 24. T1-weighted single shot Inversion-Recovery 
T1-weighted Inversion-Recovery sequence imaging a normal control 30
+5
 weeks old fetus in a sagittal plane.  
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2.3.2.1.4 T2*-weighted Gradient Echo 
T2* sequence is valuable for detecting hemosiderin present on iron molecules and visualising 
areas with haemorrhage. As illustrated in Figure 25 dark areas represent locations high in 
hemosiderin such as the germinal matrix, choroid plexus and internal cerebral veins.  
 
 
Figure 25. T2*-weighted Gradient Echo 
T2*-weighted Gradient Echo sequence imaging a normal control 34
+4
 weeks old fetus in a transverse plane. The 
great cerebral vein of Galen appears darker (arrowhead). 
 
2.3.2.1.5 Magnetic Resonance Spectroscopy 
1
H (echo times 42ms, 136ms, 270ms)  
1
HMRS data were obtained using a Point Resolved Spectroscopy (PRESS) sequence. A 
20x20x20mm voxel was placed centrally in the fetal brain sampling both white matter and gray 
matter. The positioning of the voxel is illustrated on Figure 26. Data were obtained at three 
different echo times of 42msec, 136msec and 270msec to allow for detection and quantification 
of different metabolites. Acquisition parameters are detailed in Table 4. A T2-weighted ssTSE 
sequence was obtained prior to the 
1
HMRS sequence in order to establish fetal positioning and 
place the region of interest. The region of interest was selected by the operator at the time of 
scanning. Data were acquired in averages of 4 resulting in the production of 32 individual spectra 
at each echo. Acquiring data in packages allowed for elimination of individual corrupted spectra 
while the remaining usable spectra were summed. Acquisition was performed using water 
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suppression due to the large size of the water peak that may distort the baseline and obstruct 
metabolite quantification.  
 
 
Figure 26. Voxel placement in fetal 
1
HMRS 
The voxel is placed centrally in the fetal brain sampling gray and white matter. 
 
2.3.2.2 Post-processing of data 
2.3.2.2.1 Clinical examination 
The imaging examination of all fetuses included coverage and subsequent assessment of white 
matter, basal ganglia and thalami, internal capsule, corpus callosum, extra-cerebral space, lateral 
ventricles, 3rd ventricle, 4rth ventricle, cavum septum pellucidum and vergae, orbits, cerebellum, 
vermis, brainstem, germinal matrix, cortex, biparietal diameter. An example of the clinical 
examination in a normal control fetus aged 30
+5 
weeks was performed as shown in Figure 27.  
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Figure 27. Fetal MRI clinical examination 
Fetal MRI clinical examination in a normal control fetus aged 30
+5 
weeks. 
 
   
2.3.2.2.2 Snapshot MRI with Volume Reconstruction (SVR) 
The SVR technique (Jiang et al., 2007), developed in our department, provides image datasets of 
high resolution, high signal-to-noise ratio, aligned to orthogonal planes and with full brain 
coverage essential for reliable volumetric analysis (Figure 27). During scanning the fetal brain is 
scanned very fast with each slice acquired in less than 1 second therefore ensuring that each slice 
is of good quality even if the fetus is moving (Figure 28). Rarely fetal movement is faster than 
slice acquisition. 
 
Figure 28. Fetal motion 
Example of a single fetal dataset acquired in a coronal plane. Before registration of multiple acquisitions and 
reconstruction, slices are corrupted due to fetal motion and missing data are shown as missing lines in transverse and 
sagittal planes. 
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Multiple scans in all three planes are performed with overlapping slices in order to oversample 
the fetal brain and ensure that each part of the brain has been sampled even with significant 
motion. Image registration is then undertaken where each brain scan is registered into a common 
coordinate space in order to align the acquired slices. This is performed under the assumption 
that the brain has undergone unknown motion but has not changed in shape or size. The final 
result is a 3D high resolution with high signal-to-noise volumetric dataset that can be viewed in 
any plane.  
 
The SVR protocol performed was the following: Eight T2 - weighted single shot Fast Spin Echo 
brain scans were acquired as described above (4 transverse, 2 coronal and 2 sagittal acquisitions) 
(Figure 29A). The files were converted from the DICOM format into a niftii format using the 
dcm2nii converter. The majority of maternal tissue was then removed from all 8 scans using 
ImageJ. Homogeneity of the image intensity values was calibrated (slope=1, intercept=0) to 
achieve uniformity thorough the images using mricroN. The scan with the least motion 
corruption and with full brain coverage was selected as a template and maternal tissue was 
removed in more detail from around the fetal skull using ImageJ. Using the best scan as a 
template the remaining 7 scans were manually transformed where they were spatially orientated 
and matched in close proximity to the template scan using Rview. All scans were then reviewed 
for image quality in every slice and the slices corrupted by motion artefacts where the anatomical 
detail had been lost were removed from the proceeding analysis. The 8 processed images and 
their transformations were entered into a script algorithm in Matlab (MathWorks, Natick, MA, 
USA) for registration and automatic reconstruction of the final 3D brain (Figure 29B).   
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Figure 29. Post-processing of MR images 
(A) Single loop of dynamic T2-ssFSE scan acquired in a coronal plane. (B) Reconstructed 3D brain. (C) 
Reconstructed 3D brain orientated in orthogonal planes. (D) Reconstructed orientated 3D brain resampled at a voxel 
size of 0.2x0.2x1 mm. (E) Reconstructed orientated 3D brain after removal of non-brain tissue. 
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2.3.2.2.2.1 Orientation 
The fetal reconstructed brain was oriented manually using Rview in the standard axial, coronal 
and sagittal projections in order to achieve high reproducibility and homogeneity between 
subjects (Figure 29C). Image orientation is important in volumetric segmentation in order to 
increase homogeneity between images and reduce the observer's error. 
 
2.3.2.2.2.2 Voxel size 
The voxel size of the final reconstructed brain (1.18x1.18x1.18 mm) was too large for visual 
analysis and accurate volumetric segmentation (especially of small structures) as analysis would 
be prone to errors due to partial volume. The voxel size of the oriented image was converted 
from 1.18x1.18x1.18 mm to 0.2x0.2x1 mm (Figure 29D). The specific voxel size was chosen as 
it provided high image resolution and a feasible number of slices (~100) for manual 
segmentation and editing. A visual comparison between 6 different voxel sizes was performed in 
order to select the appropriate voxel size for volumetric segmentation. The first factor 
determining the selection of the voxel size was image quality in a transverse plane so as to 
minimise pixelation and partial volume for an accurate delineation of each structure. The second 
factor was to minimise the number of slices as manual segmentation is a laborious and time 
consuming task. Evaluation of different voxel sizes is shown in Figure 30. Removal of any tissue 
or fluid surrounding the fetal skull was then performed using the BET extraction tool in fsl4 in a 
Linux workstation (Figure 29E). The latter step provided faster and more accurate volumetric 
segmentation. Voxel size modifications were performed using Rview. 
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Figure 30. Selection of voxel size for volumetric analysis 
(A) Voxel size 1.18x1.18x1.18mm, too pixelated for accurate volumetric analysis. (B) voxel size 0.5x0.5x0.5mm, 
slightly pixelated and large number of slices. (C) High resolution images in all planes, good for visual analysis, 
however slice number inappropriate for manual segmentation. (D) Good image quality in a transverse plane with 
sharp edges around the ventricular wall, appropriate slice number for manual segmentation.  
(slice number for each plane is shown and is important for the determination of the voxel size with a feasible slice 
number for manual segmentation). 
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2.3.2.3 Measurements of intracranial structures 
2.3.2.3.1 Linear measurements 
Linear measurements were made using ImageJ. Atrial diameter was measured according to 
International Society of Ultrasound in Obstetrics and Gynaecology guidelines (ISUOG, 2007) at 
the level of the atrium, perpendicular to the ventricular axis from each side of the ventricular 
wall (Figure 31A) (Horsch et al., 2009,Salomon et al., 2011). Cavum septum pellucidum width 
was measured in a transverse plane at its largest width (Figure 31B).  
 
 
Figure 31. Linear measurements 
Linear measurements included (A) atrial diameter (B) width of cavum septum pellucidum. 
 
2.3.2.3.2 Volumetric analysis 
2.3.2.3.2.1 Semi-automatic segmentation 
Volumetric segmentation of intracranial structures was performed in a semi-automatic fashion 
using ITK-SNAP (Yushkevich et al., 2006). ITK-SNAP is a user supervised imaging software 
that allows for manual or the design of semi-automatic segmentation of medical images in three 
orthogonal planes simultaneously. As manual segmentation is a laborious and time-consuming 
task, effort was concentrated on optimising a semi-automatic technique for volumetric analysis 
through ITK-SNAP. Although ITK-SNAP is designed for adult MR images with high resolution 
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and well defined borders of the different brain structures, it can be optimised for fetal scans with 
high signal-to-noise and clear structural boundaries. Using a methodology called "region 
competition", the image intensities were thresholded and classified into background and 
foreground (region of interest). A range of intensities can be classified as a region of interest and 
this assignment is based on the user’s specifications by visually assessing the image and 
manually setting the threshold. Regions of interest were filled using the "snake evolution" 
methodology where a snake refers to a closed curve representing a segmentation that evolves 
from a very rough estimate of the region of interest to a very close approximation of the 
structure. Snake evolution is governed by the velocity at every point of the snake which in turn 
depends on the shape of the snake at any given time and the intensities of the neighbouring 
pixels. The software allows the user to set upper and lower intensity thresholds, initialise the 
snake using spherical bubbles, set the velocities driving snake evolution and follow the process 
in real-time thus allowing for greater control over volume segmentation compared to automatic 
segmentation techniques. After completion of the automatic process, editing of the segmentation 
was performed manually using a drawing tablet (Intuos4, Wacom, Germany) in order to remove 
incorrectly filled areas and fill in areas were blurring did not allow for accurate thresholding. 
CSF containing structures provide clear intensity contrast at their borders make it ideal for a 
semi-automatic segmentation using ITK-SNAP. However structures such as the basal ganglia, 
thalami and cortex had to be segmented manually to achieve accurate delineation of their 
borders. Separation of the brain hemispheres was also performed manually. 
 
2.3.2.3.2.2 Segmentation of intracranial structures  
2.3.2.3.2.2.1 Lateral ventricles  
Volume included the lateral ventricles and choroid plexuses and excluded the third and fourth 
ventricles and cavum septum pellucidum and vergae. The lateral ventricles and cavum septum 
pellucidum and vergae were separated by the septal leaves (Figure 32). 
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Figure 32. Volumetric segmentation of the lateral ventricles 
 
2.3.2.3.2.2.2 Third ventricle 
The third ventricle segmentation was bounded by the cerebrospinal fluid present between the 
membranous floor of the subthalamic level inferiorly, and the cavum septum pellucidum 
superiorly. While the anterior and posterior commissures defined the longitudinal aspects of the 
third ventricle, the thalamic hemispheres outlined the lateral borders. When present, the massa 
intermedia was excluded from the third ventricle segmentation. Ventricular segmentations were 
confirmed on sagittal slices (Figure 33). 
 
 
Figure 33. Volumetric segmentation of the third ventricle 
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2.3.2.3.2.2.3 Fourth ventricle 
Omitting the cerebral aqueduct superiorly, the segmentation of the fourth ventricle began at the 
level of superior medullary velum and was halted at the obex inferiorly. On the transverse plane, 
the circumferential boundaries of the fourth ventricle were defined by the pons, cerebellar 
hemispheres and the vermis. Ventricular segmentations were confirmed on the sagittal plane 
(Figure 34). 
 
Figure 34. Volumetric segmentation of the fourth ventricle 
 
2.3.2.3.2.2.4 Extra-cerebral CSF 
Extra-cerebral CSF included all intracranial CSF space surrounding the supratentorial brain 
tissue and cerebellum and including the interhemispheric fissure space. CSF borders were 
outlined by the difference in intensity between the CSF and skull and CSF and cortex. The 
inferior boundary was defined by the differentiation of the cisterna magna (included) and spinal 
cord spinal canal. Intracranial veins were included in the segmentation (Figure 35).  
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Figure 35. Volumetric segmentation of extra-cerebral CSF 
 
2.3.2.3.2.2.5 Supratentorial brain tissue 
Brain tissue volume was defined as the supratentorial brain tissue excluding all intracerebral CSF 
spaces, choroid plexuses, brainstem, cerebellum and pons (Figure 36). Left and right brain 
hemispheres were assigned and separation was performed manually (Figure 37). Laterality was 
established by locating the fetal heart, stomach and liver in a whole fetal body scan in a coronal 
plane with knowledge from ultrasound of no situs inversus or dextrocardia. 
  
 
Figure 36. Volumetric segmentation of supratentorial brain tissue 
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Figure 37. Volumetric segmentation of supratentorial brain tissue (hemispheres) 
 
2.3.2.3.2.2.6 Cavum septum pellucidum  
Superiorly the segmentation was initiated with the appearance of the CSP distinguished by the 
contrast difference due to CSF content just below the body of the corpus callosum. Anteriorly it 
was defined by the genu of the corpus callosum whilst laterally it was delimited by the septal 
leaves separating it from the lateral ventricles. Posteriorly the cavum vergae was delineated by 
the appearance of the internal cerebral veins in a sagittal plane. Inferiorly the CSP was 
distinguished from the third ventricle on the last slice where the genu of the corpus callosum was 
visible (Figure 38). 
 
Figure 38. Volumetric segmentation of the cavum septum pellucidum 
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2.3.2.3.2.2.7 Basal Ganglia 
The substructures of the basal ganglia included in this segmentation were caudate, putamen, 
globus pallidus and nucleus accumbens (Figure 39). Most superiorly, the segmentation was 
initiated with the visualisation of the caudate head and/or body (depending on the gestational 
age) outlined between the internal capsule and the hypointense subventricular germinal matrix of 
the lateral ventricles. Positioned anteriorly across slices with a rounded shape, the caudate head 
was segmented using the clear contrast between the external capsule anterolaterally, the rather 
poor delineation of the anterior limb of the internal capsule posterolaterally, and the 
subventricular zone at the border of the lateral ventricles medially. While the external capsule of 
the insular gyrus defined the lateral borders of putamen, the internal capsule with its anterior and 
posterior limbs outlined the borders of both the putamen and the globus pallidus, giving rise to 
an overall triangular shape. Visible inferiorly to the caudate head, the nucleus accumbens was 
also segmented in a small number of slices using the borders of anterior limb of the internal 
capsule, the accumbent neuroepithelium and subventricular zone, and the preoptic and 
hypothalamic areas. The inferior cut-off point was defined as the slice with no distinction 
between the basal ganglia and the subthalamic/midbrain structures.  
 
Figure 39. Volumetric segmentation basal ganglia (yellow) and thalami (pink). 
 
2.3.2.3.2.2.8 Thalami 
The thalamic segmentation consisted of all the nuclei that were defined by the tissue contrast of 
the internal capsule laterally, the atrial region of the lateral ventricles posteriorly, the third 
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ventricle medially and the hypothalamus anteriorly (Figure 39). The most superior slice was 
segmented with the visualization of the separation between the caudate head, and the thalamic 
nuclei bulging towards the body of the lateral ventricles, whereas the most inferior border was 
defined by the appearance of the tectum, due to the poor tissue contrast against the subthalamic 
region. While the pointed pretectal areas at the posterior third ventricular and medial thalamic 
region were excluded, the massa intermedia, joining the two hemispheres of the thalamus in 
some cases, was included in the segmentation. 
 
2.3.2.3.2.2.9 Cortex 
Cerebral cortical gray matter was manually segmented in a transverse plane by tracing around 
the outer cortical border (CSF-cortex) and inner cerebral cortex (cortex-white matter) in all slices 
(Figure 40).  
 
 
Figure 40. Volumetric segmentation of the cortex 
 
After visual analysis of several normal control fetuses it was noted that specific cortical areas 
were not clearly visualised in all fetuses either due to image quality or because the limits 
surrounding developing structures at different gestations were unclear. In order to segment the 
cortex in a consistent way in all fetuses regardless of image quality and gestation and to avoid 
introducing error in "difficult areas" a detailed protocol was designed with rules defining 
uncertain cortical areas. 
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The cingulate gyrus was segmented up until the first convolution from the corpus callosum 
(Figure 41A). 
The cortical regions including all lower signal intensity areas surrounding the interhemispheric 
fissure were included in the segmentation (Figure 41B). 
The parieto-occipital sulcus was segmented up until the medial aspect of the hippocampus 
isthmus, not including the later (Figure 41C). 
The calcarine sulcus was segmented in its entirety, including deep convolutions present in 
advance GAs (Figure 41D). 
Cortical visualisation was compromised proximal to the inferior part of the frontal lobe due to 
partial volume of the frontal lobe and the eyes. The regions with obvious image blurring where 
excluded from the segmentation (Figure 41E-F). 
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Figure 41. Cortical segmentation protocol 
(A) The cingulate gyrus (arrow) was segmented up until the first convolution from the corpus callosum (arrow 
head). 
(B) Around the interhemispheric fissure, the cortex was segmented including all lower signal intensity areas close to 
the interhemispheric fissure (arrow). 
(C) The parietooccipital fissure (arrow) was included in the segmentation until medial border of the hippocampus 
isthmus (arrow head). 
(D) The entirety of the calcarine sulcus including deep convolutions (arrow) was included in the segmentation. 
(E) The cortex surrounding the inferior part of the frontal lobes was not included in the segmentation due to poor 
image quality due to partial volume. (F) Slice directly above (E) was included in the segmentation. 
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During the design of the protocol some cortical parts had to be excluded despite being visualised, 
therefore the segmented cortical volume may have introduced a small underestimation error in 
the measurement compared to the actual cortical volume. Designing a robust protocol that would 
provide consistent results regardless of image quality and gestation bias fulfilled the purpose of 
this study and we are aware that an underestimation error was introduced in all cortical 
measurements in both groups. 
 
2.3.2.3.2.3 Work done by others 
Volumetric segmentation of the basal ganglia, thalami, 3rd and 4th ventricles was performed by 
a colleague (DV). The design of the protocol for cortical volumetric segmentation was performed 
by me, however the manual segmentation was performed by a student I supervised (SE).  
 
2.3.2.3.2.4 Duration of volumetric segmentations 
The time required for segmentation of the different structures varied and were as following for 
one 28 week old fetus, total brain tissue and hemispheres (3 hours), cortex (8 hours), lateral 
ventricles (15 minutes), thalami (15 minutes), basal ganglia (30 minutes), cavum septum 
pellucidum and vergae (10 minutes). Factors determining segmentation duration included image 
quality, gestation and cortical complexity. 
 
2.3.2.3.3 Cortical development 
We wished to include both qualitative and quantitative analysis of the cortex, globally and 
regionally. Volumetric segmentation of the cortex can provide information about cortical size 
and growth trajectory through gestation however it cannot provide detailed information about 
cortical gyrification. A detailed protocol for evaluating cortical maturation was designed based 
on the cortical staging system by van der Knaap et al., (1996) which assessed the progress of 
cerebral gyration and sulcation in MR images of preterm and term neonates. In our study, the 
protocol designed assessed the development of the gyri and sulci during gestation by giving each 
one a score between 0 to 6 as illustrated in Figure 42. Sulci may receive a score from 0 to 6. Gyri 
may receive a score from 0 to 4 and 6. Gyri progress from score 4 directly to score 6 and do not 
receive a score of 5 due to their shape, the width does not equal 0 at any gestational age. 
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Figure 42. Cortical development scoring system 
Gyri and sulci are assigned a score from 0 to 6 according to their appearance at each gestational age. As an example the development of the central sulcus is 
shown. Sulci may receive a score from 0 to 6. Gyri may receive a score  from 0 to 4 and 6. Gyri progress from score 4 directly to score 6 and do not receive a 
score of 5 due to their shape as the width does not equal 0 at any GA. 
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The cortical maturation scoring system allows for the detection of delays in sulcation or 
gyrification. Whist all previous studies have visually assessed cortical maturation using the 
van der Knaap et al., (1996) scoring system, in the current project we have additionally 
measured the dimensions of the cortical landmarks in different planes. The scoring system 
can depict a delay in the development of the cortex but not a change in size or shape. 
Therefore a quantitative approach is essential for investigating changes in the size or shape 
of cortical landmarks. Furthermore, the size of each gyrus and sulcus was assessed by 
measuring the height and width at a specific plane. The major cortical landmarks from each 
brain lobe detected during gestation were selected for evaluation. These are presented in 
Table 5 and the measurements are shown in Figures 43-49. 
 
Frontal lobe Precentral gyrus 
Superior frontal gyrus 
Superior frontal sulcus 
Middle frontal gyrus 
Inferior frontal gyrus 
Inferior frontal sulcus 
Frontal/Parietal border Central sulcus 
Parietal lobe Postcentral gyrus 
Parieto-occipital fissure 
Temporal lobe Superior temporal gyrus 
Superior temporal sulcus 
Middle temporal gyrus 
Inferior temporal gyrus 
Frontal/parietal/temporal border Sylvian fissure 
Occipital lobe Calcarine sulcus 
Limbic lobe Cingulate sulcus 
Table 5. Cortical landmarks assessed 
Cortical landmarks selected were representative of each brain lobe.  
 
The factors for deciding which plane and slice to measure each landmark were as follows: 
the landmark was easily identifiable in a consistent way in all gestational ages and also 
evolved throughout gestation in accordance to the scoring system. Exceptions were the 
Sylvian fissure and cingulate gyrus which could not be assessed with this scoring system due 
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to their complex configuration, the assessment was individualised for each. Sylvian fissure 
development was assessed using the ratio of the maximum distance from frontal to temporal 
boundaries along the insula-temporal cortex to the minimum distance from frontal to 
temporal borders of the operculum (Figure 47). The cingulate sulcus was assessed by 
measuring the maximum distance of the sulcus in a sagittal plan. The detailed protocol is 
available in Appendix 5. 
 
 
Figure 43. Cortical landmarks of the frontal lobe 
Cortical landmarks of the frontal lobe included (A)(1) superior frontal gyrus (2) superior frontal sulcus (3) 
middle frontal gyrus (4) inferior frontal sulcus (5) inferior frontal gyrus (B) precentral gyrus. Measurements of 
cortical folding included height (blue) and width (red) of gyri and sulci. (Note areas of high signal intensity 
below the cortex constituting the subplate). 
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Figure 44. Cortical landmarks of the frontal/parietal border 
Cortical landmarks of the frontal/parietal border included the central sulcus. Measurements of cortical folding 
of the central sulcus included height (blue) and width (red). 
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Figure 45. Cortical landmarks of the temporal lobe 
Cortical landmarks of the temporal lobe included (1) superior temporal gyrus (2) superior temporal sulcus (3) 
middle temporal gyrus (4) inferior temporal gyrus. Measurements of cortical folding included height (blue) and 
width (red) of gyri and sulci. 
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Figure 46. Cortical landmarks of the parietal lobe 
Cortical landmarks of the parietal border included (A) the postcentral gyrus and (B) parieto-occipital fissure. 
Measurements of cortical folding of the cortical landmarks included height (blue) and width (red). 
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Figure 47. Cortical landmarks of the frontal/parietal/ temporal border 
Cortical landmarks of the frontal/parietal/temporal border included the Sylvian fissure. Sylvian fissure 
development was assessed using the ratio of (A) the maximum distance from frontal to temporal boundaries 
along the insula-temporal cortex to (B) the minimum distance from frontal to temporal borders of the 
operculum. 
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Figure 48. Cortical landmarks of the limbic lobe 
Cortical landmarks of the limbic lobe included the cingulate gryus. Cortical development of the cingulate 
sulcus was assessed using the length of the cingulate sulcus (green) on a sagittal plane. 
 
 
Figure 49. Cortical landmarks of the occipital lobe  
Cortical landmarks of the occipital lobe included the calcarine sulcus. Cortical development of the calcarine 
sulcus was assessed using (A) the length of the cingulate sulcus in a sagittal plane (green) and (B) the height 
(blue) and width (red) on a transverse plane. 
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2.3.2.3.3.1 Image pre-processing 
Consistency between images in terms of orientation was crucial for the assessment of the 
cortex and probably one of the most important steps in this process. As the measurements 
recorded were small the risk of introducing error due to improper orientation was high. All 
images previously orientated for volumetric analysis were re-checked visually and compared 
to each other in order to achieve homogeneity between the images in both groups. The voxel 
size was changed to 0.5x0.5x0.5 mm in order to achieve an isotropic voxel and achieve 
similar image quality in all planes and increase consistency in measurements. In order to 
ascertain consistency in all measurements each measurement was performed separately 
across all fetuses instead of evaluating all landmarks in each fetus in a single attempt. 
Laterality of the cerebral hemispheres was assigned according to the position of the fetal 
heart, stomach and liver as visualised in a T2-weighted MR image in a coronal plane with 
the knowledge from ultrasound of no situs inversus or dextrocardia. In the control group 
measurements were divided into left and right hemispheric sides whilst in the 
ventriculomegaly group according to the presence of the larger and smaller ventricle 
according to the atrial diameter. In bilateral cases the largest volume was used to depict the 
larger ventricle. The height and width was measured and recorded using ImageJ. All outliers 
were re-measured.  
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2.3.2.4 Spectroscopy 
2.3.2.4.1 Post-processing of 1HMRS spectra 
Analysis of 
1
HMRS spectra and quantification of metabolites was performed offline using 
jMRUI (www.mrui.uab.es/mrui/mrui_homePage.shtml, version 2.2), a widely used and 
freely available graphical user interface allowing for analysis of 1D spectra.  
 
2.3.2.4.2 Quality assessment 
An initial quality assessment of the acquired spectra was performed during scanning as the 
scanner software allows for immediate display of the data. In addition, the quality of 
individual spectra was assessed offline using jMRUI. Spectrum quality was evaluated 
according to the signal-to-noise ratio (height of metabolite peaks compared to background 
noise) and spectral resolution (peak width and differentiation between metabolites). Aberrant 
spectra indicative of fetal motion were removed and the remaining spectra were summed into 
a final spectrum. An example of a motion corrupted spectrum not available for analysis is 
presented in Figure 50. 
 
Figure 50. Motion corrupted fetal spectrum at echo time 136ms 
Spectra that have been corrupted due to fetal motion are identified by the absence of a water peak (water peak 
should be present at 4.7 ppm). 
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2.3.2.4.3 Noise reduction 
The signal of the metabolites in a FID is affected by the noise in the detector channels. A line 
broadening filter was applied which multiplies the signal by an exponentially decaying 
function leading to an increase in the signal-to-noise ratio but also broadening of the peaks 
(Drost et al., 2002). Noise reduction was followed by removal of the water peak at 4.7 ppm. 
 
2.3.2.4.4 Phasing the spectrum 
Quantification of metabolites requires evaluating the area under the peaks therefore 
distortion of the baseline may affect the accuracy of the areas. Phase adjustment of the 
spectrum was manually adjusted in order to achieve a flat baseline and for all points to have 
the same phase.  
 
2.3.2.4.5 Quantification 
Expected peaks were identified at each echo time based on their position within the spectrum 
as illustrated in Table 6. The top and midpoint of each peak were identified and a curve was 
fit by the software for each metabolite peak. Once curves had been fitted for all metabolites 
the ratios were calculated. The metabolite ratios calculated at each echo time are shown in 
Table 6. The inter-rater and intra-rater intraclass correlation coefficients were calculated for 
each echo time. 
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Echo Time (ms) Metabolite ratios 
42 
MI:Cho 
MI:Cr 
Cho:Cr 
136 
NAA:Cho 
NAA:Cr 
Cho:Cr 
Lactate presence 
270 
NAA:Cho 
NAA:Cr 
Cho:Cr 
Lactate presence 
Table 6. 1HMRS echo time and metabolite detection 
The metabolite ratios calculated at each echo time are shown. Abbreviations: myo-inositol (MI), choline (Cho), 
creatine (Cr), N-acetylaspartate (NAA), lactate (Lac) 
 
2.3.2.4.6 Work done by others 
Analysis of spectra acquired at 136ms in the control cohort was performed by a colleague 
(LS) and data have been previously published (Story et al., 2011a). 
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2.4 Neonatal Imaging 
Neonatal MRI was performed in order to assess the evolution of the ventricular dilatation, 
exclude additional abnormalities not detected on antenatal MRI and to assess white matter 
tissue microstructure. Post-processing of MR images included volumetric analysis of 
intracranial structures using an automated software and TBSS analysis of DTI data for the 
assessment of white matter. 
 
2.4.1 Patient preparation 
All participants enrolled in the fetal research program were offered a neonatal MRI scan 
which was performed from their day of delivery and up to 10 weeks after birth (ethics No. 
07/H0707/105). Informed parental consent was obtained prior to each scan. A metal 
checklist was completed before the scan to ensure the infant was free of ferrous metals and 
safe to enter the magnetic field. 
 
MRI was performed on a 3T Phillips system (Phillips, Best, The Netherland) using an eight 
channel phased array head coil. Before the scan, all neonates were assessed by an 
experienced paediatrician and a detailed neurological assessment was performed (Mercuri et 
al., 2005). Infants were imaged either in natural sleep or under light sedation (chloral hydrate 
30-50 mg/kg dose orally administered) to minimise motion. Infants were wrapped and 
positioned supine and their head was immobilised using a polystyrene bead filled pillow 
which adjusted to the head size using vacuum air removal. Neonates were monitored 
throughout with ECG and pulse oximetry and a paediatrician was present throughout the 
scan. Imaging parameters of structural scans and DTI are detailed in Tables 7 and 8. 
 
Physiological parameters including heart rate, oxygen saturation and temperature were 
monitored before and during the scan. Ear protection was used in all infants and included 
moulded earplugs made of silicone-based putty (President putty, Coltene/Whaledent, New 
Jersey, USA) and neonatal adhesive earmuffs (Natus MiniMuffs, Natus Medical Inc, CA, 
USA). An experienced neonatologist supervised all the examinations (Rutherford, 2002a).  
 
122 
 
Parameters T2 SENSE T2 dyn Dual Echo T1 
TE (ms) 160 160 100 4.6 
TR (ms) 1000 1000 1000 17 
Flip angle (deg) 90 90 90 180 
Acquisition Voxel size (mm) 1.15x1.18x2 0.98x0.99x2 1.15x1.18x2 0.82x0.97x1 
Slice gap (mm) -1 -1 -1 0 
Reconstructed voxel size (mm) 0.86x0.86x2 0.86x0.87x2 0.86x0.86x2 0.82x0.82x0.5 
FOV (mm) 220x220x107 220x176x101 220x220x141 210x157x120 
SAR (W/Kg) 0.1 0.2 0.2 2.4 
Table 7. Neonatal MRI scanning parameters 
 
 
Parameters DTI 
TE (ms) 49 
TR (ms) 1000 
Flip angle (deg) 90 
b value (s/mm
2
) 750 
SENSE factor 2 
Directions 32 
Acquisition Voxel size (mm) 2 x 2.03 x 2 
Slice gap (mm) 0 
Reconstructed voxel size (mm) 1.75 x 1.75 x 2 
FOV (mm) 224 x 224 x 98  
SAR (W/Kg) 0.1 
Table 8. Neonatal DTI scanning parameters 
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2.4.2 Neonatal volumetry 
2.4.2.1 Overview 
Volumetric segmentation was performed using a fully automatic segmentation algorithm 
designed in our department as described in Xue et al. (2007). This technique is intensity-
based and uses the Expectation-Maximization (EM) algorithm which enables parameter 
estimation in probabilistic models (Do and Batzoglou, 2008) in conjunction to a Markov 
random field (MRF) and Mislabelled partial volume voxel detection and removal (MLPV). 
The EM-MRF-MLPV analysis was performed in Matlab (MathWorks, Natick, MA, USA). 
 
2.4.2.2 Pre-processing 
T2-SENSE images of the ventriculomegaly and control cohorts were reviewed for the 
presence of motion, image quality and brain coverage (Figure 51A). When these images 
were inappropriate for volumetric analysis (motion artefact or not full brain coverage) then 
the T2 dynamic ssFSE were used. A 3D reconstructed dataset was generated using the T2 
dynamic ssFSE images as described in chapter 2.3.2.2.2. When both T2-SENSE and T2 
dynamic ssFSE scans were not available a dual echo scan was used for volumetric analysis. 
Acquisition parameters were similar between the sequences allowing for comparable 
volumetric results. Imaging parameters are summarised in table 7.  
Brain extraction was performed to exclude non-brain tissue using fsl4 in a Linux workstation 
(Figure 51B). In order to minimise the effects of intensity variability, inhomogeneity 
correction was applied using the Medical Image Processing Analysis and Visualization 
(MIPAV) (version 5.4.3). Label propagation via image registration was used for the 
exclusion of the brainstem and cerebellum in all images.  
 
2.4.2.3 Expectation-Maximization (EM) algorithm  
Each class label (CSF, gray matter and white matter) will have different image intensities for 
every voxel and the EM algorithm allows for every tissue class to be modelled by a Gaussian 
distribution. The EM algorithm requires an initial estimate of the class intensities of each 
tissue therefore initialising was performed via k-means clustering to assign each voxel to a 
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specific tissue class. The EM algorithm consists of two steps, the expectation step during 
which each voxel is classified according to a specific tissue label and the maximisation step 
which updates the estimated Gaussian distribution. The algorithm maximises the data 
likelihood and updates the tissue classification via iterations of the expectation and 
maximisation steps.  
 
2.4.2.4 Markov Random Field 
After completion of the voxel-wise tissue classification many voxels on the CSF-cortex 
boundary are incorrectly classified as white matter. A similar problem occurs at the CSF-non 
brain boundary where many voxels are classified as white matter due to the signal intensity 
at the border of the structures. In order to constrain spatial homogeneity of tissue labelling 
MRFs are commonly used. A first-order neighbourhood system was used for the removal of 
mislabelled voxels according to which the prior probability that a voxel belong to a specific 
tissue class depends on the neighbouring tissue class. The six nearest neighbouring voxels on 
the 3D image grid were used. Therefore voxels were assigned to a specific tissue class 
depending on their neighbouring voxel classification. 
 
2.4.2.5 Mislabelled partial volume voxel detection and removal 
Due to the large number of misclassified voxels in the CSF-cortex, EM and MRF alone are 
not sufficient to remove all incorrectly labelled voxels (Figure 51C). If many incorrect 
voxels are adjacent to each other this will prohibit them from being corrected. The MLPV 
removal is a knowledge-based approach and specifies that if a voxel classified as white 
matter has first order neighbouring voxels classified as CSF and cortex simultaneously then 
that voxel has been incorrectly labelled. The rule that no white matter voxel can appear in a 
CSF-cortex boundary is also applied for mislabelled voxels in the CSF-non brain boundary. 
Finally, the generated segmentations were reviewed in ITK-SNAP and incorrect labelling 
surrounding the cerebrum was manually removed using a drawing tablet (Intuos4, Wacom, 
Germany). Due to time constraints we only performed volumetric segmentation of the lateral 
ventricles and supratentorial brain tissue while delineation of white matter and cortex is 
currently underway (Figure 51D). 
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Figure 51. Automatic volumetric analysis in a neonatal brain 
(A) T2-SENSE image of a neonate aged 43
+3
 postmenstrual weeks. (B) Neonatal brain after removal of non-
brain tissue and inhomogeneity correction. (C) Automatic segmentation of intracranial structures as generated 
by Expectation-Maximization (EM) algorithm. Measurements are inaccurate without further editing due to 
voxel mislabelling. (D) Volumetry segmentation of supratentorial brain tissue and lateral ventricles after 
manual editing and correcting.  
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2.4.3 Diffusion Tensor Imaging 
2.4.3.1 Pre-processing 
DTI analysis was performed using FMRIB's Diffusion Toolbox (FDT v2.0), a freely 
available and comprehensive library of tools for the analysis of DTI brain imaging data (FSL 
v4.1; www.fmrib.ox.ac.uk/fsl; Smith et al. (2004)). Analysis was performed on a Linux 
workstation. All 32 volumes of acquired diffusion weighted data were visually checked for 
artefacts and motion distortion and corrupted volumes were removed. When more than 4 
volumes had to be removed, the whole dataset was discarded.  Removal of non-brain tissue 
was performed on the data using BET (v2.1). The generated mask was used for performing 
Brain Extraction in all DTI data for a specific subject. During data acquisition eddy currents 
in the gradients coils induce distortions in the images which are different for each gradient 
direction. Eddy Current Correction was applied to correct for these distortions and for head 
movement by affine registration of the DTI data to the reference b0 image.  
 
2.4.3.2 Image registration 
An optimised protocol (Ball et al., 2010) designed for voxel-wise registration of neonatal 
data was used for the processing of the generated FA data. The first step included linear 
registration of the FA maps to each other using FMRIB's Linear Registration Tool (FLIRT 
v5.5; default settings). The FA maps were then registered using FMRIB's Non-Linear 
Registration Tool (FNIRT v1.0; parameters defined in FA_2_FMRIB58_1mm configuration 
file) for accurate alignment. The FA map of each subject was registered to the map of every 
other subject and the warp field was recorded. The FA map with the minimum mean warp 
displacement score was chosen as a target. Each subject's FA map was then aligned in the 
target space and the mean FA map and mean FA skeleton were generated. The mean FA 
skeleton represents the centre of all white matter tracts that are common to the group. The 
skeleton was thresholded at FA>0.1 in order to remove cerebral sinuses and CSF incorrectly 
represented in the skeleton and only to include the major white matter tracts. Each subject's 
aligned FA data were projected onto the mean FA skeleton.  
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2.4.3.3 Tract-Based Spatial Statistics 
TBSS (v1.2) was used to assess the relationship between FA and presence of 
ventriculomegaly. The FA values of the control and ventriculomegaly groups were compared 
using voxel-wise cross-subject statistics controlling for postmenstrual age at scan and 
gestational age at birth. The results were corrected for multiple comparisons by using the 
family-wise error correction following threshold-free cluster enhancement (Smith and 
Nichols, 2009). P < 0.05 was considered statistically significant. 
 
2.4.3.4 Work done by others 
The steps of image pre-processing, image registration and TBSS analysis were performed by 
a colleague (GL). 
 
2.5 Neurodevelopmental assessments 
All parents were invited for a detailed neurodevelopmental assessment of their child at year 1 
and 2. Assessments were performed by the clinical psychologist or paediatric neurologist. On 
the day of the assessment the child's weight, height and head circumference were measured. 
The Griffiths Mental Development Scales (GMDS) assessment was performed at year 1 and 
the Bayley Scales of Infant Development-III (BSID-III) assessment was performed at year 2. 
A strong association has been found between the GMDS and the BSID tests (Ramsay and 
Fitzhardinge, 1977). While the two tests may be used interchangeably the numerical scores 
are not equivalent. The GMDS has traditionally been the mainstay of developmental 
assessment for infants in the UK however in recent years an increasing number of studies 
have been using the BSID test as part of their follow-up. Due to the wide use of the BSID 
and in order for our data to be comparable with other studies the BSID was used for 
assessing the development of children at 2 years. The GMDS was used for the 1 year 
assessment due to the fact that it is shorter in duration and thus more appropriate for children 
at that age. Development scores at year 2 are more predictive of later outcome however 
assessments at 1 year of age allow for the detection of obvious developmental abnormalities 
and aid in keeping parental contact. 
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2.5.1 Griffiths Mental Development Scales 
The GMDS assessment is a developmental test for children aged 0-2 years (Huntley, 1995). 
It is composed of 5 separate scales: Locomotor, Personal-Social, Hearing and Speech, Eye-
Hand Co-ordination and Performance. The Locomotor sub-scale assesses the gross motor 
skills of the child and includes co-ordination, balance and general movements. The Personal-
Social sub-scale assesses the development of skills related to social development and 
independence. The Hearing and Language sub-scale assesses active listening, expressive and 
receptive language development. The Eye and Hand Co-ordination includes fine motor 
skills, visual attention skills and manual dexterity. The Performance scale assesses how skills 
are used in novel situations and problem solving. 
 
2.5.1.1 Scoring 
Each task in the GMDS assessment is marked with 0 or 1; with 0 representing failure to 
perform a task and 1 successful performance. Upon completion of the assessment the total 
number of items passed in each sub-scale is added up producing the total raw score for each 
sub-scale. The raw scores for each sub-scale can be converted into standardised scores 
including age equivalent, sub- and general-Quotients, and percentile equivalents of the sub-
quotients (Table 9). The raw score corresponding to each developmental age represents the 
average score obtained by all children tested in the standardisation sample who were that 
age. The sub-Quotients (SQ) and Developmental Quotients (DQ) take in to account how the 
child’s raw scores vary around the mean score for each month of age. These are calculated 
for each sub-scale and for the total raw score. The sum of the total scores of all subtests and 
divided by the number of tests represents the total DQ. The DQ has a mean of 100 and a 
standard deviation of 12 while the SQ has a mean of 100 and a standard deviation of 16. DQ 
scores below 88 (1SD) and SQ scores below 84 (1SD) indicate developmental delay. The 
percentile scores are derived from the sub-quotients. 
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Sub-scale 
Total 
Raw 
score 
Age 
equivalent 
score 
Sub- and 
General 
Quotient 
Percentile 
score 
Locomotor • • • • 
Personal-Social • • • • 
Hearing and Language • • • • 
Eye and Hand Co-ordination • • • • 
Performance • • • • 
Total Scale • • •   
Table 9. Griffiths Mental Development Scales 
Areas of development assessed using the Griffiths Mental Development Scales and the scoring system. 
 
2.5.2 Bayley Scales of Infant and Toddler Development-III 
The BSID-III is a developmental test that assesses the developmental functioning of infants 
and young children between 1 month and 42 months of age (Bayley, 2006). The BSID-III 
assesses development in 3 domains; Cognition, Language (expressive and receptive) and 
Motor (fine and gross). The cognitive scale assesses sensorimotor development, exploration 
and manipulation, object relatedness, concept formation, memory and other aspects of 
cognitive processing. The Language scale is composed of the receptive communication and 
expressive communication subtests. The receptive communication assesses vocabulary 
development, preverbal behaviour and verbal comprehension. The expressive 
communication assesses preverbal communication and morpho-synaptic development. The 
motor scale was composed of the fine motor and gross motor subtests. The fine motor scale 
included items for assessing children's skills related to functional hand skills, such as 
grasping and object manipulation. The gross motor subtest assessed movement of the limbs 
and torso. Items evaluated static positioning, dynamic movement and co-ordination. The 
BSID-III also included a Social-Emotional scale, however this was not part of the routine 
examination and behaviour was informally assessed by the psychologist based on 
observation during the testing session. 
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2.5.2.1 Scoring 
Each task in the BSID-III is marked with 0 or 1 with 0 representing failure to perform a task 
and 1 successful performance. At the end of the assessment the total raw scores are 
calculated by summing the number of completed tasks for each subtest (Table 10). Scaled 
scores are calculated for all subtests and are derived from the subtest total raw scores and 
range from 1-19 with a mean of 10 and a standard deviation of 3. Composite scores are 
derived from various sums of subtest scaled scores and are generated for the Cognitive, 
Language and Motor scales. The composite scores can be used to compare a child's 
performance across all 3 BSID-III scales. They are scaled to a metric with a range from 40-
160, a mean of 100 and a standard deviation of 15. Developmental delay was classified when 
composite scores were below 85 (1SD) and scaled scores were below 7 (1SD). Percentile 
ranks are calculated indicating the performance of a child relative to that of children in the 
standardisation sample. Percentile ranks range from 1 to 99 with a mean and median of 50.  
 
              
Scale or Subtest 
Total Raw 
score 
Scaled 
score 
Composite 
score 
Percentile 
Rank 
Developmental 
Age 
Equivalent 
Cognitive Scale ● ● ● ● ● 
Language Scale   ● ●  
   Receptive Communication subtest ● ●   ● 
   Expressive Communication subtest ● ●   ● 
Motor scale   ● ●  
   Fine motor subtest ● ●   ● 
   Gross motor subtest ● ●   ● 
Table 10. Bayley Scales of Infant and Toddler Development-III 
Areas of development assessed using the Bayley Scales of Infant and Toddler Development-III and the scoring 
system. 
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2.5.3 Ages and Stages Questionnaires 
In our study, questionnaires were provided only in cases where the parents refused to attend 
a formal assessment and when we were unable to get in contact with parents and would 
otherwise have no follow-up data. Ages and Stages Questionnaires–III (ASQ-3) are parent-
completed developmental questionnaires that assess a child’s development in the areas of 
communication, gross motor, fine motor, problem solving and personal-social. An example 
of a questionnaire for a 24 month old infant is presented in the Appendix 3. Each 
questionnaire comprises 30 questions spanning the aforementioned developmental areas 
written in simple, straight-forward language and a series of overall questions to elicit 
parental concerns. They can be administered between 1 months and 5.5 years of age and the 
items required for completion of the tasks can generally be found in a family’s home. The 
ASQ-3 serves as a first-level screening system and can identify infants or young children 
who are delayed in their development. The validity of the ASQ has been examined by 
comparing with several professionally administered standardised assessments including the 
BSID. Overall agreement on children’s classifications was 86%, while studies comparing 
ASQ-2 and BSID-II in preterm infants at 2 years of age have shown sensitivity range from 
73%-100% and specificity from 65%-87% (Gollenberg et al., 2010; Woodward et al., 2011). 
ASQ-3 is a reliable screening system for identifying children with development delay 
however it should be considered that specificity is low.  
 
Work done by others 
The GMDS and BSID-III assessments were performed by a paediatrician (AC) and a clinical 
psychologist (BH). 
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2.6 Statistics 
Statistical analysis was performed using SPSS (Statistical Package for the Social Sciences) 
software package version 17 (SPSS Chicago, IL, USA). Normality of distribution was 
assessed using the Shapiro-Wilk goodness-of-fit test and the Q-Q plots for each variable. 
Data not normally distributed was log-transformed to achieve normal distribution. Log 
transformed data was tested for normality as described. Analysis of covariance (ANCOVA) 
on log-transformed data was used to compare results between groups when corrected for GA. 
A confidence level of 0.05 was considered significant. Correlation between variables was 
assessed using the Spearman's correlation coefficient (Spearman's r) on non-parametric data. 
Slope comparisons between groups were performed in StatsDirect statistics software using 
Grouped Linear Regression Analysis with a covariance as this function was not available in 
SPSS. Intra-rater and inter-rater variability was assessed using the intra-class correlation 
coefficient calculated and Bland-Altman plots on SPSS. 
 
2.6.1 Power calculations 
From previous published fetal MR volumetric and spectroscopy studies (29 intrauterine 
growth restriction [IUGR] v 46 controls) a significant decrease was detected in brain 
structure volumes and in metabolic status in association with IUGR (Damodaram et al., 
2012; Story et al., 2011a). In this study we therefore anticipate that we have a large enough 
sample size to be able to detect and identify a significant difference (p<0.05)
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3 Results 
3.1 Contribution of MRI in the sonographic diagnosis of ventriculomegaly 
3.1.1 Background 
While sonography is the mainstay for the antenatal diagnosis of ventriculomegaly, there is  
increasing evidence  for  the value of MRI in providing additional diagnostic information. As 
the prognosis for fetuses with ventriculomegaly largely depends on the presence or absence 
of additional CNS abnormalities it is essential to perform a detailed assessment of the fetal 
brain. There are two clinical considerations in fetal ventriculomegaly regarding prognosis, 
the degree of dilatation and the presence of additional abnormalities. Whilst there is good 
correlation in atrial diameter measurement between the two techniques, studies have 
evaluated the diagnostic value of MRI following an ultrasound diagnosis of isolated 
ventriculomegaly and have reported a detection rate of additional abnormalities ranging from 
14%-17% (Benacerraf and Shipp, 2007; Griffiths et al., 2010; Manganaro et al., 2009). 
Providing additional information and increasing the accuracy of diagnosis is important for 
parental counselling. The absence of additional abnormalities in this high risk group provides 
re-assurance to parents while in non-isolated cases accurate information is important for 
decision making and management of the pregnancy. 
 
3.1.2 Aims 
To evaluate the contribution of MRI in the sonographic diagnosis of fetal ventriculomegaly. 
To estimate the risk of additional CNS abnormalities in mild and moderate/severe 
ventriculomegaly. 
 
3.1.3 Cohort 
During the study period of November 2007 to May 2011, a total of 492 fetuses were referred 
from antenatal clinics or from the Fetal Medicine Unit in Queens Charlotte's and Chelsea 
Hospital for a MRI scan in our department; 110 cases with a sonographic diagnosis of 
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ventriculomegaly. All ultrasound and referral reports were reviewed and patients were 
grouped according to the sonography findings, into isolated and non-isolated 
ventriculomegaly. 66 fetuses were diagnosed on ultrasound with isolated ventriculomegaly 
and 44 with non-isolated ventriculomegaly. The mean GA at MRI scan was 27.4 weeks and 
the GA range was 18.5-37.3 weeks. 
 
3.1.4 Detection of additional abnormalities on MRI 
In the 66 isolated cases, MRI was in agreement to ultrasound in 54 cases (82%) where no 
additional abnormalities were detected and MRI confirmed the presence of isolated 
ventriculomegaly. MRI detected additional findings to those on ultrasound in 12 cases 
(18%). Abnormalities are summarised in Table 11 and included cerebellar haemorrhage, 
basal ganglia abnormality, agenesis of the corpus callosum, corpus callosum hypoplasia, 
cerebellar infarction, cerebellar structural abnormalities, subependymal heterotopia, 
abnormal white matter signal intensity, decreased white matter volume, cortical 
abnormalities, delayed cortical folding, presence of large parenchymal cysts. In 5 isolated 
cases, the maximum atrial diameter measurement was measured to be below 10 mm, 
however all measurements were ≥9 mm (range 9-9.7 mm) (Table 12). 
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# 
Atrial 
diameter 
on US 
(mm) 
Atrial 
diameter 
on MRI 
(mm) 
GA at 
MRI 
(weeks) Additional findings detected on MRI 
1 11 12 29.6 
Subependymal cysts in the caudothalamic notch, abnormal 
cortex, abnormal signal intensity in white matter 
2 n/a 11.9 32.8 
Delayed cortical folding, decreased white matter volume, small 
cerebellum. 
3 12.3/13 12.2/12.7 26.1 
Widening of the interhemispheric fissure and hypoplasia of the 
corpus callosum. 
4 10.8 10.3 29 
Large bilateral cysts within the caudate nuclei and smaller 
bilateral cysts within the temporal poles and within the posterior 
inferior lentiform nuclei. 
5 9.4/9.6 9.8/10.5 29.8 
Abnormal cerebellum fused with no obvious vermis, unusual 
cavum. 
6 12.5 11 29.8 
Hypoplastic corpus callosum, asymmetrical cerebellum, small 
vermis, small pons. 
7 13.9 16.9 29.8 Subependymal heterotopia and abnormal cortex. 
8 19/15 23.2/15.3 30.1 
Dilated 4th ventricle, bilateral cerebellar haemorrhage, obvious 
abnormal signal intensity within the basal ganglia suggestive of an 
acute hypoxic ischemic episode. 
9 15 14.9 31 Subependymal heterotopia. 
10 11.3 11.6/13.5 31.7 Agenesis of the corpus callosum. 
11 13/8.9 14.0/10.0 33.4 
Small cerebellum with infarction in left cerebellar hemisphere, 
prominence of 3rd ventricle. 
12 moderate 11.6 36.4 Large subependymal cyst within ventricle. 
Table 11. Additional findings detected on MRI 
MRI detected additional findings to those on ultrasound in 12 cases. In cases 2 and 12 the atrial diameter 
measurements on ultrasound were not available. Case 7 had progressive ventriculomegaly and the MRI was 
performed 1 month after the ultrasound. 
 
 
# 
Atrial 
diameter 
on US 
(mm) 
Atrial 
diameter 
on MRI 
(mm) 
GA at 
MRI 
(weeks) 
1 11* 9.7 24 
2 11 <10 33.1 
3 11 9.5 32.3 
4 11 9 28.1 
5 11.5 9 28.1 
Table 12. Discrepancy between ultrasound and MRI on the diagnosis of ventriculomegaly 
MRI was performed after referral for ventriculomegaly. Atrial diameter measurements were below 10 mm on 
MRI in 5 cases. *Case 1 had an atrial diameter of 11 mm on anomaly scan, while on the ultrasound performed 
the same day as the MRI in a tertiary centre the atrial diameter measurement was 9.1 mm. 
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In the 44 non-isolated cases, MRI confirmed the CNS abnormalities detected on ultrasound. 
Abnormalities included, vermis hypoplasia, cerebellar hypoplasia, agenesis of the corpus 
callosum, dandy walker malformation, choroid cysts, Arnold-chiari malformation and 
presence of inter-hemispheric cyst. MRI detected further additional abnormalities in 17 of 
the cases (38.6%) in respect to ultrasound. These abnormalities included cerebellar and 
vermis hypoplasia, brainstem hypoplasia, thin cortical mantle, agenesis of the corpus 
callosum, cortical mantle abnormal signal intensity consistent with calcification, white 
matter abnormalities, cortical abnormalities, vermis rotation, delayed cortical folding, 
haemorrhage, abnormal corpus callosum, basal ganglia and thalamic abnormalities, 
cerebellar hemispheres fusion, Arnold-chiari malformation, cerebellar infarction, 
subependymal heterotopia, abnormal pons, intraventricular haemorrhage, porencephalic cyst 
and germinal matrix haemorrhage. In 3 cases the maximum atrial diameter measurement was 
below 10 mm (range 9.5-9.6 mm). MRI demonstrated only increased ventricular size (10-
13.5 mm) and no other abnormalities in 5 cases (11.4%) in whom ultrasound had queried the 
presence of Blakes pouch/enlarged cisterna magna, agenesis of the corpus callosum, midline 
shift, a vermis defect. 
 
3.1.5 Ventricular size and risk of additional abnormalities 
The risk of finding additional CNS abnormalities was assessed with regard to ventricular 
atrial diameter and subjects were divided into mild (<12 mm) and moderate/severe (>12 mm) 
groups. As mentioned, according to the ultrasound reports, 66 cases were diagnosed with 
isolated ventriculomegaly and 44 cases with non-isolated ventriculomegaly. From the 66 
isolated cases, 41 had an atrial diameter <12 mm (mild) and 25 cases had an atrial diameter 
>12mm (moderate/severe). From the non-isolated cases there were 21 mild cases and 23 
moderate/severe. The risk of additional findings detected on MRI in mild cases was 12% for 
isolated cases and 9.5% for non-isolated. The risk of additional findings in moderate/severe 
cases was 28% for isolated cases and 65% for non-isolated (Figure 52).  
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Figure 52. Risk of additional abnormalities detected on MRI  
The risk of detecting additional abnormalities is higher in cases with an atrial diameter measurement > 12mm. 
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3.1.6 Discussion 
Our study indicates that MRI is a valuable imaging technique and can provide additional 
information in respect to ultrasound in fetuses diagnosed with ventriculomegaly.  
 
The risk of detecting additional abnormalities was higher in non-isolated cases compared to 
isolated cases (38.6% vs 18% respectively) as shown in previous studies (Benacerraf and 
Shipp, 2007). The risk of additional findings was highest when the atrial diameter exceeded 
12 mm and more significant in non-isolated cases, similar to previous studies (Benacerraf 
and Shipp, 2007; Griffiths et al., 2010; Morris et al., 2007). The lowest risk of finding 
additional abnormalities was detected in mild ventriculomegaly cases with isolated and non-
isolated cases having a similar risk.  
 
However we have not evaluated the clinical significance of the presence of additional 
abnormalities in order to establish the potential impact of MRI on this group of fetuses. This 
would include reviewing the details as to whether the additional information provided by 
MRI altered the parent’s decisions towards the progression of the pregnancy and whether it 
had an effect on clinical management of the pregnancy, delivery and future clinical referrals. 
In our cohort none of the cases diagnosed with isolated ventriculomegaly on MRI proceeded 
into termination of pregnancy. In the non-isolated group, 15 women proceeded to 
termination of pregnancy. Simon et al. (2000) showed that MRI altered pregnancy 
management in 46% out of 52 cases while Levine et al. (2003) showed that MRI changed the 
diagnosis in 31.7% of fetuses, altered management in 13.5% of cases and 49.7% in parental 
counselling. Importantly, in 11.4% of our cases diagnosed with non-isolated 
ventriculomegaly, MRI radically altered the diagnosis by excluding any additional 
abnormalities (except of ventriculomegaly) providing great reassurance to parents. All 5 
cases continued with the pregnancy. The majority of studies agree that MRI is important in 
adding information in a diagnosis of ventriculomegaly (Benacerraf and Shipp, 2007; 
Griffiths et al., 2010; Manganaro et al., 2009) although some studies suggest that a detailed 
sonographic examination from an experienced technician is equivalent to MRI in the 
diagnosis of fetal brain abnormalities (Malinger et al., 2004; Monteagudo and Timor-Tritsch, 
2009). 
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In terms of the type of abnormalities detected, our study found similar abnormalities detected 
on MRI to previous studies (Benacerraf and Shipp, 2007; Manganaro et al., 2009; Mehta and 
Levine, 2005; Salomon et al., 2006; Valsky et al., 2004). Abnormalities were located in 
regions known to be challenging to visualise using sonography and included the cortex, 
white matter, corpus callosum and cerebellum. Subtle abnormalities in these regions may be 
difficult to visualise on ultrasound. In cases where the ultrasound diagnosis is unclear or an 
abnormality is suspected, MRI can be used as an alternative imaging modality.  In 3 cases 
with isolated ventriculomegaly and 2 cases with ventriculomegaly and subependymal 
heterotopia MR images had to be reconstructed to provide non-rotated images for evaluation 
of cortical folding. 
 
MRI can also further the understanding of the appearance of specific abnormalities and thus 
improve detection on sonography, as in cases of diagnosis of heterotopia which were 
exclusively diagnosed on MRI (Benacerraf and Shipp, 2007).  In our cohort there were 3 
cases diagnosed with subependymal heterotopia. With increased understanding of the 
appearance of the disorder it may also be detected on sonography. Recent studies have 
shown that sonography techniques have improved significantly and evaluation of these 
regions is becoming accessible (Pistorius et al., 2010; Pugash et al., 2012). 
 
After diagnosis of ventriculomegaly has been made, it is important to monitor the size of the 
lateral ventricles and ascertain whether the dilatation progresses, is stable or the ventricles 
normalise. Progression of the dilatation is associated with a worse outcome compare to cases 
where the ventricles remain stable or normalise (Melchiorre et al., 2009a). Ultrasound has an 
advantage over MRI in monitoring the ventricular size due to the inexpensive and time-
efficient nature of the modality. 
 
In conclusion, we have shown in our cohort that the risk of identifying additional 
abnormalities on MRI after an ultrasound referral of ventriculomegaly, is lowest in mild 
cases. When the atrial diameter exceeded 12 mm the risk doubled in isolated cases and 
increased 6-fold in non-isolated cases. Further work can evaluate in which of our cases MRI 
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had a significant impact on clinical management, diagnosis and parental counselling. While 
it must be emphasised that ultrasound is the screening modality of choice for the assessment 
of the fetal brain, MRI is an excellent complimentary imaging technique in the diagnosis of 
fetal ventriculomegaly and can provide additional information regarding the presence of 
additional abnormalities.  
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3.2 Volumetric quantification of intracranial structures from 22-38 weeks of gestation and 
after birth 
 
3.2.1 Background 
The latter half of gestation (20-40 gestational weeks) is a dynamic period during which the 
human brain shows accelerated growth manifesting in increases in volume, cortical complexity 
and changes in the molecular and cellular composition of the different cerebral regions. In the 
first part of this chapter, we assessed the volumetric changes of the different intracranial 
structures occurring between 22-38 weeks of gestation in a cohort of normal fetuses. Global and 
regional growth trajectories were constructed and used as a reference to compare with fetuses 
diagnosed with isolated ventriculomegaly in order to identify potential alterations in brain 
development. Additionally, in a subpopulation of these fetuses, volumetric analysis of 
intracranial structures was performed during the neonatal period. We compared neonatal brain 
structures in infants with antenatally diagnosed ventriculomegaly and normal controls in order to 
assess changes that persist after birth. 
 
3.2.2 Aims 
1. In a cohort of fetuses with antenatally diagnosed isolated ventriculomegaly: To establish 
whether there is evidence of relative overgrowth and/ or aberrant development in multiple 
intracranial structures (brain parenchyma, cortex, white matter, basal ganglia, thalami, 
CSF spaces including 3rd and 4th ventricles, cavum septum pellucidum and vergae and 
extra-axial space) and how these relate to the volume of the lateral ventricles.  
2. To establish whether volumetric changes evident during fetal life persist after birth. 
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3.2.3 Fetal volumetry 
3.2.3.1 Normal control cohort 
During the study period of November 2007-August 2011, a total of 89 fetuses had a normal brain 
appearance on fetal MRI and were enrolled as normal controls. 31 cases were excluded in 
accordance with our exclusion criteria: poor image quality due to fetal motion (7), positive 
infection screening (6), declined follow-up post delivery (4), abnormal brain appearance in 
neonatal MRI (5), birth-weight below the 3
rd
 centile (3), preterm delivery and 
neurodevelopmental delay (1), pregnancy complications and abnormal brain appearance on 
neonatal MRI (1), chromosome 22 duplication (1), neurodevelopmental delay and dyskinetic 
disorder (1), neonatal hypotonia and bradycardia (1), neonatal death related to non-CNS 
abnormalities (1). 
 
In the remaining 58 fetuses, MRI was performed at a median age of 28.8 weeks GA (range 22.4-
38.9 weeks) (Figure 53). Two fetuses were scanned twice during gestation (28.1 and 38.7 
gestational weeks). The 58 mothers of included control fetuses consisted of 41 healthy volunteers 
and 17 women who had had a previous child with a confirmed abnormality or who had had a 
suspected fetal abnormality on ultrasound excluded on MRI. The number of fetuses and the 
reason for scanning are summarised in Table 13. In summary, 60 MR scans of 58 fetuses were 
included in the control group (30 males/30 females).   
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Figure 53. Gestational age distribution histogram in normal controls 
Histogram of the gestational age distribution at time of MR scans in normal fetuses (n=60). Fetal gestational age 
was estimated from a first trimester dating ultrasound scan. 
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Participants No. of cases 
Healthy volunteers 41 
Sibling diagnosed with 
pontocerebellar hypoplasia 
3 
Sibling diagnosed with 
agenesis of the corpus 
callosum 
2 
Sibling diagnosed with 
microcephaly and 
polymicrogyria 
1 
Sibling with antenatal brain 
haemorrhage 
1 
Sibling diagnosed with 
Ohtohara syndrome 
1 
Sibling neonatal death 1 
Right side suprarenal cyst 1 
Query of agenesis of corpus 
callosum 
1 
Ultrasound diagnosis of 
ventriculomegaly not 
detected on MRI 
1 
Resolved cystic hygroma 1 
Suspected vertebral 
abnormality 
1 
Increased nuchal fold but 
normal karyotype  
1 
Diaphragmatic hernia 1 
Left side congenital cystic 
adenomatoid malformation 
1 
Total 58 
Table 13. Normal control cohort participants 
The normal control cohort consisted, in the majority, of healthy volunteers, fetuses with a suspected CNS 
abnormality not present on MRI, fetuses with non-CNS abnormalities. 37 children had a normal 
neurodevelopmental assessment at either 1 or 2 years of age. 3 children declined follow-up, 14 we were unable to 
contact and 4 children are currently <12 months. 
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3.2.3.1.1 Lateral ventricles 
The lateral ventricles were assessed using the atrial diameter, the volume of each lateral ventricle 
and the total (left and right) lateral ventricular volume. Measurements are summarised in Table 
14. There was a small increase in the above measurements with increasing GA as indicated by a 
moderate correlation value in atrial diameter (Spearman’s r=0.437, p<0.0001), volume of each 
lateral ventricle (Spearman’s r=0.472, p<0.0001) and total lateral ventricular volume 
(Spearman’s r=0.511, p<0.0001) with GA (Figures 54-56). The total lateral ventricular volume 
increased at a relative growth rate of 0.03% per gestational week increasing from an average 
volume of 2.27 cm
3 
at week 22 to 4.43 cm
3 
at week 38. Increased inter-subject variation however 
was evident in all ventricular measurements. Atrial diameter and lateral ventricle volume 
correlated well in both left (Spearman's r=0.742, p<0.0001) and right (Spearman's r=0.752, 
p<0.0001) lateral ventricles (Figure 57). 
 
 
Ventricular measurement Range Mean SD R
2
 
Atrial diameter (mm) 
Left 3.5 - 8.9 6.58 1.31 0.3 
Right 3 - 8.1 5.91 1.43 0.13 
Lateral ventricle volume (cm
3
) 
Left 0.56 - 3.83 1.81 0.74 0.221 
Right 0.57 - 3.1 1.51 0.68 0.24 
Total lateral ventricular volume (cm
3
) 1.43 - 6.7 3.32 1.28 0.28 
Table 14. Ventricular measurements using MRI in normal controls 
 
When taking in account brain laterality, left atrial diameter and ventricle volumes were 
significantly larger compared to the right side with a difference of 20.2% (p=0.008) and 12.5% 
(p=0.004) respectively. There was no significant difference in atrial diameter (p=0.519), left 
(p=0.317) or right (p=0.669) lateral ventricle volumes or total lateral ventricular volume 
(p=0.304) between sexes in the control cohort however males had a trend to larger ventricular 
measurements. In males, the left lateral ventricle was significantly larger to the right (p=0.008) 
while in females this difference did not reach significance (p=0.08). 
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Figure 54. Atrial diameter measurements using MRI in normal controls 
There was a small increase in atrial diameter with increasing GA (Spearman’s r=0.437, p<0.0001). Atrial diameter 
of the left lateral ventricle was significantly larger compared to the right (p=0.008). 
147 
 
 
 
Figure 55. Lateral ventricle volumes in normal controls 
There was a small increase in the volume of each lateral ventricle with increasing GA (Spearman’s r=0.472, 
p<0.0001) The volume of the left lateral ventricle was significantly larger compared to the right (p=0.004). 
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Figure 56. Total lateral ventricular volume in normal controls 
There was a small increase in total lateral ventricular volume with increasing GA in normal controls (Spearman’s 
r=0.511, p<0.0001). 
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Figure 57. Relationship between ventricular atrial diameter and volume in normal controls  
Atrial diameter and lateral ventricle volume correlated well in both left (Spearman's r=0.742, p<0.0001) and right 
(Spearman's r=0.752, p<0.0001) lateral ventricles. 
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3.2.3.1.2 Third and fourth ventricles 
The third and fourth ventricles increased in volume with increasing GA (Spearman's r=0.927, 
p<0.0001; Spearman's r=0.733, p<0.0001 respectively) (Figures 58 and 59) (Table 18). There 
was a small increase in the volume of the third ventricle at a relative growth rate of 0.098% per 
week increasing from 0.074 cm
3
 at week 22 to 0.359 cm
3
 at week 38. Similarly, there was a 
small increase in the volume of the fourth ventricle during GA at a relative growth rate of 
0.129% per week, increasing from 0.013 cm
3 
at week 22 to 0.093 cm
3 
at week 38. The goodness 
of fit for both third and fourth ventricles was similar for linear and exponential curves. There was 
no significant difference in the volume of the third (p=0.891) or fourth (p=0.155) ventricles 
between sexes, however males had a trend for larger volumes.             
 
 
Figure 58. Third ventricle volumes in normal controls 
The volume of the third ventricle increased with increasing GA in normal controls (Spearman's r=0.927, p<0.0001). 
Lines of best fit; stippled line=exponential, solid line=linear. 
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Figure 59. Fourth ventricle volume in normal controls 
The volume of the fourth ventricle increased with increasing GA in normal controls (Spearman's r=0.733, 
p<0.0001). Lines of best fit; stippled line=exponential, solid line=linear. 
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3.2.3.1.3 Extra-cerebral CSF 
Extra-cerebral CSF increased with GA at a relative growth rate of 0.06% per week from 22.68 
cm
3 
at week 22 cm
3
 to 98.52 at week 38 (Spearman's r=0.873, p<0.0001) (Figure 60) (Table 18). 
While exponential and linear curves fitted the data similarly, the curve that best represented that 
data was a 2
nd 
order polynomial due to the large scatter of data after 30 gestational weeks. This 
may indicate a decrease in the growth rate after 31 weeks. 
 
 
Figure 60.  Extra-cerebral CSF volumes in normal controls 
Extra-cerebral CSF volumes increased with GA with increasing GA in normal controls (Spearman's r=0.873, 
p<0.0001). A reduction in growth rate was evident at around 30-32 gestational weeks. 
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3.2.3.1.4 Cavum septum pellucidum  
The CSP was assessed using the CSP width and the volume of the structure. Due to the large 
scatter of the measurements the data for the width and volume are presented in two ways, the raw 
measurements against GA (Figures 61 and 63) and also the mean measurement for each 
gestational week against GA (Figures 62 and 64). CSP width increased from 3.5 mm at week 22, 
peaked at 6.8 mm at 30 weeks and then decreased.  A 2
nd
 order polynomial was fitted in the data 
to illustrate the complex changes occurring during gestation. Similarly the volume of the CSP 
increased between 22 to 30 weeks when it reached a peak and decreased from 30 to 38 weeks. 
CSP width and volume correlated well (Spearman’s r=0.777, p<0.0001), there was however a 
large scatter of the data.  
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Figure 61. Cavum septum pellucidum width in normal controls 
Cavum septum pellucidum width increased from week 22 until week 30 and decreased thereafter. 
 
 
Figure 62. Cavum septum pellucidum width in normal controls (weekly average)  
Cavum septum pellucidum width increased from week 22 until week 30 and decreased thereafter. Data are presented 
as a mean per gestational week.  
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Figure 63. Cavum septum pellucidum volume in normal controls 
Cavum septum pellucidum volume increased from week 22 until week 30 and decreased thereafter. 
 
Figure 64. Cavum septum pellucidum volume in normal controls (weekly average) 
Cavum septum pellucidum volume increased from week 22 until week 30 and decreased thereafter. Data are 
presented as a mean per gestational week. 
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3.2.3.1.5 Supratentorial brain tissue 
Total supratentorial brain tissue volume increased at a relative growth rate of 11.65% with 
increasing GA, from 53.67 cm
3 
at week 22 to 346.7 cm
3 
at week 38 (Spearman's r=0.976, 
p<0.0001) (Figure 65) (Table 18). The goodness of fit was similar for linear and exponential 
curves, however an exponential curve was selected as it visually appears to represent the data 
better. There was no difference in the volumes of left and right hemispheres (p=0.966) (Figure 
66). There was no significant difference between total brain tissue volume (p=0.817) between the 
sexes although males had a trend for larger brain tissue volumes.  
 
 
 
Figure 65. Supratentorial brain tissue volume in normal controls 
Supratentorial brain tissue increased with increasing GA in normal controls (Spearman's r=0.976, p<0.0001). Lines 
of best fit; stippled line=exponential, solid line=linear. 
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Figure 66. Supratentorial hemispheric brain tissue in normal controls 
There was no difference in the volumes of left and right hemispheres (p=0.966). Lines of best fit; stippled 
line=exponential, solid line=linear. 
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3.2.3.1.6 Cortical gray matter 
Total cortical gray matter volume was measured in 19 control cases (GA range 22.42-37.17 
weeks, mean 29.29 weeks). There was no significant difference between the complete group 
(n=60) and this subgroup in GA, brain volume or ventricular volume. Between 22 and 37 weeks 
GA there was an exponential increase in cortical gray matter volume at a relative growth rate of 
13.2% (Figure 67). Cortical volume increased from 11.01 cm
3 
at week 22 to 105.58 cm
3
 at week 
38 (Spearman's r=0.873, p<0.0001) (Table 18).   
 
 
Figure 67. Cortical gray matter volume in normal controls 
Cortical volumes increased with increasing GA (Spearman's r=0.873, p<0.0001). 
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3.2.3.1.7 Thalami 
Total thalamic volumes were measured in the subgroup of 19 normal control cases. Thalamic 
volume increased exponentially (Spearman's r=0.993, p<0.0001) at a relative growth rate of 
13.13% per week from 0.88 cm
3
 at week 22 to 7.52 cm
3 
at week 38 (Figure 68) (Table 18).    
 
 
 
 
Figure 68. Thalamic volume in normal controls 
Thalamic volumes increased with increasing GA (Spearman's r=0.993, p<0.0001). 
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3.2.3.1.8 Basal ganglia 
The volumes of the basal ganglia were measured in 19 normal controls cases. The volumes 
increased with increasing GA at a relative growth rate of 11.39 cm
3 
per week from 1.17 cm
3
 at 
week 22 to 7.94 cm
3
 at week 38 (Spearman's r=0.975, r<0.0001) (Figure 69) (Table 18). Both 
linear and exponential curves fitted the data.  
 
 
Figure 69. Basal ganglia volumes in normal controls 
Basal ganglia volumes increased with increasing GA in normal controls (Spearman's r=0.975, r<0.0001). Lines of 
best fit; stippled line=exponential, solid line=linear. 
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3.2.3.1.9 White matter 
White matter volumes were calculated in 19 controls cases by subtracting thalamic, cortical and 
basal ganglia volumes from the supratentorial brain tissue measurements. White matter volumes 
increased at a relative growth rate of 12.27% per week from 39.15 cm
3 
at week 22 to 272.25 cm
3
 
at week 38 (Spearman's r=0.986, p<0.0001) (Figure 70) (Table 18). 
 
 
 
 
Figure 70. White matter volumes in normal controls 
White matter volumes in increased with increasing GA in normal controls (Spearman's r=0.986, p<0.0001). Lines of 
best fit; stippled line=exponential, solid line=linear. 
 
 
  
162 
 
3.2.3.1.10 Correlations of ventricular size and intracranial measurements 
There was a significant correlation between total lateral ventricular volume and supratentorial 
brain parenchyma (Spearman's r=0.54, p<0.0001), extra-cerebral CSF (Spearman's r=0.499, 
p<0.0001), third ventricle (Spearman's r=0.549, p<0.0001), fourth ventricle (Spearman's r=0.457, 
p<0.0001) and thalamic volumes (Spearman's r=0.389, p=0.05) (Table 15). There was no 
significant correlation between total lateral ventricular volume and cortex (Spearman's r=0.305, 
p=0.102), basal ganglia (Spearman's r=0.289, p=0.115) and white matter volumes (Spearman's 
r=0.34, p=0.077). 
 
Correlation of total ventricular size and intracranial measurements     
  
Total 
Brain 
Tissue 
Cortex 
Basal 
Ganglia 
Thalami 
White 
Matter 
Third 
Ventricle 
Fourth 
Ventricle 
Extra-
cerebral 
CSF 
Normal 
controls 
(Spearman's r) 
0.54** 0.305 0.289 0.389* 0.34 0.549** 0.457** 0.499** 
Table 15. Correlation of total ventricular volume and intracranial volumetric measurements  
Spearman r values are presented for each relationship. * p<0.05 and p>0.0001 ** = p<0.0001 
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3.2.3.2 Comparison of volumetric results of ventriculomegaly cohort to normal controls 
Isolated ventriculomegaly cohort 
A total of 114 fetuses presented with an ultrasound diagnosis of dilatation of the lateral ventricles 
during the study period. Out of the 114 cases, 66 were excluded according to the exclusion 
criteria: additional brain abnormalities (56), IUGR (1), positive infection/chromosomal 
abnormality (8), maternal drug abuse (1). None of the included cases had signs consistent with 
obstruction to CSF flow or atrophy of the surrounding tissue on fetal MRI. 48 fetuses (34 
males/14 females) were diagnosed with isolated ventriculomegaly with a 2D atrial diameter 
range of 10-17 mm. In 33 of the 48 fetuses the ventriculomegaly was unilateral (other atrial 
diameter <10 mm). 15 fetuses were scanned twice and one was scanned three times during 
gestation. In summary 65 MR scans of 48 cases were included in the isolated ventriculomegaly 
group (median GA 30 weeks, range 22-37.3 weeks, 48 males/17 females) (Figure 71). There was 
no significant difference in GA between groups (p=0.685). 
 
 
Figure 71.  Gestational age distribution histogram in ventriculomegaly and normal controls 
Histogram of the age distribution of fetal MR scans in the ventriculomegaly (red) and normal control (black) groups. 
Fetal gestational age was estimated from a first trimester dating ultrasound scan. 
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3.2.3.2.1 Lateral ventricles 
Measurements of atrial diameter, lateral ventricle volume and total lateral ventricular volume are 
summarised in Table 16. There was no correlation between atrial diameter and GA (Spearman's 
r=0.086, p=0.249).  There was a moderate correlation between lateral ventricle volume 
(Spearman's r=0.502, p<0.0001) and total (left and right) lateral ventricular volume (Spearman's 
r=0.481, p<0.0001) with GA.  
 
It should be noted that lateral ventricle in the ventriculomegaly cohort refers to the largest 
ventricle in both unilateral and bilateral cases. In bilateral cases, only the largest ventricle was 
used for the analysis. 
 
Ventricular measurement Range Mean SD R
2
 
Atrial diameter (mm)   10 - 17 11.99 1.46 0.036 
Lateral ventricle volume (cm
3
)   3.6 - 12.2 6.34 1.89 0.238 
Total lateral ventricular volume (cm
3
) 5.06 - 21.39 10.09 3.27 0.174 
Table 16. Ventricular measurements in ventriculomegaly  
 
 
All fetuses with an ultrasound diagnosis of ventriculomegaly had significantly larger lateral 
ventricle volumes than controls (295%, p<0.0001) (Figure 72). The range of ventricular 
measurements were 10-16.5 mm (atrial diameter), 3.6-12.2 cm
3 
(lateral ventricle volume) and 
5.06-21.39 cm
3 
(total lateral ventricular volume). One control case of a 37
+5
 week old fetus had a 
normal atrial diameter of 8.3 mm but a lateral ventricle volume of 3.8 cm
3
, within the lower 
ventriculomegaly range. With the exception of this control case, the volume of the each lateral 
ventricle between the two groups did not overlap. Conclusions regarding the evolution of the 
dilatation cannot be drawn for the ventriculomegaly group as each case had a different 
ventricular size. 
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Figure 72. Lateral ventricle volume in controls and ventriculomegaly from 22 to 38 weeks 
Fetuses with ventriculomegaly had significantly larger lateral ventricle volumes than controls (295%, p<0.0001). 
The ventriculomegaly data shown depict the large ventricle in the unilateral cases and the largest ventricle only of 
the bilateral cases. 
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Atrial diameter and lateral ventricle volume correlated well in the ventriculomegaly cohort 
(Spearman’s=0.56, p<0.0001) (Figure 73) in both the ventricle with an atrial diameter >10 mm 
and the ventricle <10 mm. 
 
 
 
Figure 73. Relationship between ventricular atrial diameter and volume in ventriculomegaly 
Atrial diameter and volume correlated well (r=0.6, p<0.00001) in the ventriculomegaly cohort. The 
ventriculomegaly atrium >10mm data shown depict the large ventricle of the unilateral cases and both enlarged 
ventricles in bilateral cases. The ventriculomegaly atrium <10mm represent the non-ventriculomegaly side in the 
unilateral cases. 
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33 of the 48 cases had unilateral ventriculomegaly as classified by an atrial diameter above 10 
mm in only one ventricle. While the volumes of the lateral ventricles did not overlap between the 
groups, in 17 out of 33 unilateral cases, the volume of the normal sized lateral ventricle (atrial 
diameter  < 10 mm) was in the ventriculomegaly range (atrial diameter mean 9.2 mm, range 7.4-
9.9 mm; lateral ventricle volume mean 4.4 cm
3
, range 3.6-5.3 cm
3
) (Figure 74). 
 
 
 
Figure 74. Relationship between ventricular atrial diameter and volume in controls and ventriculomegaly  
Atrial diameter and volume correlated well in normal controls (r=0.754, p<0.00001) and ventriculomegaly (r=0.6, 
p<0.00001). The ventriculomegaly atrium> 10mm data shown depict the large ventricle of the unilateral cases and 
both enlarged ventricles of bilateral cases. 
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3.2.3.2.2 Third and fourth ventricles 
The third and fourth ventricles increased with GA at a relative growth rate of 0.088% and 
0.119% per week respectively (Table 18). The volume of the third and fourth ventricles were 
larger in the ventriculomegaly group compared to controls by 23% (p<0.0001) and 75% 
(p<0.0001) respectively at a GA of 29.6 weeks (Figures 75 and 76) (Table 18). 
 
 
Figure 75. Third ventricle volumes in ventriculomegaly and normal controls 
The volume of the third ventricle was significantly larger in the ventriculomegaly cohort by 23% (p<0.0001).  
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Figure 76. Fourth ventricle volumes in ventriculomegaly and normal controls 
The volume of the fourth ventricle was significantly larger in the ventriculomegaly cohort by 75% (p<0.0001).  
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3.2.3.2.3 Extra-cerebral CSF 
Extra-cerebral CSF volumes increased with GA in the ventriculomegaly group at a relative 
growth rate of 0.1% per week. The ventriculomegaly cohort had significantly larger extra-
cerebral CSF volumes compared to the control group by 14% (p=0.002) at week 29.6 (Figure 77) 
(Table 18). 
 
 
 
Figure 77. Extra-cerebral CSF volumes in ventriculomegaly and normal controls 
Extra-cerebral CSF volume was significantly larger in the ventriculomegaly cohort by 14% (p=0.014).  
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3.2.3.2.4 Cavum septum pellucidum 
In the ventriculomegaly group, CSP width increased from 3.5 mm at week 22, peaked at 6.7 mm 
at 30 weeks and then decreased. The majority of cava showed absence or thinning of the cavum 
vergae after 30 weeks. There was no significant difference in CSP width between the 
ventriculomegaly and control cohorts (p=0.377) (Figure 78). There was large variation between 
34 to 36 weeks due to the limited number of cases. The volume of the CSP increased between 22 
to 30 weeks when it reached a peak and then decreased from 30 to 38 weeks (Figure 79), 
showing a similar evolution pattern to the control cohort. CSP volume was significantly larger in 
the ventriculomegaly group (p=0.014). CSP width and volume correlated well (Pearson's r=0.77, 
p<0.0001), there was however a large scatter in the data (Figure 8). The anterior pellucidum was 
more prominent in the ventriculomegaly group. 
 
 
Figure 78. Cavum septum pellucidum width in ventriculomegaly and normal controls 
There was no difference in CSP width between the ventriculomegaly and normal control cohort. 
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Figure 79. Cavum septum pellucidum volumes in ventriculomegaly and normal controls 
CSP volumes were larger in the ventriculomegaly cohort compares to the normal control cohort (p=0.014). 
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3.2.3.2.5 Supratentorial brain tissue 
Total supratentorial brain parenchyma volume increased exponentially with increasing GA at a 
relative growth rate of 11.65% and 12.35% in the control and ventriculomegaly groups 
respectively, which was not statistically different (Table 18). When comparing between groups 
and correcting for GA, fetuses with isolated ventriculomegaly had significantly larger total brain 
tissue volumes than controls (9.6%, p<0.0001) (Figure 80). In unilateral cases, the hemisphere 
containing the enlarged ventricle was 12.1% larger (p<0.0001) compared to both right and left 
hemispheres in the control cohort (Figure 80). The hemisphere containing the normal sized 
ventricle was also significantly larger than both right and left hemispheres in the normal control 
cohort (11.7%, p<0.0001) (Figure 81). There was no significant difference between the two 
hemispheres in fetuses with unilateral ventriculomegaly (p=0.667) (Figure 82). Significance was 
unchanged when data from repeat scans were excluded and when controlling for sex. 
 
 
Figure 80. Supratentorial brain tissue volumes in ventriculomegaly and normal controls 
Fetuses with isolated ventriculomegaly had significantly larger supratentorial brain tissue volumes compared to 
normal controls by 9.6% (p<0.0001).  
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Figure 81. Supratentorial hemispheric brain tissue volumes in ventriculomegaly and normal controls  
The hemisphere containing the enlarged ventricle was 9.8% larger (p<0.0001) compared to both right and left 
hemispheres in the control group. Left and right hemispheric data points of the control group are indistinguishable 
for better clarity. The ventriculomegaly data shown depict the hemisphere containing the enlarged ventricle in the 
unilateral cases and the hemisphere containing the largest ventricle only in the bilateral cases. 
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Figure 82. Hemispheric tissue volumes in unilateral ventriculomegaly 
There was no significant difference between the two hemispheres in fetuses with unilateral ventriculomegaly 
(p=0.667). 
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3.2.3.2.6 Cortical gray matter 
Total cortical gray matter volume was measured in 19 ventriculomegaly cases (GA range 22.14-
37.29 weeks, mean 30.16 weeks). There was no significant difference between the complete 
group and this subgroup in GA, brain volume and ventricular volume. As expected, when 
comparing between subgroups, brain volumes were significantly larger in the ventriculomegaly 
fetuses compared to controls (p=0.027). The ventriculomegaly group also had significantly larger 
cortices than the controls across the GA range studied (17.2%, p=0.002), even when corrected 
for brain volume (14.6%, p=0.008) (Figure 83).  
 
 
Figure 83. Cortical volume in ventriculomegaly and normal controls 
Fetuses with ventriculomegaly had significantly larger cortices compared to normal controls by 17.25 (p=0.002). 
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3.2.3.2.7 White matter 
White matter increased with GA (Spearman's r=0.963, p<0.0001) at a relative growth rate of 
9.27% per week (Table 18). When comparing between groups there was no significant difference 
in white matter volume (p=0.637), even when correcting for brain tissue volume (0.228) (Figure 
84). 
 
Figure 84. White matter volumes in ventriculomegaly and normal controls 
There were no significant difference  in white matter volumes between the cohorts (p=0.228). 
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3.2.3.2.8 Basal ganglia  
In the ventriculomegaly group, basal ganglia volumes increased at a relative growth rate of 
9.29% per week (Spearman's r=0.946, p<0.0001) (Table 18). There was no difference in volume 
between the two groups (p=0.29) (Figure 85).  
 
Figure 85. Basal ganglia volumes in ventriculomegaly and normal controls 
There were no significant differences in basal ganglia volumes between the cohorts (p=0.29). 
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3.2.3.2.9 Thalami 
Thalami increased with GA at a relative growth rate of 10.61% per week (Spearman's r=0.98, 
p<0.0001) (Table 18). When comparing between groups, there was no significant different in 
volume (p=0.656) (Figure 86). 
 
 
 
Figure 86. Thalamic volumes in ventriculomegaly and normal controls 
There were no significant differences in thalamic volumes between the cohorts (p=0.656). 
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3.2.3.2.10 Correlations with ventricular size  
As described earlier, in the normal controls group the total ventricular volume correlated with the 
total brain tissue, thalamic, third ventricle, fourth ventricle and extra-cerebral CSF volumes 
while there was no correlation with cortical or white matter volume. On the contrary, in the 
ventriculomegaly group the total ventricular volume significantly and positively correlated with 
all measurements. Results are summarised in Table 17. 
Correlation of total ventricular size and intracranial measurements     
  
Total 
Brain 
Tissue 
Cortex 
Basal 
Ganglia 
Thalami 
White 
Matter 
Third 
Ventricle 
Fourth 
Ventricle 
Extra-
cerebral 
CSF 
Normal controls 
(Spearman's r) 
0.54** 0.305 0.289 0.389* 0.34 0.549** 0.457** 0.499** 
Ventriculomegaly 
(Spearman's r) 
0.475** 0.544* 0.640* 0.649* 0.630* 0.449** 0.567** 0.457** 
Table 17. Correlation of total ventricular volume and intracranial volumetric measurements  
Spearman r values are presented for each relationship. * p<0.05 and p>0.0001 ** = p<0.0001 
 
To further assess the relationship between total lateral ventricular volume and brain tissue during 
gestation we assessed the cases that had multiple scans (Figure 87). The paired volumetric data 
from both scans were plotted against GA and compared against the normal controls. While the 
majority of ventriculomegaly paired data have slopes with similar trends there were 2 cases that 
exhibited large changes in volume. The total lateral ventricular volumes of one fetus that was 
scanned three times during gestation showed a steep increase and doubled in volume from 25 to 
32 weeks (case +). However the increase in ventricular volume was not accompanied by a 
change in the total brain tissue volume slope compared to the controls or ventriculomegaly 
group. Another case of a fetus scanned twice during GA, showed a decrease in total lateral 
ventricular volume from 29.7 to 34.7 weeks (case ▲). Similarly to the previous case there was no 
difference in the slope of brain tissue volume compared to controls or ventriculomegaly. 
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Figure 87. Ventricular and supratentorial brain tissue changes in serial scans 
(A) Total ventricular volume change between sequential scans in ventriculomegaly. Fifteen fetuses were scanned 
twice during gestation and 1 fetuses had 3 scans. (B) Brain tissue volume change between sequential scans in 
ventriculomegaly. A change in the total ventricular volume was not accompanied with significant deviation in 
supratentorial brain tissue. 
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The volumetric results for both the control and ventriculomegaly cohorts are summarised in 
Table 18. 
  
Total 
Lateral 
Ventricles 
Total 
Brain 
Tissue 
Cortex 
Basal 
Ganglia 
Thalami 
White 
Matter 
Third 
Ventricle 
Fourth 
Ventricle 
Extra-
cerebral 
CSF 
Normal controls                   
Spearman's r 0.511** 0.976** 0.964** 0.975** 0.993** 0.986** 0.927** 0.733** 0.873** 
Relative Growth Rate 
(%/week) 
3.43 11.65 13.15 11.39 13.13 12.27 0.098 0.129 0.06 
Average volume (cm
3
) 
         
at 22 GW 2.27 53.67 11.01 1.17 0.88 39.15 0.074 0.013 22.68 
at 26 GW 2.68 85.56 19.37 1.89 1.51 63.58 0.110 0.022 57.67 
at 30 GW 3.17 136.41 34.09 3.05 2.57 103.25 0.163 0.035 81.98 
at 34 GW 3.75 217.47 60.00 4.93 4.40 167.66 0.242 0.057 95.59 
at 38 GW 4.43 346.70 105.58 7.94 7.52 272.25 0.359 0.093 98.52 
Ventriculomegaly                   
Spearman's r 0.481** 0.968** 0.971** 0.946** 0.98** 0.963** 0.803** 0.849** 0.769** 
Relative Growth Rate 
(%/week) 
5.58 12.35 12.50 9.29 10.61 9.27 0.088 0.119 0.10 
Average volume (cm
3
) 
         
at 22 GW 7.31 61.10 13.84 1.46 0.99 49.41 0.092 0.029 23.66 
at 26 GW 8.44 96.56 23.48 2.16 1.60 73.01 0.137 0.046 64.73 
at 30 GW 9.74 152.59 39.85 3.18 2.60 107.88 0.203 0.074 91.97 
at 34 GW 11.24 241.14 67.62 4.69 4.20 159.40 0.301 0.119 105.38 
at 38 GW 12.97 381.07 114.74 6.92 6.79 235.53 0.446 0.192 104.96 
Table 18. Volumetric results for control and ventriculomegaly cohorts  
Correlation of each intracranial structure and GA is indicated by the Spearman’s r value. Relative growth rate 
(%/per week) represents the percent volume increase relative to the average volume of the structure.** p<0.0001. 
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3.2.3.3 Statistics 
Volumetric data were not normally distributed and were therefore log-transformed to achieve 
normal distribution. Log transformed data were tested for normality and achieved normal 
distribution. Analysis of covariance (ANCOVA) on log-transformed data was used to compare 
results between groups when corrected for GA. Correlation between variables was assessed 
using the Spearman's correlation coefficient (Spearman's r) correcting for GA, unless otherwise 
specified.  
 
3.2.3.3.1 Intra-rater and inter-rater variability for volumetric analysis  
Intra and inter-rater reliability for the left and right lateral ventricle segmentations and left and 
right hemispheres were performed between 2 raters (VK,DV) in 5 fetal datasets (at GA 23.14, 
23.57, 24.57, 25.57, 36.29 weeks). The  ICC for both intrarater and interater variability was 0.99 
(p<0.0001) suggesting negligible variability between raters and excellent reproducibility in the 
same rater. In order to evaluate the spatial overlap accuracy of the segmentations between raters 
the Dice similarity coefficient was measured for the segmentation of the lateral ventricles in 10 
cases. The Dice similarity coefficient, similar to the Pearsosn's r, has a range of -1 to +1 with 
values close to 1 indicating highly similar data. The Dice similarity coefficient was calculated at 
0.9 indicating excellent agreement between raters. For cortical segmentations, intra and inter-
rater reliability were performed between 2 raters (SE,NM) by calculating the cortical volume of 
five consecutive transverse slices. This was performed for five different fetal datasets (at GA 
24.71, 26.29, 28.57, 30.43, 32.00 weeks). The mean intra-rater difference for the cortical volume 
was 1.2% and mean inter-rater difference was 2.7%.  
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3.2.4 Neonatal volumetry 
3.2.4.1 Normal controls 
The normal control cohort consisted of 24 neonates scanned in the neonatal unit during the study 
period from March 2007 to February 2012. Fourteen neonates were enrolled in the fetal research 
program and had undergone fetal MR imaging. Ten neonates were enrolled as normal controls in 
the following MR research studies of the preterm brain (Optimising functional MRI techniques 
in the study of neuronal development in preterm infants, 07/H0707/101; Computational analysis 
of brain abnormalities and neurodevelopmental impairments in preterm infants, 04/Q0406/125).  
Seven neonates had high signal intensity in the white matter, normal for their postmenstrual age. 
The mean post-menstrual age at scan was 42.5 weeks and the range from 37.9-49.1 weeks. The 
mean GA at birth was 39.2 weeks and the range from 37-41.7 weeks. Cohort characteristics are 
presented in Table 19. 
 
Normal control cohort characteristics     
Male 12   
Female 12   
Gestational age at birth (weeks) 39.2 (37-41.7) 
Post-menstrual age at scan (weeks) 42.5 (37.9-49.1) 
Birthweight (g) 3279 (2410-4242) 
Apgar scores                             1 minute 9 (8-10) 
                                                       5 minutes 10 (9-10) 
Table 19. Normal control cohort characteristics 
 
3.2.4.2 Isolated ventriculomegaly 
During the study period from August 2008 to April 2012, 27 neonates with a diagnosis of 
antenatal isolated ventriculomegaly underwent MR imaging. 26 neonates were enrolled in the 
research program and had undergone fetal MRI. One neonate had not had fetal MR imaging as 
the mother felt claustrophobic during the scan. This subject was a sibling of one of the fetal 
participants and had an ultrasound and a neonatal MR diagnosis of isolated ventriculomegaly. 
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One neonate was excluded from the analysis because of poor image quality due to motion. In 
summary, 26 neonates were used for the analysis with a mean post-menstrual age at scan at 45.3 
weeks and range 41.4-50.4 weeks (Figure 88). The mean GA at birth was 39.5 weeks and the 
range was 34.3-41.4 weeks. Cohort characteristics are presented in Table 20. While there was no 
difference in the age at birth between cohorts there was a significant different in the post-
menstrual age at scan (p=0.001) with the ventriculomegaly cohort being scanned at a later age. 
 
 
Figure 88. Histogram of age distribution of post-menstrual age at scan in the ventriculomegaly and normal 
control groups 
Fetal gestational age was estimated from a first trimester dating ultrasound scan. 
 
Ventriculomegaly cohort characteristics   
Male 19   
Female 7   
Gestational age at birth (weeks) 39.5 (34.3-41.4) 
Post-menstrual age at scan (weeks) 45.3 (41.4-50.4) 
Birthweight (g) 3427 (2530-4260) 
Apgar scores                            1 minute 9 (7-10) 
                                                   5 minutes 10 (9-10) 
Table 20. Ventriculomegaly cohort characteristics 
186 
 
There were no additional CNS structural abnormalities detected on neonatal MRI to alter the 
diagnosis of isolated ventriculomegaly. However mild changes in brain appearance were 
reported on clinical MR examination and have been summarised in Table 21.  
 
Findings on neonatal MRI No. of cases 
Increased extra-cerebral space      10 
Thinning of the corpus callosum       9 
Increased signal intensity in white matter       8 
Signs of delayed gyrification       3 
Table 21. Additional findings on neonatal MRI in the ventriculomegaly cohort 
The findings detected on neonatal MRI in the ventriculomegaly cohort did not alter the diagnosis of isolated 
ventriculomegaly. 
 
Statistics 
Between group comparison was performed using analysis of covariance (ANCOVA). All 
comparisons and correlations were corrected for gestational age at birth and postmenstrual age at 
scan.  
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3.2.4.3 Volumetric analysis 
3.2.4.3.1 Lateral ventricles 
In the normal control group, the total lateral ventricular volume increased with postnatal age 
after birth and correlated significantly with age at scan when corrected for gestational age at birth 
(Pearson's r=0.665, p=0.0003) (Figures 89 and 90). Neonates with ventriculomegaly had 
significantly larger lateral ventricle volumes compared to controls (206% larger, p<0.0001) 
(Figure 89). There was overlap in lateral ventricle volumes in 2 cases. The volumes of both 
lateral ventricles in a ventriculomegaly case were within the limits of the normal control 
volumes. This neonate had two fetal scans, the first at 22 weeks showed 11 mm unilateral 
ventriculomegaly whilst in the second scan at 32 weeks the lateral ventricles had normalised and 
were below 10 mm. One control neonatal case had a lateral ventricle volume in the 
ventriculomegaly range. In the ventriculomegaly cohort, there was correlation between the 
antenatal lateral ventricle volume and neonatal lateral ventricle volume (Pearson's r=0.66, 
p=0.001).  
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Figure 89. Lateral ventricle volumes in normal controls and neonates with antenatal ventriculomegaly  
Neonates with antenatal ventriculomegaly had significantly larger lateral ventricle volumes than controls (206%, 
p<0.0001). There was overlap in 2 cases. Lateral ventricle volumes in the controls cohort represent right and left 
ventricles.  
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Figure 90. Total lateral ventricular volume in normal controls and neonates with antenatal ventriculomegaly 
Neonates with antenatal ventriculomegaly had significantly larger total lateral ventricular volumes than controls 
(p<0.0001). There was overlap in 4 cases.  
 
3.2.4.3.2 Supratentorial brain tissue volume 
Supratentorial brain tissue volume increased in both groups with postmenstrual age and 
correlated with postmenstrual age at scan when corrected for GA at birth (Controls: Spearman's 
r=0.772, p<0.0001; Ventriculomegaly: Spearman's r=0.423, p=0.018) (Figure 90). When 
comparing between groups, neonates with antenatal ventriculomegaly had significantly larger 
total brain tissue volumes than controls (14.8% larger, p=0.002). This difference was not 
statistically significant when looking at each gender separately, probably due to the small sample 
size (males p=0.071, females p=0.938). 
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Figure 91. Supratentorial brain tissue volumes in normal controls and neonates with antenatal 
ventriculomegaly 
Neonates with antenatal ventriculomegaly had significantly larger supratentorial brain tissue volumes compared to 
normal controls by 14.8% (p=0.002).  
 
Out of the 26 neonates, 18 were also included in the fetal volumetric analysis. To ensure the 
neonatal subgroup was representative of the fetal group these 18 cases were identified on the 
fetal chart of supratentorial brain tissue volumes against GA (Figure 92). The selection of cases 
appear to be representative of the fetal cohort. 
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Figure 92. Fetal cases with antenatal ventriculomegaly used in neonatal volumetric analysis 
Fetal sub-population used for neonatal volumetric analysis appears representative of the total fetal population. 
Selected cases are highlighted in blue circles. 
 
3.2.4.3.3 Correlation between lateral ventricles and supratentorial brain tissue volumes 
In the control group, total lateral ventricular volume correlated with supratentorial brain tissue 
volume when corrected for postmenstrual age at scan and GA at birth (Spearman's r=0.639, 
p=0.0001). On the contrary in the ventriculomegaly group there was no correlation between total 
lateral ventricular volume and brain tissue volume when corrected for postmenstrual age at scan 
and GA at birth (Spearman's r=0.303, p=0.07). 
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3.2.5 Discussion 
In this study, using volumetric MRI of the fetal brain we present the first in vivo MRI evidence 
indicating brain overgrowth in fetuses with isolated ventriculomegaly. Fetuses with 
ventriculomegaly had significantly increased brain tissue volumes when compared to controls 
with enlargement restricted to the cortical gray matter. The third and fourth ventricles and extra-
cerebral CSF were also enlarged. White matter, thalamic, and basal ganglia volumes were not 
significantly different between cohorts. Brain overgrowth and ventriculomegaly also persisted 
during neonatal life. 
 
In normal fetuses, supratentorial brain tissue increased between 22 to 38 weeks GA at a relative 
growth rate of 11.65% per week. This is comparable to previous fetal MR volumetric studies 
performed on reconstructed datasets with growth rates ranging from 10.22% to 17% (Clouchoux 
et al., 2011; Rajagopalan et al., 2011a). Cortical volume in our normal fetuses increased at a 
relative growth rate of 13.15%, in agreement with the study of Scott and colleagues (Scott et al., 
2011) in 34 normal fetuses between 20 and 31 weeks GA. In addition, cortical volume increased 
at a higher rate than supratentorial brain volume in our control cohort, as previously shown in the 
fetal (Scott et al., 2011) and in the preterm brain (Kapellou et al., 2006).  
 
Ultrasound studies have shown that the atrial diameter remains relatively stable in the second and 
third trimesters although an increase in absolute values is observed (Almog et al., 2003). Our 
results showed a small but significant increase in absolute ventricle volumetric values from 22 to 
38 weeks of gestation.  Previous fetal MRI volumetric studies have been inconclusive as to 
whether the volume of the lateral ventricles increases (Scott et al., 2011; Snijders and Nicolaides, 
1994), decreases (Clouchoux et al., 2011) or remains stable (Kazan-Tannus et al., 2007) during 
gestation. This variability may be due to heterogeneous cohorts and inclusion of the third 
ventricle or the CSP in the measurements. As shown in our study, enlargement of the lateral 
ventricles with increasing gestation was associated with enlargement of the third and fourth 
ventricles, CSP and extra-cerebral CSF. 
 
As expected, fetuses with ventriculomegaly diagnosed on 2D measurement of the atrial diameter 
(on ultrasound and MRI) had significantly larger lateral ventricle volumes compared to controls. 
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In our cohort, boys were more likely to have ventriculomegaly than girls with a female/male 
ratio of 1:2.4; consistent with previous studies (Gilmore et al., 2008; Melchiorre et al., 2009a). 
Interestingly, in 1/3 of the unilateral ventriculomegaly cases, the normal measuring ventricle 
(atrium <10 mm) demonstrated a ventricular volume outside the normal range. In addition, 
whilst atrial diameter and volume of the lateral ventricles correlated well in both cohorts, data 
were scattered in the ventriculomegaly cohort. For example, an atrial diameter of 12.3 mm 
corresponded to volumes ranging from 4.4-9.2 cm
3
. The atrial diameter only reflects the size of 
the posterior aspect of the lateral ventricles however enlargement may also be present in the 
anterior part of the ventricles. Whilst atrial diameter may be an accurate tool for the diagnosis of 
ventriculomegaly it does not appear to be sensitive to intra-group volumetric differences 
potentially impairing its ability to predict subsequent clinical neurodevelopmental outcome. 
 
Fetuses with isolated ventriculomegaly had significantly larger total brain tissue volumes than 
controls supporting the hypothesis that ventriculomegaly may be associated with brain 
overgrowth which is apparent from mid gestation. Interestingly, in unilateral cases both 
hemispheres were enlarged and brain overgrowth was not localised to the hemisphere containing 
the larger ventricle.  
   
In the control cohort, whilst total lateral ventricular volume correlated with other ventricles, 
extra-cerebral CSF, total brain and thalamic volume, there was no correlation with the other 
brain structures. On the contrary, in the ventriculomegaly cohort, total ventricular volume 
correlated well with all measured intracranial structures suggesting an altered relationship 
between the ventricles and developing structures in this cohort.  
 
There have been four published studies on MR brain volumetry comparing fetuses with 
ventriculomegaly to controls (Grossman et al., 2006; Kazan-Tannus et al., 2007; Pier et al., 2011; 
Scott et al., 2012). Three studies were performed on non-reconstructed T2 MR datasets, not 
corrected for fetal motion and these did not find any significant differences in brain parenchyma 
volume between cohorts (Grossman et al., 2006; Kazan-Tannus et al., 2007; Pier et al., 2011). 
Results from these studies are difficult to interpret due to the selection criteria of normal control 
fetuses, non-homogeneous ventriculomegaly population and volumetric analysis on non-
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reconstructed MR datasets known to be sensitive to fetal motion. These issues have been 
addressed in our study by the use of registered volumetric datasets, the rigid entry criteria of 
normal controls and the follow up of all participants to ensure normal development. In addition, 
a homogeneous “developmental” ventriculomegaly cohort was selected for analysis by excluding 
cases with chromosomal abnormalities, infection, brain parenchyma damage or additional 
abnormalities. Scott et al. (Scott et al., 2012) performed a volumetric comparison of intracranial 
structures between fetuses with isolated ventriculomegaly (n=16) and control subjects (n=16) at 
an age range from 22-25.5 weeks. Structures were automatically segmented. They found no 
significant difference in brain tissue or cortical volume between groups. We repeated our 
analysis in a subgroup of our cohorts using the same age range (22-25.5 weeks) and found that 
fetuses with isolated ventriculomegaly had significantly enlarged brain tissue volumes over a 
similar age range (p=0.038) (ventriculomegaly n=14 and controls n=18). Increased accuracy of 
the manual segmentation method may account for the detection of a volumetric difference.  
 
Ventricular dilatation persisted after birth with the ventriculomegaly cohort having significantly 
larger lateral ventricle volumes compared to controls. In one case with ventriculomegaly, that 
had undergone two fetal scans, the lateral ventricles had "normalised" in the second scan (atrial 
diameter <10 mm). In the neonatal scan, the "normalised" case had lateral ventricle volumes in 
the control range however the supratentorial brain tissue volume was well above the control 
range and more specifically it was the third largest data point. There was no correlation between 
total lateral ventricular volume and supratentorial brain tissue while there was a significant 
correlation in the control group. The clinical MR examination also revealed mild visually 
apparent changes in brain appearance that were not consistent with a specific disorder nor altered 
the diagnosis of isolated ventriculomegaly. The most common change reported was increased 
extra-cerebral space which is in accordance to the volumetric result during fetal life. Thinning of 
the corpus callosum was reported in 9 cases however the clinical significance of this finding is 
unknown and callosal volumetric studies are warranted. Signs of delayed gyrification reported in 
3 cases are in accordance with delayed appearance of cortical landmarks discussed in chapter 
3.3. There were no signs of delayed gyrification during fetal life (scans performed at 28, 28
+5
 and 
30
+5
 gestational weeks) visually overt high signal intensity within the white matter  was reported 
in 8 cases. When reviewing the fetal MR clinical reports high signal intensity in the white matter 
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was reported in one case scanned at 37 gestational weeks. Quantitative analysis with DTI is 
underway. In addition, neonates with ventriculomegaly had significantly larger supratentorial 
brain tissue volumes compared to controls although we have not determined whether brain 
overgrowth is attributed to cortical overgrowth as shown in the fetal volumetric analysis. 
 
Our volumetric results including the absolute volumetric ranges and relative growth rates of the 
white matter and deep gray matter (basal ganglia and thalami) in the control cohort are 
comparable with the study of Scott et al. (2011) in normal fetuses from 20 to 31 gestational 
weeks. Interestingly, when comparing between our two cohorts, there were no significant 
differences in the basal ganglia, thalamic and white matter volumes between control fetuses and 
those with ventriculomegaly. The brain overgrowth documented in our study was attributed to an 
increase in cortical volume. Our results from the fetal volumetric analysis are consistent with the 
study of Gilmore and colleagues (Gilmore et al., 2008) which used volumetric T1 datasets 
acquired postnatally and showed that neonates with isolated ventriculomegaly (n=34) (diagnosed 
on antenatal ultrasound) had significantly larger cortical gray matter volumes than control 
subjects (n =34)  by 10.9% whilst there was no difference in absolute white matter volume 
(decreased when corrected for intracranial volume). In their small follow-up study 
(ventriculomegaly n=11, controls n=12) they showed that ventricular enlargement persisted at 
the age of 2 years and was then associated with increases in both gray and white matter volumes 
(Lyall et al., 2012). The authors suggested that increased surface area along the enlarged 
ventricular wall may result in a larger number of progenitor neurons. Indeed the human cortical 
germinal zone has several cytoarchitectonically distinct zones, that contain the various progenitor 
populations in different proportions (Hansen et al., 2010; Smart et al., 2002). Cortical 
overgrowth from an increase in progenitor neurons from the germinal zone would require the 
presence of ventriculomegaly from early in gestation and would not account for overgrowth 
documented in fetuses with VM diagnosed later in pregnancy with a normal appearance at 20 
weeks. Over migration for these areas after 20 weeks would be more likely due to glial 
populations as late migrating inhibitory neurons arise from different regions in the ganglionic 
eminence. In our study, while the majority of fetuses were diagnosed with ventriculomegaly on 
their anomaly ultrasound scan performed around 20 weeks, 3 fetuses had a normal anomaly scan 
and developed ventriculomegaly at a later age. Greater brain parenchyma and cortical gray 
196 
 
matter volume could also be due to lack of normal developmental apoptosis in the developing 
brain (Kuan et al., 2000) rather than an increased number of migrating cells. Early in gestation 
apoptosis is involved in the development and morphogenesis of the neural tube supporting the 
role of apoptosis in adjusting the initial progenitor pool size (Kuan et al., 2000). At around 4.5 
weeks apoptotic activity is seen in the ventricular zone but is very low. By week 6-7 apoptosis in 
the ventricular zone increases five-fold and there is evidence of apoptosis in the preplate 
(Zecevic and Rakic, 2001). By week 11 apoptosis has commenced in all cortical layers although 
it is most prominent in the proliferative zones. Between 12 and 22 weeks apoptosis increases 
significantly throughout the telencephalon. After 32 weeks apoptosis continues in all cortical 
layers. Apoptosis is an integral part of cortical development, initially related to morphogenesis, 
proliferation and regulation of progenitor size and during the late fetal and postnatal period to 
synaptogenesis. Previous studies in preterm and IUGR infants (Peterson et al., 2000; Tolsa et al., 
2004) have shown that cortical volume and outcome data correlate well; the cortex mediates 
cognitive abilities, and a reduction in cortical volume has been associated with 
neurodevelopmental delay. Interestingly, fetuses with isolated ventriculomegaly also have an 
increased risk of neurocognitive delay (Leitner et al., 2009; Lyall et al., 2012; Sadan et al., 2007)  
but according to this study exhibit increased cortical volumes. This implies that it may be the 
quality of the cortical tissue and its connections not the absolute volume that relates to 
neurocognitive outcome. An increase in cortical volume could be due to an increase in cell 
numbers, synapses or in the extracellular matrix. Ventriculomegaly has been associated with 
brain and cortical overgrowth in a rat model of gestational Vitamin D deficiency. Cortical 
overgrowth in the affected rats was associated with an increase in proliferating cells and a 
decrease in apoptotic cells in the studied cortical regions of the cingulate and dentate gyri (Eyles 
et al., 2003). However it is unclear which cell types contributed to the larger brains. 
 
Cortical development and organisation is regulated by the basic coordinated morphogenetic 
processes of proliferation, apoptosis, migration and differentiation of both neurons and glia 
(Haveman and Lavorel, 1975). Apoptosis is prominent in areas that undergo dramatic 
morphogenetic changes and is essential for the regulation of the proper size and shape of the 
cortex during development. Several animal knockout studies have shown that alterations in genes 
regulating developmental apoptosis lead to changes in cortical size and shape (Chenn and Walsh, 
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2002; Depaepe et al., 2005; Oppenheim et al., 2001). Cortical overgrowth has been described in 
children with neurofibromatosis Type 1 and cortical volume has correlated with the degree of 
learning disability (Moore et al., 2000). The presence of brain overgrowth in autistic children at 
the ages of 2-4 years is well established (Courchesne et al., 2011a). Cortical gray matter and 
white matter enlargement have been found in MRI volumetric studies in children with autism 
with enlargement most prominent in the frontal lobe (Carper and Courchesne, 2005; Courchesne 
et al., 2001; Hazlett et al., 2011). An excess of cerebral cortical neurons (67% increase) has been 
found at autopsy in 7 autistic patients (age median 4 years, range 2-16 years) compared to 
controls which could underlie the volume increases in cerebral gray matter reported (Courchesne 
et al., 2011b). In our cases white matter was not enlarged during fetal life and it was not possible 
to analyse the lobes of the brain separately. The group of Lyall et al. (2012)  detected increases in 
white matter volume at 2 years of age but not in the neonatal period in fetuses with antenatally 
diagnosed ventriculomegaly.  
 
There are several limitations to the current study. Cortical volume segmentations were performed 
only in a subset of fetuses due to the extensive work required to perform detailed and accurate 
manual segmentations. However, we are currently developing and assessing an automatic 
protocol for cortical segmentation. In addition, developmental data for the fetuses in our study 
are currently being collected. Detailed neurodevelopmental assessments using the Griffiths 
Mental Development Scales and BSID-III Scales of Infant and Toddler Development are 
performed at 1 and 2 years respectively and a battery of autism tests including the Autism 
Diagnostic Observation Schedule (ADOS) and Autism Diagnostic Interview-Revised (ADI-R) at 
3 years. The question of homogeneity of the ventriculomegaly cohort has arisen on many 
occasions and it has been an issue not addressed in previous studies. In order to achieve 
homogeneity we excluded cases of infection and chromosomal abnormalities, metabolic 
syndromes and cases with ventriculomegaly and associated CNS abnormalities. The only 
limitation that may influence homogeneity in our cohort would be ventricular size. Previous 
studies have shown that moderate/severe ventricular size is associated with an abnormal 
outcome. However we thought important to include cases of all ventricular sizes in order to 
correlate the volume of the lateral ventricles with other MR biometric parameters measured. 
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In this study we have demonstrated brain overgrowth, restricted to cortical enlargement, in 
association with fetal ventriculomegaly while brain overgrowth persisted into neonatal life. 
Cortical overgrowth may occur secondary to disruption in the regulation of cell proliferation and 
apoptosis and subsequent altered brain connectivity may explain the high risk of later 
neurodevelopmental delay in these children. Importantly, brain overgrowth persisted during 
neonatal life in the cohort of fetuses with ventriculomegaly scanned as neonates although further 
analysis is required in order to determine whether brain overgrowth is attributed to cortical 
overgrowth and to subjectively quantify changes in white matter signal intensity and tract 
volume e.g. corpus callosum using advanced MR techniques such as DTI and tractography.
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3.3 Assessment of cortical development and maturation 
Cortical development occurs with an invariable temporospatial schedule and has therefore been 
relied upon by neuropathologists as an accurate marker of fetal brain maturation. Deviations 
from this highly orchestrated sequence of gyral-sulcal formation may be associated with later 
neurocognitive deficits. Cognitive impairment is thought to have a neurobiological origin within 
the developing cerebral cortex. Therefore, investigating cortical development in-utero may 
provide a useful tool for predicting outcome amongst those fetuses affected with 
ventriculomegaly. In this chapter we have characterised the developmental stages of the fetal 
cortex during normal development and compared these normative indices to fetuses with isolated 
ventriculomegaly.  
 
3.3.2 Aims 
To design a detailed protocol for the evaluation of cortical development and establish whether 
ventriculomegaly is associated with delayed or abnormal cortical maturation. 
 
3.3.3 Normal control cohort 
The normal control cohort consisted of 72 fetuses scanned at a mean GA of 29.4 weeks and a 
GA range from 22.4-38.9 weeks. Six fetuses were scanned twice during gestation and one fetus 
was scanned three times. 
 
3.3.3.1 Gestational age of early sulcation 
Gestational age at scan and presence of early sulcation (score 1) of each sulcus and gyrus is 
presented in a whisker box plot in Figure 93 to depict the variation in the appearance of sulci and 
gyri between fetuses. The GA range at which each landmark has a score of 1 in 25-75% of 
fetuses is presented in Table 22 and results are comparable with previous studies using MRI and 
ultrasound. 
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Figure 93. Gestational age and presence of early sulcation (score 1) of cortical landmarks in normal controls 
The boxes represent the gestational age range at which 25-75% of fetuses had a score of 1. Box plot represents the 
median (light blue/dark blue boundary), lower (light blue) and upper (dark blue) quartiles and minimum and 
maximum values (box plot wiskers). 
PO: parieto-occipital fissure, Cal: calcarine, STG: superior temporal gyrus, STS: superior temporal sulcus, MTG: 
middle temporal gyrus, ITG: inferior temporal gyrus, SFG: superior frontal gyrus, SFS: superior frontal sulcus, 
MFG: middle frontal gyrus, IFG: inferior frontal gyrus, IFS: inferior frontal sulcus, Postcentral: postcentral gyrus, 
Precentral: precentral gyrus, Central: central sulcus. 
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  Fetal MRI       Ultrasound 
Cortical landmarks 
This study 
25-75% 
Levine 
>75% 
Garel  
25-75% Fogliarini 
Pistorius  
25-75% 
Sylvian fissure  Before 22  16-17  Before 20 Before 22 
Parieto-occipital fissure 23 18-19 22-23  22 
Postcentral gyrus 24-25 26-27  27   
Central sulcus 24-25 26-27 24-25 24 26 
Calcarine sulcus 24-27 18-19 22-23 24   
Cingulate sulcus 26-27 26-27     
Superior temporal gyrus 24      
Superior temporal sulcus 27-29 26-27 30 28 25 
Middle temporal gyrus 27-30      
Inferior temporal gyrus 29-30      
Precentral gyrus 24-25 26-27  27   
Inferior frontal gyrus 24-25      
Superior frontal gyrus 27      
Middle frontal gyrus 27      
Inferior frontal sulcus 27 30-31 27    
Superior frontal sulcus 27-28   24-25     
Table 22. Gestational age of early appearance (score 1) of cortical landmarks in normal controls 
Gestational age of early appearance of cortical landmarks as detected in our study and in comparison with previous 
fetal studies using MRI and ultrasound (Fogliarini et al., 2005; Garel, 2004; Levine and Barnes, 1999; Pistorius et 
al., 2010). The Sylvian fissure was present in all fetuses. 
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The strength of association for each cortical landmark between development scores and GA in 
the normal control cohort is presented in Table 23. Cortical development scores were highly 
correlated with GA and were similar for all areas. 
Cortical 
landmark 
Central 
sulcus 
Pre 
central 
gyrus 
Post 
central 
gyrus 
Parieto-
occipital 
fissure 
Calcarine 
sulcus 
Sylvian 
fissure 
ratio 
Cingulate 
length 
Superior 
frontal 
gyrus 
Spearman's r 0.946** 0.962** 0.945** 0.913** 0.938** 0.909** 0.943** 0.939** 
Cortical 
landmark 
Superior 
frontal 
sulcus 
Middle 
frontal 
gyrus 
Inferior 
frontal 
gyrus 
Inferior 
frontal 
sulcus 
Superior 
temporal 
gyrus 
Superior 
temporal 
sulcus 
Middle 
temporal 
gyrus  
Inferior 
temporal 
gyrus 
Spearman's r 0.932** 0.925** 0.958** 0.929** 0.928** 0.925** 0.938** 0.913** 
Table 23. Correlation of cortical development scores with GA in normal controls 
Correlation was assessed using the Spearman's correlation coefficient (r). * p<0.05 and p>0.0001 ** p<0.0001 
 
The height of each sulcus and gyrus increased with increasing GA and correlated strongly with 
increasing GA in the normal control cohort (Table 24). The width of different cortical landmarks 
either decreased or remained stable with increasing GA as summarised in Table 24.   
Cortical 
landmark 
Central 
sulcus 
Pre 
central 
gyrus 
Post 
central 
gyrus 
Parieto-
occipital 
fissure 
Calcarine 
sulcus 
Superior 
frontal 
gyrus 
Superior 
frontal 
sulcus 
Height 0.938** 0.934** 0.938** 0.887** 0.831** 0.613** 0.760** 
Width -0.296 -0.21* -0.49** -0.679** -0.405* 0.212 -0.106 
Cortical 
landmark 
Middle 
frontal 
gyrus 
Inferior 
frontal 
gyrus 
Inferior 
frontal 
sulcus 
Superior 
temporal 
gyrus 
Superior 
temporal 
sulcus 
Middle 
temporal 
gyrus  
Inferior 
temporal 
gyrus 
Height 0.786** 0.66** 0.739** 0.922** 0.781** 0.757** 0.665** 
Width 0.225 0.224** 0.151 -0.268* -0.28* -0.182 -0.026 
Table 24. Correlation of height and width of cortical landmarks with GA in normal controls 
Correlation was assessed using the Spearman's correlation coefficient (r). * = p<0.05 and >0.0001 ** = <0.0001 
 
The cortical development scores and linear measurements for each cortical landmark assessed in 
the normal control cohort are presented in Figures 94-101. 
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3.3.3.2 Frontal lobe 
(Precentral gyrus, superior frontal gyrus, superior frontal sulcus, middle frontal gyrus, 
inferior frontal gyrus, inferior frontal sulcus) 
 
In the normal control cohort, the cortical development scores and height of all five landmarks 
representing the frontal lobe increased with GA. The width of the superior, middle and inferior 
gyri increased and correlated weakly with GA and was significant only for the inferior gyrus. 
The width of the superior frontal sulcus and precentral gyrus decreased with GA although it did 
not reach significance. The results for the frontal lobe are presented in Figures 94-96. There were 
9 control fetuses with one degree of asymmetry and 1 control fetus with two degrees of 
asymmetry in the precentral gyrus. There were 5 control fetuses with one grade of asymmetry for 
the superior frontal gyrus, 6 control fetuses with one grade of asymmetry and 1 control fetus with 
a two grade asymmetry in the superior frontal sulcus. The middle frontal gyrus showed one grade 
of asymmetry in 1 control fetus and two grades of asymmetry in another control fetus. Five 
control fetuses showed one grade of asymmetry in the inferior frontal gyrus and 5 control fetuses 
in the inferior frontal sulcus. In five control fetuses the asymmetry was present in more than one 
landmarks of the frontal lobe. 
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Figure 94. Precentral gyrus and superior frontal gyrus development in normal controls 
(A-D) Precentral gyrus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) and width 
(red). Development score (r=0.962, p<0.0001) and height (r=0.934, p<0.0001) increased whilst the width decreased with GA (r=-0.21, p<0.05). 
(E-H) Superior frontal gyrus development in normal controls (E) Development scores (F) Height, (G) Width, (H) Linear measurements of height (blue) and 
width (red). Development score (r=0.939, p<0.0001) and height (r=0.613, p<0.0001) increased whilst the width remained stable with GA (r=0.212, p>0.05). Only 
one case had a score of 1. 
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Figure 95. Superior frontal sulcus and middle frontal gyrus development in normal controls 
(A-D) Superior frontal sulcus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) and 
width (red). Development score (r=0.932, p<0.0001) and height (r=0.76, p<0.0001) increased whilst the width remained stable with GA (r=-0.106, p>0.05). 
(E-H) Middle frontal gyrus development in normal controls (E) Development scores (F) Height, (G) Width, (H) Linear measurements of height (blue) and 
width (red). Development score (r=0.925, p<0.0001) and height (r=0.786, p<0.0001) increased whilst the width remained stable with GA (r=0.225, p>0.05).  
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Figure 96. Inferior frontal gyrus and inferior frontal sulcus development in normal controls 
(A-D) Inferior frontal gyrus development in normal controls 
Development score (r=0.958, p<0.0001), height (r=0.66, p<0.0001) and width (r=0.224, p<0.0001) increased with GA. (A) Development scores (B) Height, (C) 
Width, (D) linear measurements of height (blue) and width (red).  
(H-E) Inferior frontal sulcus development in normal controls 
Development score (r=0.929, p<0.0001) and height (r=0.739, p<0.0001) increased whilst the width remained stable with GA (r=0.151, p>0.05). (E) Development 
scores (F) Height, (G) Width, (H) Linear measurements of height (blue) and width (red). 
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3.3.3.3 Frontal/parietal border and frontal/parietal/temporal border 
(Central sulcus and Sylvian fissure) 
 
In the normal control cohort, the cortical development score and height of the central sulcus 
increased with GA (score: Spearman's r=0.962, p<0.0001; height: Spearman's r=0.938, 
p<0.0001) whilst the width showed a trend for decrease although this was not statistically 
significant (Spearman's r=0.962, p>0.05) (Figure 97A-D). Four control fetuses had one grade 
asymmetry while all other fetuses were symmetrical. 
 
The Sylvian fissure development ratio increased with GA (Spearman's r=0.909, p<0.0001) 
(Figure 97E-H). As the fissure matured the maximum distance from frontal to temporal 
boundaries along the insula-temporal cortex increased (Spearman's r=0.959, p<0.0001) while the 
minimum distance frontal to temporal borders of the operculum decreased with GA (Spearman's 
r=-0.749, p<0.0001).  
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Figure 97. Central sulcus and Sylvian fissure development in normal controls  
(A-D) Central sulcus development in normal controls (A) Development scores (B) Height, (C) Width, (D) linear measurements of height (blue) and width 
(red). Development score (r=0.946, p<0.0001) and height (r=0.938, p<0.0001) increased whilst the width remained stable with GA (r=-0.296, p>0.05). 
(E-H) Sylvian fissure development in normal controls (A) Development score representing the ratio of the insula distance to the opercular distance, (B) Insular 
distance (C) Opercular distance, (H1-H2) Linear measurements of (1) insula (blue) (2) operculum (black). The development score (r=0.959, p<0.0001) and insula 
distance (r=0.959, p<0.0001) increased whilst the operculum distance (p=-0.749, p<0.0001) decreased with GA. 
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3.3.3.4 Parietal lobe 
(Postcentral gyrus, parieto-occipital fissure) 
 
In the normal control cohort, the development score and height of the postcentral gyrus increased 
with GA (score Spearman's r=0.945, p<0.0001; height Spearman's r=0.938, p<0.0001) while the 
width of the gyrus significantly decreased (Spearman's r=-0.49, p<0.0001) (Figure 98A-D). 
There were 3 control fetuses with one grade of asymmetry while the rest of the fetuses were 
symmetrical. 
The development score of the parieto-occipital fissure and the height increased with GA (score 
Spearman's r=0.945, p<0.0001; height Spearman's r=0.938, p<0.0001) while the width of the 
sulcus significantly decreased (Spearman's r=0.647, p<0.0001) (Figure 98E-H). Seven control 
fetuses showed one grade of asymmetry. There were 4 control fetuses with one grade of 
asymmetry and 1 control fetus with 2 grades of asymmetry. 
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Figure 98. Postcentral gyrus and parieto-occipital fissure development in normal controls 
(A-D) Postcentral gyrus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) and width 
(red). Development score (r=0.945, p<0.0001) and height (r=0.938, p<0.0001) increased whilst the width decreased with GA (r=-0.49, p<0.001). 
(E-H) Parieto-occipital fissure development in normal controls (E) Development scores (F) Height, (G) Width, (H) Linear measurements of height (blue) and 
width (red). Development score (r=0.913, p<0.0001) and height (r=0.887, p<0.0001) increased whilst the width decreased with GA (r=-0.679, p<0.001).
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3.3.3.5 Temporal lobe 
(Superior temporal gyrus, superior temporal sulcus, middle temporal gyrus, inferior 
temporal gyrus) 
 
In the normal control cohort, the cortical development scores and height of all four landmarks 
representing the temporal lobe increased with GA. The width of all landmarks decreased 
although there was a weak correlation with GA and it did not reach significance for the middle 
temporal and inferior temporal gyrus. Results for the temporal lobe are presented in Figures 99 
and 100. There were 4 control fetuses with one grade of asymmetry and 1 control fetus with two 
grades of asymmetry in the superior temporal gyrus. For the temporal sulcus there were 8 control 
fetuses with one grade of asymmetry, 2 control fetuses with two grades of asymmetry and 1 
control fetus with three grades of asymmetry. For the middle temporal gyrus there were 6 control 
fetuses with one grade of asymmetry and 1 control fetus with two grades of asymmetry. Lastly 
for the inferior temporal gyrus there were 4 control fetuses with one grade of asymmetry and 1 
control fetus with two grades of asymmetry. In 4 control fetuses asymmetry was present in more 
than one landmark of the temporal lobe. 
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Figure 99. Superior temporal gyrus and superior temporal sulcus development in normal controls 
(A-D) Superior temporal gyrus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) 
and width (red). Development score (r=0.613, p<0.0001) and height (r=0.922, p<0.0001) increased whilst the width decreased with GA (r=-0.268, p<0.05). 
(E-H) Superior temporal sulcus development in normal controls (E) Development scores (F) Height, (G) Width, (H) Linear measurements of height (blue) 
and width (red). Development score (r=0.925, p<0.0001) and height (r=0.781, p<0.0001) increased whilst the width decreased with GA (r=-0.28, p<0.05). 
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Figure 100. Middle temporal gyrus and inferior temporal gyrus development in normal controls 
(A-D) Middle temporal gyrus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) and 
width (red). Development score (r=0.938, p<0.0001) and height (r=0.757, p<0.0001) increased whilst the width remained stable with GA (r=-0.182, p>0.05). 
(E-H) Inferior temporal gyrus development in normal controls (E) Development scores (F) Height, (G) Width, (H) Linear measurements of height (blue) and 
width (red). Development score (r=0.913, p<0.0001) and height (r=0.665, p<0.0001) increased whilst the width remained stable with GA (r=-0.026, p>0.05). 
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3.3.3.6 Occipital lobe 
(Calcarine sulcus) 
 
In the normal control cohort, the cortical development score, calcarine height and length 
increased with GA (score Spearman's r=0.938, p<0.0001; height Spearman's r=0.771, p<0.0001; 
length Spearman's r=0.923, p<0.0001) while the width decreased with GA (Spearman's r=-0.521, 
p<0.0001) (Figure 101A-F). Seven control fetuses had one grade of asymmetry.  
 
 
3.3.3.7 Limbic lobe 
(Cingulate sulcus) 
 
In the normal control cohort, the cingulate sulcus length increased with increasing GA 
(Spearman's r=0.943,p<0.0001) (Figure 101G-H). There was no significant difference in 
cingulate sulcus length between the left and right hemispheres (p=0.945). 
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Figure 101. Calcarine sulcus and cingulate sulcus development in normal controls 
(A-F) Calcarine sulcus development in normal controls (A) Development scores (B) Height, (C) Width, (D) Linear measurements of height (blue) and width 
(red), (E) Length, (F) Linear measurement of length (blue). Development score (r=0.938, p<0.0001) length (r=0.923, p<0.0001) and height (r=0.771, p<0.0001) 
increased whilst the width remained stable with GA (r=-0.521, p<0.0001). 
(G-H) Cingulate sulcus development in normal controls (G) Length, (H) Linear measurements of length (blue). Cingulate sulcus length increased with GA 
(r=0.943, p<0.0001). 
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3.3.4 Comparison with ventriculomegaly cohort 
The ventriculomegaly cohort consisted of 63 fetuses scanned at a mean GA of 29.7 weeks and a 
GA range of 22-37.3 weeks. 14 fetuses were scanned twice during gestation while one fetus was 
scanned three times. 
 
3.3.4.1 Gestational age of early sulcation 
The gestational age at which the individual landmarks had most immature configuration (score 
1) in the ventriculomegaly cohort and normal control cohort are presented in a whisker box plot 
in Figure 102. There was an apparent delayed appearance in the ventriculomegaly cohort of all 
cortical landmarks assessed, by an average of 2 gestational weeks. The delay was statistically 
significant for the majority of sulci and gyri with the exception of the central sulcus, superior 
frontal sulcus, inferior frontal sulcus and superior temporal gyrus in which although a delay in 
appearance was evident it did not reach statistical significance.  
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Figure 102. Gestational age of early sulcation (score 1) of cortical landmarks in normal controls (blue) and 
ventriculomegaly (pink) cohorts 
Box plot represents the median (light/dark colour boundary), lower (light colour) and upper (dark colour) quartiles 
and minimum and maximum values (box plot whiskers). 
PO: parieto-occipital fissure, Cal: calcarine, STG: superior temporal gyrus, STS: superior temporal sulcus, MTG: 
middle temporal gyrus, ITG: inferior temporal gyrus, SFG: superior frontal gyrus, SFS: superior frontal sulcus, 
MFG: middle frontal gyrus, IFG: inferior frontal gyrus, IFS: inferior frontal sulcus. 
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The strength of association between development scores and GA for the ventriculomegaly cohort 
is presented for each cortical landmark in Table 25. Cortical development scores highly 
correlated with GA and were similar for all areas.  
Cortical 
landmark 
Central 
sulcus 
Pre 
central 
gyrus 
Post 
central 
gyrus 
Parieto-
occipital 
fissure 
Calcarine 
sulcus 
Sylvian 
fissure 
ratio 
Cingulate 
length 
Superior 
frontal 
gyrus 
Spearman's r 0.891** 0.944** 0.932** 0.91** 0.926** 0.883** 0.898** 0.925** 
Cortical 
landmark 
Superior 
frontal 
sulcus 
Middle 
frontal 
gyrus 
Inferior 
frontal 
gyrus 
Inferior 
frontal 
sulcus 
Superior 
temporal 
gyrus 
Superior 
temporal 
sulcus 
Middle 
temporal 
gyrus  
Inferior 
temporal 
gyrus 
Spearman's r 0.947** 0.937** 0.915** 0.929** 0.864** 0.924** 0.923** 0.894** 
Table 25. Correlation of cortical development scores with GA in ventriculomegaly 
Correlation was assessed using the Spearman's correlation coefficient (r). * =<0.05 and >0.0001 ** = <0.0001 
 
In the ventriculomegaly cohort, the height of each sulcus and gyrus increased and strongly 
correlated with GA. The width of different cortical landmarks varied with increasing GA for 
each landmark as summarised in Table 26.   
Cortical 
landmark 
Central 
sulcus 
Pre 
central 
gyrus 
Post 
central 
gyrus 
Parieto-
occipital 
fissure 
Calcarine 
sulcus 
Superior 
frontal 
gyrus 
Superior 
frontal 
sulcus 
Height 0.843** 0.878** 0.931** 0.833** 0.659** 0.626* 0.603* 
Width -0.182 -0.343* -0.180 -0.776* -0.532* 0.498* -0.304 
Cortical 
landmark 
Middle 
frontal 
gyrus 
Inferior 
frontal 
gyrus 
Inferior 
frontal 
sulcus 
Superior 
temporal 
gyrus 
Superior 
temporal 
sulcus 
Middle 
temporal 
gyrus  
Inferior 
temporal 
gyrus 
Height 0.829** 0.867** 0.736* 0.963** 0.665** 0.753* 0.767** 
Width 0.439* 0.598* 0.055 0.001 -0.382* -0.763** -0.077 
Table 26. Correlation of height and width of cortical landmarks with GA in ventriculomegaly  
Correlation was assessed using the Spearman's correlation coefficient (r). Asterisk indicates significance    * p<0.05 
and p>0.0001 ** p<0.0001 
 
The cortical development score and linear measurements for each cortical landmark assessed in 
the control and ventriculomegaly cohorts are presented in Figures 103-110. 
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3.3.4.2 Frontal lobe 
(Precentral gyrus, superior frontal gyrus, superior frontal sulcus, middle frontal gyrus, 
inferior frontal gyrus, inferior frontal sulcus) 
 
Precentral gyrus 
In the ventriculomegaly cohort, the cortical development score and height of the precentral gyrus 
increased with GA (score Spearman’s r=0.944, p<0.0001; height Spearman’s r=0.878, p<0.0001) 
while the width decreased during gestation (Spearmans's r=-0.343, p<0.05). There was a 
significant difference in GAs in cortical development scores 1 and 2 between ventriculomegaly 
and control cohorts (p=0.017 and p=0.045 respectively) with higher GA values in the 
ventriculomegaly cohort (Figure 103A-D). There was no difference in scores 3, 4 and 6 between 
ventriculomegaly and control cohorts. There were 5 fetuses with ventriculomegaly with one 
grade asymmetry with 2 fetuses more advanced in the non-ventriculomegaly case. There were 2 
fetuses with ventriculomegaly with two grades of asymmetry both more advanced on the 
ventriculomegaly side. There was no difference in height (p=0.531) or width (p=0.532) of the 
precentral gyrus between ventriculomegaly and control cohorts.  
 
Superior frontal gyrus 
In the ventriculomegaly cohort, the cortical development score, height and width of the superior 
frontal gyrus increased with GA (score Spearman’s r=0.925, p<0.0001; height Spearman’s 
r=0.626, p<0.05; width Spearman's r=0.498, p<0.05). There was no difference in GAs in scores 
1, 2, 4 and 6. The ventriculomegaly group had lower GA values in score 3 compared to the 
control group (p=0.022), however the number of cases was limited (Figure 103E-H). There were 
2 fetuses with ventriculomegaly with one grade of asymmetry. One fetus was more advanced on 
the non-ventriculomegaly side. There was no difference in the height of the superior frontal 
gyrus between ventriculomegaly and control cohorts (p=0.724). There was a significant 
difference in the width of the superior frontal gyrus between ventriculomegaly and control 
cohorts with higher values in the ventriculomegaly group (p=0.001). This difference however 
was not significant when removing the three outliers (p=0.076).  
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Figure 103. Precentral gyrus and frontal gyrus development in normal control and ventriculomegaly cohorts 
(A-D) Precentral gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) Width, 
(D) Linear measurements of height (blue) and width (red). There was a significant delay in development scores 1 (p=0.017) and 2 (p=0.045) in the 
ventriculomegaly cohort. There was no difference in the height (p=0.531) or width (p=0.532) between cohorts.  
(E-H) Superior frontal gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) 
Width, (H) Linear measurements of height (blue) and width (red). There was a significant difference in score 3 between cohorts although numbers were limited. 
There was no significant difference in height between cohorts (p=0.724) between cohorts. The width was significantly increased (p=0.001) in the 
ventriculomegaly cohort, however significance was lost when removing the 3 outliers (0.076).  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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Superior frontal sulcus 
In the ventriculomegaly cohort, the cortical development score and height of the superior frontal 
sulcus increased with GA (score Spearman’s r=0.947, p<0.0001; height Spearman’s r=0.603, 
p<0.05) while there was a weak non-significant decrease in the width of the sulcus with GA 
(Spearman's r=-0.304, p>0.05). The was no difference in the GA in any of the cortical 
development scores between ventriculomegaly and control cohorts (Figure 104A-D). There were 
3 fetuses with ventriculomegaly with one grade asymmetry with 1 fetus being more advanced on 
the non-ventriculomegaly side. There was 1 fetus with ventriculomegaly with three grade 
asymmetry with a higher score on the non-ventriculomegaly side. There was no difference in the 
height (p=0.994) or width (p=0.451) of the superior frontal sulcus between ventriculomegaly and 
control cohorts. 
 
Middle frontal gyrus  
In the ventriculomegaly cohort, the cortical development score, height and width of the middle 
frontal gyrus increased with GA (score Spearman’s r=0.937, p<0.0001; height Spearman’s 
r=0.829, p<0.0001; width Spearman's r=0.439, p<0.05). However there was missing data in 
scores 3 and 4. The ventriculomegaly cohort had significantly higher GA values in score 1 
compared to controls (p=0.016). The was no difference in GAs in scores 2 and 6 (Figure 104E-
H). There were 2 fetuses with ventriculomegaly with one grade asymmetry with the non-
ventriculomegaly side being more advanced. There was 1 fetus with ventriculomegaly with a 
four grade asymmetry more advanced on the non-ventriculomegaly side. There was no 
difference in the height (p=0.624) or width (p=0.558) of the middle frontal gyrus between 
ventriculomegaly and control cohorts. 
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Figure 104. Superior frontal sulcus and middle frontal gyrus development in normal control and ventriculomegaly cohorts 
(A-D) Superior frontal sulcus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) 
Width, (D) Linear measurements of height (blue) and width (red). There was no difference in development scores (p>0.05), height (p=0.994) or width (p=0.451) 
between cohorts. 
(E-H) Middle frontal gyrus development in normal (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) Width, (H) 
Linear measurements of height (blue) and width (red). There was a significant delay in development score 1 in the ventriculomegaly cohort (p=0.016). There was 
no difference in height (0.624) or width (p=0.558) between cohorts.  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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Inferior frontal gyrus  
In the ventriculomegaly cohort, the cortical development score, height and width of the inferior 
frontal gyrus increased with GA (score Spearman’s r=0.915, p<0.0001; height Spearman’s 
r=0.876, p<0.0001; width Spearman's r=0.598, p<0.05). There was no difference in GAs in 
cortical development scores of 2, 3, 4 and 6 between ventriculomegaly and control cohorts 
(Figure 105A-D). There was a significant difference in GA in score 1 with the ventriculomegaly 
cohort exhibiting higher GA values (p=0.048). There were 2 fetuses with ventriculomegaly with 
one grade of asymmetry and both were advanced on the non-ventriculomegaly side. There was a 
significant difference in the height of the inferior frontal gyrus with the ventriculomegaly group 
having higher values at a mean of 0.68 mm at 27.9 weeks (p=0.022). In addition, the 
ventriculomegaly group had higher width measurements compared to controls at a mean of 0.59 
mm (p=0.022). When removing the one outlier the significance was lost (p=0.06). 
 
Inferior frontal sulcus 
In the ventriculomegaly cohort, the cortical development score and height of the inferior frontal 
sulcus increased with GA while the width remained stable through gestation (score: Spearman’s 
r=0.929, p<0.0001; height: Spearman’s r=0.736, p<0.05; width: Spearman's r=0.055, p>0.05). 
There was no difference in GA in any of the cortical development scores between 
ventriculomegaly and control cohorts (Figure 105E-H). There were 2 fetuses with 
ventriculomegaly with one grade asymmetry more advanced on the non-ventriculomegaly side. 
There was no significant difference in the height (p=0.681) or width (p=0.227) of the inferior 
frontal sulcus between ventriculomegaly and control cohorts. 
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Figure 105. Inferior frontal gyrus and inferior frontal sulcus development in normal control and ventriculomegaly cohorts 
(A-D) Inferior frontal gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) 
Width, (D) Linear measurements of height (blue) and width (red). There was a significant delay in development score 1 in the ventriculomegaly cohort 
(p=0.048). The height was significantly increased in the ventriculomegaly cohort (p=0.022). The width was significantly increased (p=0.022) in the 
ventriculomegaly cohort however significance was lost when removing the 1 outlier (p=0.06). 
(E-H) Inferior frontal sulcus development in normal control (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) 
Width, (H) Linear measurements of height (blue) and width (red). There was no difference in development scores (p>0.05), height (p=0.681) or width (p=0.227) 
between cohorts. 
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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3.3.4.3 Frontal/parietal border and frontal/parietal/temporal border 
(Central sulcus and Sylvian fissure) 
 
Central sulcus 
In the ventriculomegaly cohort, the cortical development score and height of the central sulcus 
increased with GA (score Spearman’s r=0.891, p<0.0001; height Spearman’s r=0.843, p<0.0001) 
whilst the width showed a weak trend for decrease although this was not statistically significant 
(Spearman’s r=-0.182, p>0.05) (Figure 106A-D). Four fetuses with ventriculomegaly had one 
grade asymmetry while all other fetuses were symmetrical. Two of the 4 fetuses with 
ventriculomegaly had a lower score on the ventriculomegaly side. When comparing the GAs at 
each development score the ventriculomegaly cohort had lower GAs for scores 1, 4, 5 and 6. 
Only score 5 had a significant difference between ventriculomegaly and control cohorts 
(p=0.0009). Scores 2 and 3 had limited number of cases. There was no significant difference in 
the height or width of the central sulcus between ventriculomegaly and control cohorts (height 
p=0.844, width p=0.259). 
 
Sylvian fissure 
In the ventriculomegaly cohort, the Sylvian fissure development ratio increased with GA 
(Spearman's r=0.883, p<0.0001). As the fissure matured the maximum distance from frontal to 
temporal boundaries along the insula-temporal cortex increased (Spearman's r=0.955, p<0.0001) 
while the minimum distance frontal to temporal borders of the operculum decreased (Spearman's 
r=-0.65, p<0.0001). There was no difference between ventriculomegaly and control cohorts in 
the maximum distance from frontal to temporal boundaries along the insula-temporal cortex 
(p=0.369) or the development ratio (p=0.106) (figure 106E-H). There was a significant 
difference (p=0.03) in the minimum distance frontal to temporal borders of the operculum with 
the ventriculomegaly cohort having higher values. The mean distance at 29.1 weeks in the 
control group was 11.96 mm while in the ventriculomegaly cohort the mean distance was 12.97 
mm. 
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Figure 106. Central sulcus and Sylvian fissure development in normal control and ventriculomegaly cohorts 
(A-D) Central sulcus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) Width, (D) 
Linear measurements of height (blue) and width (red). There was a significant delay in score 5 in the ventriculomegaly cohort (p=0.009). There was no difference 
in the height (p=0.844) or width (p=0.259) between cohorts. 
(E-H) Sylvian fissure development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development score representing the ratio of the 
insula distance to the opercular distance, (B) Insular distance (C) Opercular distance, (H1-H2) Linear measurements of (1) insula (blue) (2) operculum (black). 
There was no significant difference in the score or insular distance between cohorts. The opercular distance was significantly increased in the ventriculomegaly 
cohort (p=0.03).  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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3.3.4.4 Parietal lobe 
(postcentral gyrus, parieto-occipital fissure) 
 
Postcental gyrus 
In the ventriculomegaly cohort, the development score and height of the postcentral gyrus 
increased with GA (score Spearman’s r=0.932, p<0.0001; height Spearman’s r=0.931, p<0.0001) 
while the width of the gyrus showed a weak non-significant decrease (Spearman’s r=-0.18, 
p>0.05) (Figure 107A-D). There were 7 fetuses with ventriculomegaly with one grade of 
asymmetry with the lower scores on the ventriculomegaly side. There were 6 fetuses with 
ventriculomegaly with two grades of asymmetry with the lower score on the ventriculomegaly 
side. There was 1 fetus with ventriculomegaly with 3 grades of asymmetry with the lower score 
on the ventriculomegaly side. When comparing between ventriculomegaly and control cohorts, 
the GAs in each development score were higher in the ventriculomegaly group. The 
ventriculomegaly cohort showed a delay in appearance of each score however this reached 
significance only in scores 1 and 4. There was no significant difference in the height (p=0.138) 
or width (p=0.61) of the postcentral gyrus between ventriculomegaly and control cohorts.  
 
Parieto-occipital fissure 
In the ventriculomegaly cohort, the development score and height of the parieto-occipital 
increased with GA (score Spearman’s r=0.91, p<0.0001; height Spearman’s r=0.833, p<0.0001) 
while the width decreased with GA (Spearman’s r=-0.776, p<0.05) (Figure 107E-H). There were 
4 fetuses with ventriculomegaly with one degree of asymmetry with 2 more advanced on the 
non-ventriculomegaly side. There was 1 fetus with ventriculomegaly with 2 degrees of 
asymmetry with the ventriculomegaly side being more advanced. When comparing between 
ventriculomegaly and control cohorts, the GAs in each development were higher in the VM 
group. Significance was reached for scores 1, 2, 3 and 5. The height of the fissure was 
significantly decreased in the ventriculomegaly group by an average of 0.6 mm at 30.2 weeks. 
The width of the fissure was significantly increased in the ventriculomegaly cohort by an average 
of 0.8 mm at 28.4 weeks. 
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Figure 107. Postcentral gyrus and parieto-occipital fissure development in normal control and ventriculomegaly cohorts 
(A-D) Postcentral gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) Width, 
(D) Linear measurements of height (blue) and width (red). There was a significant delay in scores 1 (p=0.054) and 4 (p=0.053) in the ventriculomegaly cohort. 
There was no difference in the height (p=0.138) or width (p=0.61) between cohorts.  
(E-H) Parieto-occipital fissure development in normal control (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) 
Width, (H) Linear measurements of height (blue) and width (red). There was a significant delay in scores 1 (p=0.004), 2 (p<0.0001), 4 (p=0.007) and 5 
(p<0.0001). The height was significantly reduced (p=0.012) whilst the width was significantly increased (p<0.0001) in the ventriculomegaly cohort. 
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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3.3.4.5 Temporal lobe 
(superior temporal gyrus, superior temporal sulcus, middle temporal gyrus, inferior 
temporal gyrus) 
 
In the ventriculomegaly cohort, the development score and height of all landmarks of the 
temporal lobe increased with GA. The width of the superior temporal sulcus and gyrus decreased 
with GA while the width of the superior and inferior temporal gyri remained stable with 
increasing GA. Results for the temporal lobe are presented in Figures 108-109. 
 
Superior temporal gyrus 
In the superior temporal gyrus, the ventriculomegaly cohort had higher GAs at scores 1, 2 and 4, 
with only score 4 being significant (Figure 108A-D). In score 3 the ventriculomegaly cohort had 
lower GA values that controls and score 6 did not have sufficient numbers to compare. There 
was one grade asymmetry in 4 fetuses with ventriculomegaly all more advanced on the non-
ventriculomegaly side. There was 1 fetus with ventriculomegaly with two grade asymmetry more 
advanced on the non-ventriculomegaly side. There was no difference in the height (p=0.783) of 
the superior temporal gyrus between ventriculomegaly and control cohorts while the difference 
in width measurements was borderline significant (p=0.057) with the higher values in the 
ventriculomegaly group. The average width in the control group at 30.4 weeks was 3.27 mm and 
in the ventriculomegaly group 3.51 mm. 
 
Superior temporal sulcus 
In the superior temporal sulcus, there was no difference in GAs between cohorts in the different 
cortical development scores except for score 1 (p=0.037) (Figure 108E-H). There were 6 fetuses 
with ventriculomegaly with one grade asymmetry, out of which 5 were more advanced on the 
non-ventriculomegaly side. There was 1 fetus with ventriculomegaly with a three grade 
asymmetry more advanced on the non-ventriculomegaly side. There was no difference in the 
height (p=0.109) or width (p=0.693) of the superior temporal sulcus between ventriculomegaly 
and control cohorts. 
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Figure 108. Superior temporal gyrus and superior temporal sulcus development in normal control and ventriculomegaly cohorts 
(A-D) Superior temporal gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) 
Width, (D) Linear measurements of height (blue) and width (red). There was a significant delay in score 5 (p=0.035) in the ventriculomegaly cohorts. There was 
no significant difference in height (p=0.783) whilst the width was increased (p=0.057) in the ventriculomegaly cohort. 
(E-H) Superior temporal sulcus development in normal control (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) 
Width, (H) Linear measurements of height (blue) and width (red). There was a significant delay score 1 in the ventriculomegaly cohort. There was no difference 
in the height (p=0.109) or width (p=0.693) between cohorts.  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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Middle temporal gyrus 
In the middle temporal gyrus, the ventriculomegaly cohort had higher GA values in scores 1 
(p=0.021) and 4 (p=0.01) while there was no difference in scores 2, 3 and 5 (p=0.93, p=0.64, 
p=0.48 respectively) (Figure 109A-D). There were 7 fetuses with ventriculomegaly with one 
grade asymmetry, 5 of which were more advanced on the non-ventriculomegaly side. There was 
1 fetus with ventriculomegaly with two grade asymmetry more advanced on the 
ventriculomegaly side. There was no difference in the height (p=0.299) or width (p=0.329) of the 
middle temporal gyrus between ventriculomegaly and control cohorts. 
 
Inferior temporal gyrus 
In the inferior temporal gyrus, the ventriculomegaly cohort had higher GA values in scores 1 and 
4 (significant for score 1). There were 8 fetuses with ventriculomegaly with one grade 
asymmetry, in 7 of which the non-ventriculomegaly side was more advanced (Figure 108E-H). 
There was a significant difference in the height of the inferior temporal gyrus (p=0.004) with a 
mean difference of 0.64 mm at 34 weeks. There was no difference in the width of the inferior 
temporal gyrus between ventriculomegaly and control cohorts (p=0.332).  
 
 
 
 
232 
 
 
 
 
Figure 109. Middle temporal gyrus and inferior temporal gyrus development in normal control and ventriculomegaly cohorts 
(A-D) Middle temporal gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) 
Width, (D) Linear measurements of height (blue) and width (red). There was a delay in scores 1 (p=0.021) and 4 (p=0.01) in the ventriculomegaly cohort. There 
was no difference in height (p=0.299) or width (p=0.329) between cohorts.  
(E-H) Inferior temporal gyrus development in normal control (green/black) and ventriculomegaly (red) cohorts (E) Development scores (F) Height, (G) 
Width, (H) Linear measurements of height (blue) and width (red). There was a delay in score 1 (p=0.003) in the ventriculomegaly cohort. The height was 
significantly reduced (p=0.004) in the ventriculomegaly cohort whilst there was no difference in the width between cohorts.  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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3.3.4.6 Occipital lobe 
(Calcarine sulcus) 
 
In the ventriculomegaly cohort, the development score and height of the calcarine sulcus 
increased with GA (score Spearman’s r=0.926, p<0.0001; height Spearman’s r=0.0.659, 
p<0.0001) while the width decreased (Spearman’s r=-0.532, p<0.05) (Figure 110A-F). There 
were 13 fetuses with ventriculomegaly with one grade of asymmetry with 12 being more 
advanced on the non-ventriculomegaly side. There were 2 fetuses with ventriculomegaly with 
two grades of asymmetry, both more advance on the non-ventriculomegaly side. 
When comparing between ventriculomegaly and control cohorts, the GAs in development scores 
1, 2, 3 and 4 were higher in the ventriculomegaly group. There was no difference in score 5 
while in score 6 there were insufficient numbers in the ventriculomegaly cohort. Score 3 had a 
clear difference between ventriculomegaly and control cohorts however significance was 
borderline (p=0.06). There was no difference in the height of the sulcus (p=0.126), however the 
width was significantly larger in the ventriculomegaly cohort by 0.8 mm at 30
+5
 weeks.  
 
3.3.4.7 Limbic lobe 
(Cingulate sulcus) 
 
In the ventriculomegaly cohort, the cingulate sulcus length increased with increasing GA 
(Spearman’s r=0.898, p<0.0001). There was no difference in length between the groups 
(p=0.474) (Figure 110G-H). 
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Figure 110. Calcarine sulcus and cingulate sulcus development in normal control and ventriculomegaly cohorts 
(A-F) Calcarine sulcus development in normal control (green/black) and ventriculomegaly (red) cohorts (A) Development scores (B) Height, (C) Width, 
(D) Linear measurements of height (blue) and width (red), (E) Length, (F) Linear measurement of length (blue). There was no difference in the length of the 
cingulate sulcus between cohorts (p=0.474). 
(G-H) Cingulate sulcus development in normal control (black) and ventriculomegaly (red) cohorts (G) Length, (H) Linear measurements of length (blue). 
There was a significant delay in scores 1 (p=0.0004), 2 (p=0.004) 3 (p=0.06), and 4 (p=0.047) in the ventriculomegaly cohort. There was no significant 
difference in the length (p=0.158) or height (p=0.126) between cohorts. The width was significantly increased (p=0.0002) in the ventriculomegaly cohort.  
Data shown include both left and right sides for controls and only the side with the larger ventricle for fetuses with ventriculomegaly. 
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3.3.5 Statistics 
To access the strength of the association between the development score and GA, Spearman 
correlation coefficient (r) was used. Degrees/grades of asymmetry refer to the number of 
difference in score between hemispheres. Cortical asymmetry in the ventriculomegaly cohort 
was assessed only in the unilateral cases. All measurements were performed by the same 
examiner (VK) to exclude confounding factors of inter-observer variability. To ensure 
reproducibility between the same examiner, 40 linear measurements (including height and 
width) of the superior temporal gyrus were performed twice. The ICC was calculated at 
0.969 (p<0.0001) indicated excellent reproducibility of measurements. Between group 
comparisons were performed using ANOVA. Detailed results presented so far in this chapter 
are not corrected for multiple comparisons.  
 
3.3.5.1 Correction for multiple comparisons 
In order to correct for multiple comparisons performed and minimise the Type-1 error the 
Bonferroni correction was applied to the results of the cortical analysis by multiplying all p 
values by the total number of measurements performed (n=32). The results prior to and after 
correction are presented in Table 27. When comparing between cohorts and applying the 
Bonferroni correction significance remained for the width and score 2 of the parieto-occipital 
fissure and for the width, score 1 and score 2 for the calcarine sulcus. 
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    Linear measurements Development scores       
Cortical landmarks Height Width Length 
score 
1 
score 
2 
score 
3 
score 
4 
score 
5 
score 
6 
Central sulcus NS NS n/a NS NS NS NS 0.009 NS 
Precentral gyrus NS NS n/a 0.017 0.045 NS NS n/a NS 
Postcentral gyrus NS NS n/a 0.054 NS NS 0.053 n/a NS 
Parieto-occipital fissure 0.008 0.00002 n/a 0.054 0.0001 NS 0.007 0.019 NS 
Superior frontal gyrus NS NS n/a NS NS 0.022 NS n/a NS 
Superior frontal sulcus NS NS n/a NS NS NS NS NS NS 
Middle frontal gyrus NS NS n/a 0.016 NS NS NS NS NS 
Inferior frontal gyrus 0.043 NS n/a 0.048 NS NS NS n/a NS 
Inferior frontal sulcus NS NS n/a NS NS NS NS NS NS 
Superior temporal gyrus NS 0.057 n/a NS NS NS 0.035 n/a NS 
Superior temporal sulcus NS NS n/a 0.037 NS NS NS NS NS 
Middle temporal gyrus NS NS n/a 0.021 NS NS 0.01 n/a NS 
Inferior temporal gyrus 0.004 NS n/a 0.003 NS NS NS n/a NS 
Calcarine sulcus NS 0.001 NS 0.0004 0.001 0.022 0.041 NS NS 
Cingulate length n/a n/a NS n/a n/a n/a n/a n/a n/a 
Table 27. Inter-group comparisons of cortical measurements 
P values for inter-group comparisons of linear measurements and development scores not corrected for multiple 
comparisons. Results that remain significant after Bonferroni correction are highlighted in red. NS non-
significant (p>0.05), n/a not available (measurement was not performed). 
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3.3.6 Discussion 
In this study, we describe regional differences in cortical development between fetuses with 
isolated ventriculomegaly and control fetuses. Between 22 and 38 weeks of gestation there 
were differences in gyrification in cortical regions including a delayed appearance of cortical 
gyri and sulci representative of each brain lobe. The major differences in cortical maturation 
that persisted throughout gestation were detected in the calcarine sulcus and parieto-occipital 
fissure although a delay was evident throughout the cerebral cortex but did not reach 
significance. More cortical asymmetries between hemispheres were detected for the 
calcarine sulcus in the ventriculomegaly cohort with the ventriculomegaly side being more 
delayed. The Sylvian fissure showed aberrant development with a significant increase in the 
opercular distance length. 
 
Normal controls 
The process of development and maturation of gyri and sulci can be quantified/documented 
in the fetus using the revised cortical development scheme which appropriately depicts 
gradual stages of cortical folding and maturation as indicated by the highly significant 
correlation values between development scores and GA. This individual delineation of sulci 
and gyri allows the detection of a differential temporal maturation pattern related to brain 
spatial location. Our findings on the timescale of gyrification corroborate previous in vivo 
studies although not all landmarks assessed in our study are included in previous imaging 
studies (Fogliarini et al., 2005; Garel, 2004; Levine and Barnes, 1999; Pistorius et al., 2010). 
Some variation exists which may be due to the strict anatomic criteria used in our study. 
Gyrification scoring and measurements were performed on specific image slices to achieve 
consistency between measurements and obtain comparable results. In addition variation 
amongst studies may be due to inaccuracies in the determination of gestational ages, small 
cohorts and inclusion of twin pregnancies. A simplified but accurate way for scoring normal 
development would be a visual score of several sulci or gyri at each gestational age. 
 
The earliest appearing landmark which was already present at 22 weeks was the Sylvian 
fissure which is recognisable at around 14 weeks as a smooth lateral depression (primary 
Sylvian fissure) (Toi et al., 2004). As the temporal and parietal lobes form and enlarge they 
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overgrow the insula, a process known as operculisation which proceeds in a well-defined 
manner. By term, the insular is completely embedded by the operculum (Chen et al., 1996). 
The second appearing landmark was the parieto-occipital fissure which appeared at week 23 
weeks of gestation and between 34-36 weeks complex folds had started to appear. The 
appearance of the parieto-occipital fissure was followed by the superior temporal gyrus 
which was the earliest appearing cortical landmark in the anterior part of the temporal lobe at 
week 24. The remaining landmarks of the temporal lobe, including the inferior and middle 
temporal gyri and superior temporal sulcus, do not appear until weeks 27-30. Between 24-27 
weeks the calcarine begins to form which is followed by the appearance of the postcentral 
gyrus and central sulcus at weeks 24-25 and the precentral gyrus at week 26. At weeks 24-25 
the inferior frontal gyrus also starts to form while the rest of the frontal lobe landmarks 
including the inferior and superior frontal sulci and middle frontal gyrus all start to form at 
weeks 27-28. The latest appearing landmarks include the inferior and middle temporal gyri 
and superior temporal sulcus which start to form at weeks 27-30. The cingulate sulcus which 
was assessed using the full length of the sulcus appears at approximately 27-29 weeks and 
forms in a posterior to anterior manner. The asynchronous development of the cortex may 
reflect differential development of underlying white matter connections during the fetal 
period. 
 
Isolated ventriculomegaly 
When comparing the gestational age of the early form of each cortical landmark between 
cohorts, the ventriculomegaly cohort showed delayed appearance of all cortical landmarks 
studied although significance was not reached for the inferior and superior frontal and central 
sulci. Interestingly altered cortical development was not restricted to the regions proximal to 
the ventricular dilatation suggesting altered global brain development. However, except for 
the calcarine and parieto-occipital fissure we were not able to establish whether cortical 
maturation delay persisted throughout gestation in all brain regions because of the time 
required for full maturation of each sulcus. It is evident that a delay in reaching different 
developmental scores was present however statistical significance was not achieved in many 
cases. The data may be suggestive of delay in cortical maturation throughout gestation 
however this would have to be confirmed in a larger sample size. In addition as there is 
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normal variability in the appearance of cortical folding in normal fetuses this introduced 
'noise' into the data not allowing for statistical significance to be achieved with small 
numbers. Alteration in the shape of cortical regions was detected for the calcarine sulcus 
(width), parieto-occipital fissure (height and width), inferior frontal gyrus (height), superior 
temporal gyrus (width), and inferior temporal gyrus (height). There was no obvious 
alteration in shape detected on visual assessment. A delay in cortical development score may 
be accompanied by an increased width and/or decreased height of the landmarks. These 
results are consistent with a delay in the maturation of the different cortical regions with the 
exception of the inferior frontal gyrus where the height of the gyrus was significantly higher 
in the ventriculomegaly cohort. 
 
The Bonferroni correction was applied to correct for multiple comparisons and significant 
differences remained in the calcarine and parieto-occipital landmarks. Although the 
Bonferroni is a conservative approach for correction it may be inappropriate to assume that 
individual cortical sulci and gyri are developing independent to each other. The data suggest 
that there are significant changes in cortical folding more prominent in the calcarine and 
parieto-occipital areas. 
 
There have been few studies reporting cortical gyrification differences between high-risk and 
control cohorts. The mean time lag of appearance of cortical landmarks between 
ventriculomegaly and control cohorts observed in our study was approximately 2 weeks. 
There was some overlap between cohorts in the GA range as shown in the mean and SD 
plots presented in the Appendix 6.5. Levine and Barnes (1999) compared the gestational age 
of appearance of different cortical regions in 9 fetuses with isolated mild ventriculomegaly 
on MRI with the expected age of appearance based on neuroanatomical studies. Similar to 
our study, they reported a 2-week mean lag in the time of appearance of the cortical regions 
studied. Scott et al. (2012) used curvature analysis to compare cortical development in 16 
fetuses with isolated ventriculomegaly (10-15 mm) and 16 controls over a gestational age 
period of 22-25.5 weeks. They reported reduced cortical folding only in the parieto-occipital 
fissure in fetuses with ventriculomegaly but the lack of difference in cortical regions 
identified in comparison to our study may be due to the limited gestational period studied. 
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When reviewing our data during the gestational period 22-25.5 weeks a difference in the age 
of appearance was only observed in the parieto-occipital fissure as the majority of cortical 
folds have not yet appeared. Cortical development has also been assessed in preterm infants 
as a substrate for neurodevelopment impairment and studies have shown delayed cortical 
development at term equivalent age (Ajayi-Obe et al., 2000; Kapellou et al., 2006).  
 
Fetuses with ventriculomegaly also exhibited altered development of the Sylvian fissure. 
While there was no difference in the length of the insula, the open distance length of the 
operculum was larger in the ventriculomegaly cohort. If the increased opercular distance was 
simply an effect of an enlarged brain it would be expected that the insular distance would be 
increased as well giving a stable ratio and therefore similar maturational status. Our results 
suggest altered development of the operculum in fetuses with ventriculomegaly. Increased 
interopercular distance ('open operculum’) accompanied with a normal insular and normal 
appearing frontal lobe has been described as the most common opercular abnormality by 
Chen et al. (1996) in 58 infants presenting with macrocephaly, microcephaly, seizures, 
developmental delay and tonal abnormalities. The authors reported that there were no other 
associated cerebral abnormalities while 50 cases did not have an obvious underlying disease. 
Because the operculum encompasses regions involved in language, speech, auditory and 
secondary somatic sensory and motor function aberrant development or malformation at this 
area may cause impairments with developmental delay (Barkovich et al., 1992; Chen et al., 
1996). It is unclear whether the changes in cortical development detected in our study have a 
functional impact on the later neurodevelopment of these children, long-term outcome 
studies are required to investigate an association. 
 
Regional delays in gyrification may indicate abnormal cortical development and a 
neurobiological substrate for neurodevelopmental deficits in children with antenatal 
ventriculomegaly. As discussed previously there have been several theories regarding the 
mechanisms of cortical folding. The tension-based theory supports that cortical folding is an 
effect of mechanical tension excreted by white matter fibre bundles (VanEssen, 1997). 
Cortical regions that are strongly interconnected are "pulled together" leading to the 
formation of sulci. Imaging studies however support that white matter fibre endings 
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concentrate on gyri and growing axons result in expansion of the gyral regions in tangenital 
directions (Nie et al., 2011). Although there is a debate regarding the precise underlying 
mechanisms of cortical folding, it is agreed that white matter fibre and synaptic development 
play an important role in the fine-tuning of cortical development. Thus our data on altered 
cortical development may reflect abnormal cortical connectivity as a substrate for later 
impairment.
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3.4 Assessment of metabolite ratios during gestation 
3.4.1 Background 
Fetal brain development involves changes in biochemistry as well as morphology and 
1
HMRS is an invaluable tool for studying the in vivo metabolism in normal development and 
pathology. However little is known about the biochemical changes that occur during fetal 
brain development due to the technical limitations of 
1
HMRS which include fetal motion. In 
this chapter we have used an optimised approach to quantify the metabolic changes 
occurring during normal development in fetuses from 22 to 38 weeks of gestation and 
compare these with changes in metabolism associated with isolated ventriculomegaly. Data 
were obtained at three different echo times of 42msec, 136msec and 270msec to allow for 
detection and quantification of different metabolites 
 
3.4.2 Aim 
To assess differences in brain metabolite ratios between fetuses with isolated 
ventriculomegaly and normal fetuses at three different echo times. 
 
3.4.3 Reproducibility 
The 136ms echo time datasets in the normal control cohort were analysed by another 
examiner (LS) and have been previously published (Story et al., 2011a). To ensure 
reproducibility of pre-processing between investigators, 8 spectra were analysed by both the 
same and two different investigators and the results were compared. Datasets from 8 normal 
fetuses (echo time 136ms) were blindly analysed by 2 different investigators (VK and LS) 
and the ratios of NAA:Cho, NAA:Cr, Cho:Cr were calculated and the presence of lactate 
recorded. The same 8 datasets were analysed twice on separate occasions by the same 
investigator (VK) to evaluate intra-rater variation. The inter-rater and intra-rater intraclass 
correlation coefficients were 0.972 (p<0.0001) and 0.964 (p<0.0001) respectively suggesting 
excellent agreement between rates and within the same rater. 
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3.4.4 Spectral acquisition at echo time 136ms 
3.4.4.1 Cohorts 
53 normal controls and 46 fetuses diagnosed with isolated ventriculomegaly were included in 
the analysis. At an echo time of 136ms, 71% of the spectra obtained in the normal control 
and 67% from the ventriculomegaly cohorts were suitable for analysis. Therefore, 37 
interpretable spectra were obtained from the control (GA range 21.3-38.3, mean 30.7 weeks) 
and 31 from the ventriculomegaly cohort (GA range 22-37, mean 29.4 weeks). 3 fetuses with 
ventriculomegaly and 1 normal control fetus had spectroscopy data from two separate scans 
at different GAs. The remaining spectra were uninterpretable due to fetal motion.  
 
NAA, choline and creatine were identified in all spectra. In 1 case although choline was 
identified it was not detected by the software due to the small size of the peak. An example 
of a typical spectrum is shown in Figure 111.  
 
Figure 111. Fetal spectrum at 136ms of a normal control fetus at 32
+2
 gestational weeks 
Representative fetal spectrum acquired at echo time 136ms. Choline, creatine and NAA peaks are 
distinguished. 
3.4.4.2 Metabolite ratios during gestation in normal control fetuses at echo time 136ms 
In the control group NAA:Cho and NAA:Cr increased with increasing GA (Spearman's 
r=0.595, p<0.0001; Spearman's r=0.309, p=0.031 respectively) while Cho:Cr ratios 
decreased (Spearman's r=-0.275, p=0.049) (Figure 112). 
244 
 
 
 
 
Figure 112. NAA:Cho, Cho:Cr and NAA:Cr ratios varying with gestation in normal control fetuses 
acquired at an echo time of 136ms 
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Lactate was present in 5 normal fetuses (GA range 24.57-37.71 weeks). There was no 
difference in NAA:Cho (p=0.813), NAA:Cr (p=0.772) or Cho:Cr (p=0.39) ratios in the 
control cohort between fetuses with and without lactate. 
 
3.4.4.3 Differences in metabolite ratios between normal controls and fetuses with 
ventriculomegaly at echo time 136ms 
In the ventriculomegaly cohort, NAA:Cho increased with GA (Spearman’s r=0.577, 
p<0.0001), NAA:Cr remained stable (Spearman’s r=0.21, p=0.129) and Cho:Cr decreased 
(Spearman’s r=-0.338, p=0.031). The NAA:Cho ratios corrected for GA were significantly 
lower in fetuses with ventriculomegaly compared to controls (p=0.004) (Figure 113). There 
was no significant difference in the NAA:Cr and Cho:Cr ratios between ventriculomegaly 
and control cohorts (p=0.231 and p=0.087 respectively). In the ventriculomegaly group, 
lactate was present in 7 fetuses while in an additional 1 fetus the presence of lactate was 
equivocal. There was no difference in NAA:Cho (p=0.813), NAA:Cr (p=0.105) or Cho:Cr 
(p=0.058) ratios in the ventriculomegaly cohort between fetuses with and without lactate. 
The GA range of the 7 fetuses with lactate was 24.7-33.7 weeks and the atrial diameter range 
was 10-15.3 mm. There was no difference in GA or atrial diameter between fetuses with and 
without lactate. There was no difference in GA between fetuses with ventriculomegaly and 
controls with lactate present. 
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Figure 113. NAA:Cho, Cho:Cr and NAA:Cr ratios varying with gestation in normal control fetuses and 
fetuses with isolated ventriculomegaly acquired at an echo time of 136ms 
Fetuses with ventriculomegaly had significantly lower NAA:Cho (p=0.004) ratios while there was no 
difference in Cho:Cr (p=0.231) and NAA:Cr (p=0.087) ratios. 
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3.4.5 Spectral acquisition at echo time 270ms 
41 normal controls and 36 fetuses diagnosed with isolated ventriculomegaly were included in 
the analysis. At an echo time of 270ms, 56% of the spectra obtained in the control and 66% 
from the ventriculomegaly cohorts were suitable for analysis. Therefore, 23 interpretable 
spectra from the control (GA range 22.4-38.7, mean 30.8 weeks) and 24 interpretable spectra 
from the ventriculomegaly cohort were obtained (GA range 22.1-37.4, mean 29.4 weeks). 
The remaining spectra were uninterpretable due to fetal motion. An example of a 
representative spectrum is shown in Figure 114. 
 
 
Figure 114. Fetal spectrum at 270ms in a normal control fetus at 24
+4
 gestational weeks 
Representative fetal spectrum acquired at echo time 270ms. Choline, creatine and NAA peaks are 
distinguished. 
 
3.4.5.1 Metabolite ratios during gestation in normal control fetuses at echo time 270ms 
In the control group NAA:Cho increased with increasing GA (Spearman's r=0.69, p<0.0001) 
while NAA:Cr showed a weak non-significant increase (Spearman's r=0.296, p=0.085) and 
Cho:Cr ratios remained stable (Spearman's r=0.034, p=0.44) (Figure 115). Lactate was 
present in 6 normal control fetuses. 
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Figure 115. NAA:Cho, Cho:Cr and NAA:Cr ratios varying with gestation in normal control fetuses 
acquired at an echo time of 270ms 
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3.4.5.2 Differences in metabolite ratios between normal control and fetuses with 
ventriculomegaly at echo time 270ms 
 
In the ventriculomegaly cohort, NAA:Cr, NAA:Cho and Cho:Cr ratios were stable through 
gestation (Spearman’s r=0.237, p=0.132, r=0.124, p=0.281, r=-0.11, p=0.48 respectively). 
There was no difference in the NAA:Cr, NAA:Cho and Cho:Cr ratios between 
ventriculomegaly and control cohorts (p=0.560, p=0.581 and p=0.111 respectively) (Figure 
116). In the ventriculomegaly cohort, lactate was present in 11 fetuses while in an additional 
4 fetuses the presence of lactate was equivocal. 
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Figure 116. NAA:Cho, Cho:Cr and NAA:Cr ratios varying with gestation in normal control fetuses and 
fetuses with isolated ventriculomegaly acquired at an echo time of 270ms 
 There was no significant difference in NAA:Cho, Cho:Cr and NAA:Cr rations between cohorts. 
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3.4.6 Lactate presence at 136ms and 270ms 
In 22 normal control fetuses, data were interpretable in both 136ms and 270ms echo times 
allowing for comparison. Five fetuses at echo time 136ms had a lactate peak while only 2 of 
those fetuses also had a lactate peak at echo time 270ms. An additional 3 fetuses had a 
lactate peak in echo time 270ms not present in 136ms. An example of a discrepancy case is 
shown in Figure 117. 
 
 
Figure 117. Lactate detection at 136ms and 270ms echo times 
Discrepancy of lactate peak in a 37
+5
 old fetus at echo times 136ms and 270ms. An obvious lactate peak is 
present at 136ms but not at 270ms. 
 
3.4.7 Spectral acquisition at echo time 42ms 
37 normal controls and 41 fetuses diagnosed with isolated ventriculomegaly were included in 
the analysis. At an echo time of 42ms, 62% of the spectra from the control and 73% from the 
ventriculomegaly cohorts were suitable for analysis. Therefore, 23 interpretable spectra from 
the control (GA range 23.1-37.4, mean 31.6 weeks) and 30 interpretable spectra from the 
ventriculomegaly group (GA range 22-37.4, mean 29 weeks) were obtained. The remaining 
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spectra were uninterpretable  due to fetal motion. An example of a representative spectrum is 
shown in Figure 118. 
 
Figure 118. Fetal spectrum at 42ms 
Representative fetal spectrum acquired at echo time 42ms. Myo-inositol, choline and creatine peaks are 
distinguished. 
 
3.4.7.1 Metabolite ratios during gestation in normal control fetuses at echo time 42ms 
In the control group MI:Cho ratios were stable with increasing GA (Spearman's r=0.049, 
p=0.412) while MI:Cr and Cho:Cr ratios showed a weak non-significant decrease 
(Spearman's r=-0.295, p=0.081; Spearman's r=-0.289, p=0.081) (Figure 119).  
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Figure 119. MI:Cho, MI:Cr and Cho:Cr ratios varying with gestation in normal control fetuses acquired 
at an echo time of 42ms 
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3.4.7.2 Differences in metabolite ratios between normal controls and fetuses with 
ventriculomegaly at echo time 42ms 
In the ventriculomegaly cohort, MI:Cho, MI:Cr and Cho:Cr ratios were stable with 
increasing GA (Spearman’s r=-0.23, p=0.111, r=-0.243, p=0.098, r=-0.057, p=0.382 
respectively). The MI:Cho and MI:Cr ratios corrected for GA were significantly lower in 
fetuses with ventriculomegaly compared to controls (p=0.001 and p=0.028 respectively) 
while the Cho:Cr were significantly higher in the ventriculomegaly cohort (p=0.028) (Figure 
120).  
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Figure 120. MI:Cho, MI:Cr and Cho:Cr ratios varying with gestation in normal control fetuses and 
fetuses with isolated ventriculomegaly acquired at an echo time of 42ms 
Fetuses with ventriculomegaly had significantly lower MI:Cho (p=0.001) and MI:CR (p=0.028)  ratios while 
Cho:Cr ratios were significantly higher (p=0.028) compared to the control cohort. 
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3.4.8 Discussion 
This study has demonstrated that fetuses with isolated ventriculomegaly had significant 
alterations in their metabolic pattern compared to normal control fetuses. More specifically, 
NAA:Cho, MI:Cho, MI:Cr ratios were significantly lower in fetuses with ventriculomegaly 
whilst Cho:Cr were significantly higher at echo time 42ms in the ventriculomegaly cohort 
compared to controls. However there was no significant difference in Cho:Cr ratios at echo 
times 136ms and 270ms. 
 
Normal controls 
In the normal control cohort, NAA:Cho and NAA:Cr ratios increased with GA at echo times 
136ms and 270ms while Cho:Cr ratios decreased in echo times 136ms and 42ms. These 
results are in accordance with the study by Kok et al. (2002) in a cohort of 35 fetuses from 
30 to 41 weeks GA. They showed that NAA:Cho and NAA:Cr increased whilst Cho:Cr 
ratios decreased with advancing GA and suggested that these changes reflected brain 
maturation. The NAA:Cho increase with advancing gestation shown in our results may be 
due to increasing NAA and may reflect the development of dendrites and synapses and 
proliferation and differentiation of oligodendrocytes (Fenton et al., 2001). Decreasing 
choline levels may also account for the observed increase in NAA:Cho ratios (Girard et al., 
2006b). The choline peak comprises of glycerophosphocholine, phosphocoline and free 
choline and the prominence of the peak likely represents the high levels of substrate required 
for the formation of cell membranes and myelin synthesis (Huppi and Inder, 2001). Both 
glial and neurons are involved in its uptake (Girard et al., 2006a). Previous fetal studies 
measuring the absolute levels of choline during gestation have been conflicting as to whether 
the levels decrease (Girard et al., 2006a) or remain stable (Kok et al., 2002). These 
differences may be due to the different GA ranges studied. The decrease in NAA:Cr ratios 
may be attributed to an increase in NAA levels and relatively stable creatine levels during 
gestation. The creatine peak comprises of creatine and phosphocreatine which are involved 
in energy production. Previous studies have shown that absolute creatine levels are stable 
during gestation and have suggested that it is an ideal reference for quantification of other 
metabolites (Heerschap et al., 2003; Kok et al., 2002).  
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At an echo time of 42ms, the MI:Cho ratios were stable whilst the MI:Cr decreased, this may 
reflect a decrease in the MI levels and relatively stable creatine levels and decreasing choline 
levels. Girard et al. (2006b) was able to calculate absolute levels of MI in the fetal brain from 
22 to 39 weeks GA based on assumptions of spin relaxation times and brain tissue water 
content. They found a decrease in myo-inositol levels with GA and later suggested that this 
may reflect the high density of glial cells in between 22 and 28 weeks (Girard et al., 2006a).  
 
In the normal control cohort, lactate was detected in 5 normal control fetuses at an echo time 
of 136ms and 6 normal control fetuses at an echo time of 270ms. Agreement between echo 
times 136ms and 270ms was observed in only 2 fetuses. There has been controversy 
regarding the role of lactate in the fetal brain as studies using animal models indicated that it 
is a product of anaerobic glycolysis and accumulates in cases of acute hypoxia, while in 
human neonates lactate production is a result of a hypoxic insult (van Cappellen van Walsum 
et al., 1998). When reviewing our cases in which lactate was present 1 fetus was aged 37
+5 
weeks GA and the woman ruptured her membranes shortly after her MRI scan and 
retrospectively reported of tightenings during the scan. It is possible that she was in the early 
stages of labour and lactate levels were reflecting transient hypoxaemia. The rest of the 
normal control fetuses however were between 24 and 34 weeks in gestation. The role of 
lactate as a supplementary fuel for activated neurons has also been debated (Korf, 2006). It is 
suggested that lactate synthesised by astrocytes may be used by neurons as an aerobic 
substrate under certain circumstances (Pellerin et al., 2007). In the study by Leth et al. (1995) 
lactate was present in 10 out of 13 preterm appropriately grown for gestational age infants 
and they showed that its concentrations were inversely related to postmenstrual age. The 
authors suggested that lactate may support brain metabolism. In a study by Roelants-van Rijn 
et al. (2004) lactate was present in preterm infants appropriately grown for gestational age. 
These children were assessed at 2 years of age using the GMDS and had a normal 
developmental quotient. Lactate has also been detected in amniotic fluid samples during the 
second trimester of pregnancy in fetuses at risk for genetic disorders referred for an 
amniocentesis but with a normal karyotype (Cohn et al., 2009).  
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Alteration in metabolite ratios between fetuses with isolated ventriculomegaly and 
normal controls 
Fetuses with ventriculomegaly had significantly lower NAA:Cho (136ms), MI:Cho and 
MI:Cr (42ms) and significantly higher Cho:Cr (42ms and 136ms) compared to normal 
controls when corrected for GA. There was no difference in NAA:Cr levels in either 136ms 
or 270ms echo times. There was no difference detected in any metabolite ratios in echo time 
270ms. Specific metabolic patterns have not been previously identified for fetuses with 
isolated ventriculomegaly.  
 
The observed reduction in NAA:Cho may be due to a reduction in NAA and/or increase in 
choline. A reduction in NAA may reflect immaturity, neuronal/axonal damage or neuronal 
viability however no overt structural lesions were present in our cohort on fetal MRI (Baslow 
et al., 2003). NAA is also found in oligodendrocyte type-2 astrocyte progenitor cells and 
immature oligodendrocytes and is essential for myelin synthesis. The acetate portion is used 
for myelin synthesis while the aspartate for energy production. NAA levels increase during 
normal development reflecting synaptic complexity and increasing myelination (Girard et al., 
2006b; Kok et al., 2002). Therefore lower levels may reflect delayed or abnormal white 
matter development. Indeed, human studies indicate that midgestation is the beginning of a 
critical period for myelination processes that extends until the second postnatal year 
(Brighina et al., 2009; Kinney et al., 1994). Therefore reduced NAA levels may reflect 
alterations in the myelination process during the fetal period. A meta-analysis of 
1
HMRS in 
children with autism demonstrated a significant reduction in NAA levels in the cerebrum 
highly significant in the frontal lobe and the authors suggested that this may indicate a 
relative increase in glial cells (Aoki et al., 2012). They commented that if brain enlargement 
in autism was a consequence of increased neuronal numbers this should be accompanied by 
an increase in NAA levels. Therefore the reduction in NAA most likely represents decreased 
neuron density induced by brain enlargement due to increased glial numbers (dilution effect). 
In contrast, autopsy data from a small cohort of children with autism have shown increased 
neuronal numbers in the frontal lobe (Courchesne et al., 2011b). In addition, NAA is 
synthesised in neuronal mitochondria and is considered to reflect mitochondrial function 
(Clark, 1998). Therefore changes in NAA levels may reflect dysfunction of mitochondrial 
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energy metabolism in the absence of neuronal loss. A reduction in NAA levels has been 
detected in IUGR fetuses and has been attributed to mitochondrial dysfunction as suggested 
from many animal models of IUGR (Story et al., 2011a). Other explanations may involve a 
cellular redistribution of NAA resulting in changes in the ratio of free to bound NAA. 
1
HMRS can only detect unbound molecules therefore a redistribution may alter the NAA 
signal. 
 
The observed reduction in MI:Cho and MI:Cr in combination to increased levels of Cho:Cr 
may indicate a reduction in myo-inositol levels and/or increase in choline. The group of Kok 
et al. (2003) compared 
1
HMRS data from normal fetuses and fetuses with isolated 
hydrocephalus (n=2), hydrocephalus with spina bifida (n=4) and hydrocephalus with 
agenesis of the corpus callosum (n=4). They did not define how they diagnosed fetuses with 
isolated hydrocephalus therefore it is unclear whether these were fetuses with isolated 
ventriculomegaly similar to our cohort, most probably not. The GA range studied was 28 to 
37 weeks. They showed that hydrocephalic fetuses had significantly reduced levels of 
inositol to creatine ratios and suggested that this reflected reduced inositol levels as creatine 
is relatively stable during gestation. They concluded that inositol may influence the 
development of the fetal CNS early and later during pregnancy. In an animal model with 
susceptibility to neural tube defects it has been shown that inositol is essential for the closure 
of the neural tube therefore is important for brain morphogenesis (Cogram et al., 2004; 
Greene and Copp, 1997). Myo-inositol has a role in the inositol/lipid cycle and is involved in 
signal transduction, steroid synthesis and intracellular calcium regulation. Myo-inositol 
stimulates embryonic cell proliferation via activation of protein kinase C leading to normal 
closure of the neural tube in transgenic mice (Cogram et al., 2004; van Straaten and Copp, 
2001). Increased myo-inositol levels have been reported in the brain of adults with Down's 
syndrome (Beacher et al., 2005; Huang et al., 1999) while myo-inositol concentration 
significantly (negatively) has been correlated with cognitive performance (Beacher et al., 
2005). Beacher et al. (2005) suggested that this increase may reflect an underlying metabolic 
process linked to neuronal dysfunction and is probably due to an up-regulation of the 
metabolite's transport associated with an extra copy of the gene on chromosome 21. 
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Choline levels may be increased in the ventriculomegaly cohort as indicated by a reduction 
in NAA:Cho, MI:Cho and an increase in Cho:Cr. Creatine levels appear unchanged between 
our cohorts. Studies in fetuses aged 22-28 weeks have shown that as gestation progresses 
choline levels decrease (Girard et al., 2006b). This decrease has been ascribed to accelerated 
myelination during the third trimester as choline is incorporated into the myelin constituent 
lipids (Inder and Huppi, 2000; Kok et al., 2002). Increased choline levels may indicate a 
failure of choline to incorporate into myelin lipids thus higher levels of unbound choline 
being present. This may lead to delayed white matter development and myelination.   
 
The fact that lactate was identified in both normal control fetuses and fetuses with 
ventriculomegaly suggests that it is not simply a marker of acute hypoxia and may have a 
role in normal fetal development. Although lactate was present in higher percentage of 
fetuses with ventriculomegaly compared to controls we are unable to ascertain whether 
higher concentrations were present in the ventriculomegaly cohort.  
 
Limitations 
1
HMRS is sensitive to fetal motion as indicated by the large number of cases that were 
unusable due to movement. In addition, sampling specific brain regions is not feasible in the 
fetus due to the large voxel size required for adequate signal-to-noise and due to fetal 
motion. Differences in metabolite ratios between cohorts at echo time 136ms were not 
replicated in echo time 270ms. Due to technical difficulties it is not always possible to 
acquire usable spectra at each echo time in every fetus which probably explains variations 
between the same metabolite ratios between echo times. Different echo times may alter the 
ability to identify different metabolite ratios. At short echo times there is better signal-to-
noise ratio for the detection of metabolites however lipids signals may be present while in 
longer echo times there is a clearer baseline and lipid signals are significantly reduced 
allowing for easier quantification of metabolites. Due to different intrinsic metabolite T2 
relaxation times between long and short echo times the normal spectra heights may appear 
significantly different.  
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Conclusions 
In our study we have shown that fetuses with ventriculomegaly had significantly lower 
NAA:Cho, MI:Cho and MI:Cr ratios whilst significantly higher Cho:Cr ratios. These results 
may indicate a reduction in NAA and myo-inositol and an increase in choline. These changes 
may reflect a delay or impairment in white matter development in fetuses with isolated 
ventriculomegaly.
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3.5 Assessment of white matter microstructure in neonates with ventriculomegaly 
3.5.1 Background 
While conventional MRI is able to delineate early structural developmental events such as 
cortical gyrification, DTI provides quantitative data on anatomical connectivity. It has been 
extensively used to characterise microstructural changes associated with normal and 
abnormal development via quantification of the physical integrity and maturity of white 
matter fibres. Thus providing an insight into white matter microstructure and organisation, 
important early markers or later neurodevelopmental outcome (Counsell et al., 2008; Groppo 
et al., 2012; Tusor et al., 2012). The quantitative parameters of DTI include the Apparent 
Diffusion Coefficient (ADC) which depicts the degrees of water diffusion and the Fractional 
Anisotropy (FA) which reflects the degree of directional preference of water diffusion 
(Roberts and Schwartz, 2007). An optimised protocol (Ball et al., 2010) designed for voxel-
wise registration of neonatal data was used for the processing of the generated FA data. The 
FA maps of each subject were aligned and registered to each other to create the mean FA 
map representing the mean of all aligned FA images and the mean FA skeleton which 
represents the centre of all white matter tracts that are common to all subjects. Tract-Based 
Spatial Statistics (TBSS) analysis was used to assess the relationship between FA and 
presence of ventriculomegaly by comparing the FA values throughout the white matter tracts 
between the control and ventriculomegaly cohorts. TBSS is an automated, observer-
independent technique for assessing FA throughout the white matter tracts on a voxelwise 
basis across groups of subjects (Smith et al., 2006). Therefore in this chapter we have used 
TBSS to compare white matter microstructure in term born neonates with antenatally 
diagnosed isolated ventriculomegaly, with a cohort of control term-born neonates with 
normal brain appearances.  
 
3.5.2 Aim 
To assess white matter development in neonates with antenatal ventriculomegaly.  
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3.5.3 Cohorts 
3.5.3.1 Normal controls 
The normal control group consisted of 25 term-born neonates with a normal brain 
appearance on MR, either enrolled in the fetal research program (n=10) or enrolled as normal 
controls in the following MR research studies of the preterm brain (n=15) (Optimising 
functional MRI techniques in the study of neuronal development in preterm infants, 
07/H0707/101; Computational analysis of brain abnormalities and neurodevelopmental 
impairments in preterm infants, 04/Q0406/125). The mean GA at birth was 39.6 weeks 
(range 38-41.7 weeks) and mean post-menstrual age at scan was 41.9 weeks (range 39-49.1 
weeks). Cohort characteristics are presented in Table 28.  
 
Normal control cohort characteristics     
Male 13   
Female 12   
Gestational age at birth (weeks) 39.6 (38-41.7) 
Post-menstrual age at scan (weeks) 41.9 (39-49.1) 
Birthweight (g) 3364 (2410-4242) 
Apgar scores                          1 minute 9 (8-10) 
                                               5 minutes 10 (9-10) 
Table 28. Normal control cohort characteristics 
Gestational age at birth, post-menstrual age at scan and birthweight are presented as mean (range). Apgar 
scores are presented as median (range). 
 
Neurological examination in normal control neonates 
A complete neurological and visual examination was performed prior to the scan in all term 
neonates with a normal brain appearance. A normal neurological and visual examination was 
reported in all 25 neonates.  
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3.5.3.2 Isolated ventriculomegaly  
The ventriculomegaly cohort was the same as in chapter 3.2.4.3 for the neonatal volumetric 
analysis. All neonates had antenatally diagnosed isolated ventriculomegaly detected on 
ultrasound and confirmed on MRI. From the 26 neonates used previously for volumetric 
analysis, 4 cases had significant motion and DTI data from these cases were discarded. The 
remaining 22 neonates had a mean GA at birth 39.8 weeks (range 36-41.4 weeks) and mean 
post-menstrual age at scan 45.4 weeks (range 41.4-50.4 weeks). Cohort characteristics are 
presented in Table 29. There was a significant difference in post-menstrual age at scan with 
neonates with ventriculomegaly being scanned at a later age by an average of 3.4 weeks 
(p<0.0001). There was no significant difference in gestational age at birth between cohorts. 
The results presented are corrected for both gestational age at birth and post-menstrual age at 
scan. 
 
Ventriculomegaly cohort characteristics   
Male 16   
Female 6   
Gestational age at birth (weeks) 39.8 (36-41.4) 
Post-menstrual age at scan (weeks) 45.4 (41.4-50.4) 
Birthweight (g) 3462 (2528-4260) 
Apgar scores                             1 minute 9 (7-10)* 
                                                  5 minutes 10 (9-10)* 
Table 29. Ventriculomegaly cohort characteristics 
Gestational age at birth, post-menstrual age at scan and birthweight are presented as mean (range). Apgar 
scores are presented as median (range). * apgar scores were not available in 4 neonates. 
 
Neurological examination in neonates with ventriculomegaly 
A complete neurological examination was performed in all neonates with antenatal 
ventriculomegaly prior to the scan. A normal neurological examination was reported in 18 
out of 22 neonates. In the remaining cases the examination revealed 3 cases with head 
lag/lower neck tone and 1 case with reduced central tone and head lag. Visual examination 
was normal for all 22 neonates.  
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3.5.4 FA quantification 
The mean FA map constructed from the normal control and ventriculomegaly cohorts is 
shown in Figure 121. The mean FA skeleton overlaid on the mean FA map is shown in 
Figure 122. Intergroup statistical comparisons were performed on the mean FA map in order 
to identify which regions on the mean white matter skeleton in each cohort had higher, lower 
or of no statistical difference FA values. All statistical comparisons were corrected for 
gestational age at birth and post-menstrual age at scan. FA values were significantly lower in 
the ventriculomegaly cohort in the splenium of the corpus callosum, sagittal stratum 
bilaterally and right posterior corona radiate (Figures 123-125). The tracts that go through 
these white matter regions are presented in Table 30. There was no significant difference in 
FA in the rest of the white matter tracts between cohorts.  
 
Figure 121. Mean FA images 
Mean FA images of white matter tracts constructed from the normal control and ventriculomegaly cohorts. 
Data shown in (A) sagittal (B) coronal and (C) transverse planes. 
 
 
Figure 122. Mean FA skeleton 
Mean FA skeleton (green) overlain on mean FA images constructed from the normal control and 
ventriculomegaly cohorts. Data shown in (A) sagittal (B) coronal and (C) transverse planes. 
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Figure 123. Splenium of the corpus callosum 
FA values in the splenium (arrows) of the corpus callosum were significantly lower in the ventriculomegaly 
cohort as shown in (A) transverse and (B) sagittal planes. The fibres passing through the splenium of the corpus 
callosum form the forceps major (arrowheads). Tapetum projections originate from the splenium and sweep 
inferiorly along the lateral margin of the posterior horn of the lateral ventricles. Mean FA skeleton (green) was 
overlain on the mean FA images constructed from the normal control and ventriculomegaly cohorts. 
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Figure 124. Sagittal stratum 
FA values in the sagittal striatum (arrowheads) were significantly lower in the ventriculomegaly cohort as 
shown in (A,C) transverse and (B,D) sagittal planes. The sagittal striatum consists of the inferior and superior 
longitudinal fasciculus, inferior fronto-occipital fasciculus and optic radiations. Mean FA skeleton (green) was 
overlain on the mean FA images constructed from the normal control and ventriculomegaly cohorts. 
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Figure 125. Posterior corona radiata 
FA values in the right posterior corona radiate (arrowheads) were significantly lower in the ventriculomegaly 
cohort as show in (A) transverse and (B) coronal planes. The tracts going through the posterior corona radiata 
include the inferior and superior longitudinal fasciculus, inferior fronto-occipital fasciculus, corticopontine 
tracts and posterior thalamic radiations (mainly consisting of the optic radiations). Mean FA skeleton (green) 
was overlain on the mean FA images constructed from the normal control and ventriculomegaly cohorts. 
 
White matter region White matter tracts 
Splenium of corpus callosum 
Forceps major 
Tapetum 
Sagittal stratum 
Inferior longitudinal fasciculus 
Superior longitudinal fasciculus 
Inferior fronto-occipital fasciculus 
Optic radiations 
Posterior corona radiata 
Inferior longitudinal fasciculus 
Superior longitudinal fasciculus 
Inferior fronto-occipital fasciculus 
Corticopontine 
Posterior thalamic radiations 
Table 30. White matter regions and tracts 
White matter regions and tracts that run through the specific regions. Table constructed from data described in 
(Oishi et al., 2010; Wakana et al., 2004). 
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3.5.5 Discussion 
 
TBSS analysis in this study has demonstrated that in neonates with antenatally diagnosed 
isolated ventriculomegaly, white matter microstructure as determined by FA, showed altered 
development. Reductions in FA values, compared to term born control neonates with normal 
imaging, were detected in white matter regions including the splenium of the corpus 
callosum, sagittal stratum bilaterally and right posterior corona radiate. 
 
Neurobiological basis of FA changes 
In normal development white matter maturation is accompanied by an increase in FA which 
is likely influenced by early neurogenesis, fibre organisation, pre-myelination and 
myelination (Huppi et al., 1998; Neil et al., 1998; Wimberger et al., 1995).  At term age 
myelination has only occurred in the posterior limb of the internal capsule and the brainstem 
(Yakovlev and Lecours, 1967) therefore a reduction in FA probably reflects deficits or 
delays in pre-myelination including increased axonal thickness, alteration in axonal 
permeability and pre-myelination wrapping of the oligodendrocytes around axons 
(Wimberger et al., 1995). During the pre-myelination stage an increase in FA is attributed to 
numerous histological changes including an increase in the number of axonal microtubule-
associated proteins, a change in axon calibre, changes in axonal membrane (Na
+
/K
+
 activity) 
and an increase in the number of oligodendrocytes (Fields and Waxman, 1988; Wimberger et 
al., 1995). The highest FA values in the immature brain are in the genu and splenium of the 
corpus callosum (Partridge et al., 2004) due to their compactness and high degree of parallel 
organisation. A more sustained increase in FA is noted during myelination of the posterior 
limb of the internal capsule in the newborn infant and is visible on T1 and T2 weighted 
images. In addition to myelination, other factors influence FA changes such as axon 
compactness, relative membrane permeability to water, internal axonal structure and tissue 
water content. DTI is an indirect method of assessing white matter microstructure and the 
reduction in FA may have different aetiologies as described above. Post-mortem studies in 
cases with isolated ventriculomegaly would provide insights into the underlying mechanism 
leading to a reduction in FA. However, there are currently no post-mortem studies in this 
population as the majority of cases have a good outcome and a high survival rate. In chapter 
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3.4 we showed a potential increase in choline in fetuses with ventriculomegaly which may 
reflect alterations in myelin synthesis and therefore a reduction in FA as observed during 
neonatal life. 
 
Comparison with previous neonatal DTI studies 
In our study we have found that neonates with isolated ventriculomegaly have significantly 
reduced FA values compared to controls in the splenium of the corpus callosum, sagittal 
stratum bilaterally and right posterior corona radiate. White matter microstructure has been 
previously assessed using DTI in 34 neonates with antenatally diagnosed isolated 
ventriculomegaly and compared with 34 age- and sex-matched controls (Gilmore et al., 
2008). Analysis was performed using a region of interest approach on non-registered images 
and FA was compared between groups in pre-determined regions including the corpus 
callosum and the corticospinal tracts. They showed that neonates with ventriculomegaly had 
a significant reduction in FA in the central splenium, left cortical splenium, left cortical 
corticospinal and right central corticospinal regions. Subsequently they developed a 
population-based registration method, similar to our methodology, and compared FA values 
in predetermined regions of interest including the genu and splenium of the corpus callosum 
and the corticospinal tracts (Goodlett et al., 2009). The comparison was performed between 
13 neonates with isolated ventriculomegaly and 85 term controls. They showed a significant 
reduction only in the splenium of the corpus callosum. Our study is in agreement with the 
results from this study showing a reduction in FA values in the splenium of the corpus 
callosum. Unfortunately their investigation did not include FA quantification throughout the 
white matter tracts therefore we are unable to compare our results any further. 
 
Additional studies on white matter microstructure in neonates have been performed in 
preterm-born children imaged at term equivalent age (Anjari et al., 2007; Skiold et al., 2010; 
van Kooij et al., 2012). The brain appearance of the neonates included in these studies was 
considered normal. Van Kouij et al. (2012) performed DTI in 63 preterm-born term 
equivalent neonates with no evidence of lesions on MRI and reported a positive relationship 
between FA in the body and the splenium of the corpus callosum and  cognitive outcome at 2 
years corrected age. FA throughout the white matter significantly correlated with fine motor 
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scores at 2 years corrected age, with particular significance including the corpus callosum, 
corona radiata, superior longitudinal fasciculus, and inferior longitudinal and fronto-occipital 
fasciculi. Additional studies using DTI and TBSS have been performed on preterm infants 
with no evidence of focal lesions compared to term-born neonates. Reductions in FA in 
white matter regions (Anjari et al., 2007; Skiold et al., 2010) have been reported, there is 
however no overlap between the regions identified in these studies and our study. Correlation 
between FA values and outcome was not performed in these studies. 
 
White matter tracts and function 
Our study revealed reductions in FA in the splenium of the corpus callosum, right posterior 
corona radiate and sagittal striatum. Multiple white matter tracts run in parallel through these 
regions and it is not possible to extrapolate which white matters tracts specifically contribute 
to the changes in FA observed. The majority of white matter pathways highlighted in our 
study and including the superior and inferior longitudinal fasciculi, inferior fronto-occipital 
fasciculus, splenium of the corpus callosum and posterior thalamic radiations are involved  
mainly in language circuitry and also in cognitive and attention skills (Catani, 2007; Doricchi 
and Tomaiuolo, 2003; Dramsdahl et al., 2012; Duffau et al., 2002; Gazzaniga, 2000; Hynd et 
al., 1995; Leclercq et al., 2010; Nosarti et al., 2004; Qiu et al., 2011; Tanabe et al., 1987). 
The regions highlighted in our study do not contain major tracts involved in motor 
functioning. This would be expected as outcome studies in children with antenatally 
diagnosed ventriculomegaly have shown an increased risk of abnormal development 
outcome mostly in cognitive, behavioural and communication domains with few motor 
impairments documented (Beeghly et al., 2010; Bloom et al., 1997; Gomez-Arriaga et al., 
2012; Leitner et al., 2009; Lyall et al., 2012; Sadan et al., 2007). 
 
Neurological examination 
The presence of head lag or low neck tone may be a sign of later neurological impairment 
however as part of a normal otherwise neurological exam it is unclear whether it is predictive 
of later deficits.  
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Limitations 
There was a significant difference in post-menstrual age at scan between cohorts, with the 
neonates with ventriculomegaly being scanned at a later age compared to controls. However 
FA values should increase with postmenstrual age and therefore higher values would have 
been expected in the ventriculomegaly cohort. The reason for this difference in 
postmenstrual age at scan lies in the recruitment of the normal controls enrolled in the 
different studies. Term-controls for studies other than the fetal research program recruited 
their participants shortly after birth in Queen Charlotte's and Chelsea Hospital. However 
participants enrolled in the fetal research program were invited for a scan after the parents 
had left the hospital while the majority were born in other London hospital therefore 
delaying the day of scan. 
 
Due to spatial resolution limitation of current DTI methods, distinction between pathways 
crossing the same white matter regions is not possible with the current method although 
additional techniques such as DTI-tractography can be used for the delineation of individual 
groups of white tracts (Mori et al., 2002). Specificity of tracts is lost when tracts run parallel 
or merge together. At the resolution achieved in vivo, it is inevitable that the voxels will 
contain fibre population with different orientations. These areas also introduce bias due to 
intra-subject variation.  
 
While there is a higher proportion of male subjects in the ventriculomegaly cohort we have 
not controlled for sex in the TBSS analysis due to the restricted participant numbers. 
However, a study (Geng et al., 2012) in preterm-born children imaged at term (with normal 
brain appearance) showed no difference in FA in white matter tracts between males and 
females. While not performed during this study a comparison between sex in the controls 
should be included in future work. 
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Conclusions 
Antenatally diagnosed isolated ventriculomegaly is a significant risk factor for later 
development delay. Previous studies have shown that the areas of development mostly 
affected in these children include language, behaviour, attention and cognitive skills 
(Beeghly et al., 2010; Bloom et al., 1997; Gomez-Arriaga et al., 2012; Leitner et al., 2009; 
Lyall et al., 2012; Sadan et al., 2007). We have shown that neonates with antenatally 
diagnosed ventriculomegaly exhibit significant reductions in FA in white matter tracts 
involved in language, cognition and attention. These results may be consistent with a delay 
in maturation or abnormal development of the specific white matter tracts. Future work 
should involve the detailed neurodevelopmental assessment of the children enrolled in this 
study with specific aim to correlate changes in FA with specific developmental scores. 
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3.6 Neurodevelopmental outcome in children with antenatal ventriculomegaly 
(Preliminary results as part of on-going study) 
 
In this chapter we present preliminary results of the neurodevelopmental outcome of a small 
cohort of children with isolated antenatal ventriculomegaly enrolled in our study. Follow-up 
is still on-going and currently the participant numbers are small however they provide an 
insight in the developmental deficits present in this cohort and allow for comparison with the 
current literature.  
 
3.6.1 Aim 
To assess the neurodevelopmental outcome of children with antenatal isolated 
ventriculomegaly at 1 and 2 years of age and correlate developmental scores with MR 
measurements. 
 
3.6.2 Developmental assessments at year 1 of age 
All fetuses with an antenatal diagnosis of isolated ventriculomegaly enrolled in the research 
program were invited for a developmental assessment at year 1 and year 2 of age. 
Assessment at 1 year of age was performed using the Griffiths Mental Development Scales 
(GMDS). A total of 45 children were diagnosed with ventriculomegaly and born during the 
period of March 2008-July 2011 and were invited for a developmental assessment when they 
reached their first year of age. A complete assessment was performed in 28 children 
representing a 62.2% follow up rate at a mean chronological age of 12.5 (± 1.5) months and 
a range of 9-16.5 months (Table 31). 17 infants did not take part due to the following 
reasons: refusal to attend for an assessment (6), unable to contact parents (5), assessment 
missed (5), neonatal death due to non-CNS abnormalities (1). There was no significant 
difference (p=0.483) in atrial diameter between the children that had an assessment and those 
that did not attend. Parental filled questionnaires were posted to the parents that we were 
unable to contact and those that refused to attend for an assessment. In 2 cases completed 
questionnaires were sent back. In addition, in 2/5 cases that the assessments were missed at 1 
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year of age the infants were assessed at 2 years of age. Therefore some information was 
available on 32 out of 44 children (71%). 
 
Neurodevelopmental assessment at 1 year  of age 
Total children assessed 28 out of 45   
Male 22   
Female 6   
Age (months) 12.5 (±1.5) (9-16.5) 
Atrial diameter (mm) 11.8 (±1.2) (10.1-14.8) 
Table 31. Year 1 cohort characteristics 
For the age and atrial diameter, measurements are shown in mean (SD) and range. 
 
According to the results of the GMDS, 71.4% of the children assessed had scores within the 
normal range in all the developmental scales. 
 
In the Locomotor domain 26 children (92.8%) showed normal development while 1 infant 
showed borderline delay and 1 infant severe delay. Two children with normal motor 
development had reduced tone in their lower limbs and both were re-assessed at 2 years of 
age. In one case this normalised while it persisted in the second case. No children had signs 
consistent with cerebral palsy. 
 
On the Language and Hearing scale, 20 children (71.4%) had normal language development 
while 8 children (28.6%) showed mild delay. 
 
On the Personal-Social and Eye-Hand Co-ordination scales all children had scores within the 
normal range.  
 
The Performance scores revealed normal development in 25 cases, borderline scores in 2 
cases (7%) and mild delay in 1 case (3.6%).  
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Three children (10.7%) had poor attention skills and difficulty concentrating during the 
assessment as observed by the clinical psychologist although this was not formally assessed. 
 
Two cases that completed ASQ assessments and scores within the normal range in all sub-
scales. 
 
As a provisional analysis and accepting follow up is not complete and numbers are small, the 
sub-quotient scores for each sub-scale in the GMDS were correlated with the atrial diameter, 
larger lateral ventricle volume and total lateral ventricular volume (Table 32). There was a 
significant negative correlation between eye and hand co-ordination and total lateral 
ventricular volume (Spearman's r=-0.4, p=0.019). However this correlation did not withstand 
Bonferroni correction for multiple comparisons. There was also a negative correlation, of 
borderline significance (p~0.06), between atrial diameter and eye and hand co-ordination 
scores and performance scores.  
 
  
Language and 
Hearing 
Personal 
and social 
Locomotor 
Eye and hand 
co-ordination 
Performance DQ 
Atrial diameter 0.07 -0.04 -0.08 -0.28 -0.29 -0.13 
Larger lateral ventricle volume -0.04 -0.07 -0.11 -0.25 -0.07 -0.1 
Total lateral ventricular volume -0.07 -0.18 -0.19 -0.4* -0.22 -0.24 
Table 32. Relationship between MR measurements and GMDS outcome scores at year 1 
Eye and hand co-ordination scores correlated negatively with the total lateral ventricular volume. Correlation 
was assessed using the Spearman's r. * p<0.05 
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3.6.3 Developmental assessments at year 2 of age 
A total of 25 children were diagnosed with antenatal ventriculomegaly and born in the period 
of March 2008-July 2011 and were invited for a developmental assessment when they 
reached their second year of age. Assessments at 2 years of age were performed using the 
Bayley Scales of Infant and Toddler Development-III (BSID-III). A complete assessment 
was performed in 16 children (64%) at a mean chronological age of 25.2 (±3) months and a 
range of 19.5-33 months (Table 33). 12 children had assessments at both years 1 and 2. 
There were 9 children that did not have an assessment for reasons including refusal to attend 
(5), unable to contact parents (3) and neonatal death (1). There was no significant difference 
(p=0.261) in atrial diameter between the children that had an assessment and those that did 
not attend. Questionnaires were sent to the parents that declined to attend or those who we 
were unable to contact. One of the cases that declined assessment and 1 case that we were 
unable to contact completed the questionnaires. Out of the 16 children that attended, 13 were 
assessed using the BSID-III and 3 were assessed using the GMDS.  
 
Neurodevelopmental assessment at 2 years of age 
Total children assessed 16 out of 25   
Male 11   
Female 5   
Age (months) 25.2 (±3) (19.5-33) 
Atrial diameter (mm) 12.2 (±1.6) (10.1-16.4) 
Table 33. Year 2 cohort characteristics 
For the age and atrial diameter, measurements are shown in mean (SD) and range. 
 
According to the results of the BSID-III for 13 children and the GMDS for 3 children, only 
37.5% of the children assessed had scores within the normal range in all developmental 
scales. 
 
On the Gross Motor scale, 14 children (87.5%) showed normal development and 2 children 
(12.5%) were delayed in their gross motor skills. No children had signs consistent with 
cerebral palsy. In the Fine Motor scales 1 child had delayed development while another child 
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had borderline scores. Only one of these children had both fine motor and gross motor delay. 
One child with normal motor development had slightly lower tone in his knees, hips and 
shoulders.  
 
On the Language scale, only 8 children (50%) had normal language skills, of which two had 
scores in the borderline/lower normal range, one of which was raised in a bilingual 
environment. Delayed language development was detected in 8 children (50%). One of the 
children with severe language delay had signs of autism.  
 
The Cognitive scale scores revealed normal cognitive development in 14 children (87.5%) 
while 4 children (25%) had delayed cognitive scores. All children with delayed cognitive 
development also had language delay. One child with language delay had cognitive scores in 
the lower normal range.  
 
As observed by the clinical psychologist seven children (43.8%) had a short attention span 
and 5/7 of those also had language delay. However attention skills were not formally 
assessed. 
 
Two cases that completed ASQ assessments showed scores within the normal range in all 
sub-scales.  
 
Whilst the numbers are very small we did some preliminary statistical analysis as follows. In 
the 8 children with language delay at 2 years of age the mean atrial diameter was 12.9 mm 
(±1.7) and a range of 11-16.4 mm while in the 8 children with normal language development 
for their age the mean atrial diameter was 11.8 mm (±1.5) and a range of 10.1-14.1 mm. 
There was no significant difference between the atrial diameter measurements between the 
two groups however all children with language delay had an atrial diameter >11 mm. 
 
The scores for each sub-scale in the BSID-III were correlated with the atrial diameter, larger 
lateral ventricle volume and total lateral ventricular volume (Table 34). There was a 
significant negative correlation between fine motor scores and atrial diameter (Spemann's r=-
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0.64, p=0.017) however significance was lost after applying the Bonferroni correction. There 
was a negative correlation of borderline significance (p~0.05) between atrial diameter and 
cognitive scores (prior to Bonferroni correction). These correlations have been limited by the 
small number of data available for statistical analysis. BSID-III data were only available for 
11 children as 1 autistic child did not complete any tasks and 3 children had the GMDS at 2 
years. These 3 children without BSID-III scores had the largest ventricular atrial diameters in 
the cohort and all had language delay while 2 also had motor delay. In addition, volumetric 
data were not available in 1 case due to excessive fetal motion prohibiting brain 
reconstruction.  
 
  Cognitive 
Language 
(Receptive) 
Language 
(Expressive) 
Language 
sum 
Fine 
motor 
Gross 
motor 
Motor 
sum 
Atrial diameter -0.47 -0.40 -0.25 -0.38 -0.64* 0.01 -0.45 
Larger lateral ventricle volume 0.25 0.27 0.20 0.29 0.03 0.06 0.12 
Total lateral ventricular volume 0.36 0.33 0.16 0.36 0.08 0.16 0.21 
Table 34. Relationship between MR measurements and BSID-III outcome scores at year 2 
Fine motor scores correlated negatively with the total lateral ventricular volume. Correlation was assessed using 
the Spearman's r. * p<0.05 
 
There were 3 children that were born preterm (32
+4
-36
+3
 weeks) and were assessed at year 1 
and year 2 of age. One child born at 35 weeks GA had scores within normal limits in all 
developmental scales however the neurological exam showed reduced tone in knees, hips 
and shoulders at both assessments. One child born at 32
+4
 weeks GA showed normal 
development in all scales at 1 and 2 years of age. One child was born at 36
+3
 weeks GA and 
at year 1 of age had language delay while at year 2 was delayed in the language, cognitive 
and motor scales. 
 
 
 
280 
 
Children assessed at both year 1 and year 2 
Twelve children were assessed at year 1 and year 2 of age. The results of the developmental 
assessments are summarised in Table 35.  
 
# Development at year 1 Development at year 2 
1 normal language/cognitive delay 
2 normal borderline fine motor 
3 normal normal 
4 normal language/cognitive delay 
5 normal language/cognitive delay 
6 normal normal 
7 normal normal 
8 language delay language/cognitive/motor delay 
9 normal language/cognitive 
10 language delay borderline language 
11 language/performance delay borderline language 
12 language/motor delay language/motor delay 
Table 35. Comparison between developmental outcomes at 1 and 2 years of age in 12 cases 
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3.6.4 Discussion 
While the majority of children (71.4%) at year 1 had a normal neurodevelopmental outcome, 
only 37.5% of children at 2 years of age had scores within the normal range in all 
developmental domains. The deficits detected in this preliminary cohort were mostly within 
language and cognitive domains. At 2 years of age, 50% of children had significant language 
delay requiring referral to speech and language therapy. Language delay was associated with 
cognitive delay in half of the cases. All cases with language delay had an atrial diameter 
above 11 mm. As observed by the clinical psychologist, children with language delay also 
had difficulties concentrating and had short attention span although this was not formally 
assessed. Out of the 8 cases that had language delay only 2 cases were identified at 1 year of 
age  indicating as expected that follow-up studies before 2 years of age will underestimate 
the risk of this abnormal outcome. There was a significant negative correlation between fine 
motor scores and ventricular size at year 1 and year 2. These results require verification with 
a larger number of participants. 
 
Our study is in agreement with the study by Sadan et al. (2007) who assessed 20 children 
with antenatal isolated ventriculomegaly (10-15 mm) at a mean age of 32.3 months (1-42 
months) using the BSID-II. They showed that the deficits present in their cohort were mostly 
of a mental (including language) and behavioural nature while motor development was the 
least affected. 25% of the children required early intervention. Lyall et al. (2012) assessed 28 
children with antenatal ventriculomegaly at 2 years of age and found reduced developmental 
scores in expressive language and fine motor scales while there was no difference in gross 
motor, visual perception and receptive language. Gomez-Arriaga et al. (2012) assessed 18 
children diagnosed with antenatal ventriculomegaly (10-12 mm) at a mean age of 4.4 years 
and found that the areas with the highest number of affected children were the personal-
social, adaptive (including attention) and motor areas followed by cognitive and language 
areas. They commented that 60% of the motor deficits were minor deviations from 
normality. The reasons for an increased incidence of motor problems may be due to that 
diagnosis of isolated ventriculomegaly made solely on ultrasound. Therefore some of the 
cases diagnosed as isolated ventriculomegaly may have had additional abnormalities not 
detected on antenatal ultrasound, such as subependymal heterotopia and agenesis of the 
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corpus callosum. Bloom et al. (1997) assessed 22 children with antenatal ventriculomegaly 
(10-15 mm) at a mean age of 21.6 months using the BSID-II and the Vineland Behaviour 
scales. They reported that 8 out of the 22 children assessed had developmental delay whilst 
their scoring analysis revealed significantly reduced scores in the ventriculomegaly group for 
mental and motor development. There was no difference in scores in the behaviour scale. 
Atrial diameter and mental developmental index score correlated negatively (r=-0.5, 
p=0.001). Similarly to the previous study, ultrasound was the sole diagnostic modality for 
isolated ventriculomegaly therefore cases with additional abnormalities may be present in 
their group. As reported by the authors, one case required placement of a 
ventriculoperitoneal shunt at 2 months of age which is atypical for isolated 
ventriculomegaly. 
 
There have been only 2 studies that have used MRI to confirm no additional abnormalities 
after an ultrasound referral of ventriculomegaly and have excluded cases with chromosomal 
abnormalities and positive infection screening (Beeghly et al., 2010; Leitner et al., 2009). 
Leitner et al. (2009) showed that children (n=28) with antenatal isolated bilateral 
ventriculomegaly as assessed at 4.4 years had significantly reduced attention span and 
working memory scores compared to controls and suggested that these specific difficulties 
could later influence academic performance at school. Similarly, a number of the children in 
our study were reported to have a short attention span and difficulty focusing. Beeghly et al. 
(2010) reported that while the average scores in mental, motor and behaviour development 
were within normal limits, individual scores in either sub-scale varied from severely or 
mildly delayed to within normal limits. Surprisingly the average motor score at 1 year of age 
was significantly higher (more advanced skills) in the ventriculomegaly cohort compared to 
controls.  
 
We investigated the relationship between developmental scores at year 1 and year 2 and 
ventricular size. While the number of children assessed to date is limited there was a 
significant negative correlation between fine motor scores and ventricular size. Fine motor 
skills included the tasks of block stacking, drawing and manipulation of small objects. Such 
tasks involve somatosensory and visual perception, motor control and different cognitive 
processes. Larger numbers of cases are required to validate these results. 
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There were 2 children that had delayed motor development at year 2. One child had 
persistent ventriculomegaly as was shown on fetal scans (GA 22 and 31 weeks, ~12 mm) and 
after birth on serial cranial ultrasounds and two MRIs (PMA 45.9 weeks 10.7 mm and 50.4 
weeks moderate/severe ventriculomegaly). The ventricles had an abnormal shape while the 
thalami appeared fused in the latest MRI. One could argue that this case should be excluded 
from out cohort. The second child with motor delay had mild ventriculomegaly as a fetus 
(10.7 mm) while in the neonatal MRI at 43
+2
 weeks the ventricles had normalised (atrial 
diameter <10 mm) and no other brain abnormality was detected. This child also experienced 
problems in the first year of life due to lactose intolerance. 
 
Of interest 1 child in our young cohort showed autistic features including lack of response to 
name, severely delayed language development, lack of facial expressions, avoidance of eye-
contact, lack of interaction and repetitive motor behaviour at 25.5 months of age. A 
diagnosis of autism is usually not made until approximately the age of 4 because features of 
the disorder may not be evident or may be subtle before 3-4 years of age. Developments in 
clinical diagnosis including increased expertise and use of standardised diagnostic 
instruments (ADOS and ADI-R) show that diagnosis can be reliable, valid and stable from 
the age of 2 years  (Kleinman et al., 2008; Lord et al., 2006). The children in our cohort 
where not tested specifically for autistic spectrum disorders and therefore we cannot at the 
moment ascertain the incidence of autism in our study. As part of our future plan we aim to 
test our cohort using a battery of autism tests including the ADOS and ADI-R at 3 years. 
Ideally follow-up should be extended to school age as mild manifestation of developmental 
delay including communication disorders and attention deficits and learning disorders may 
not be apparent at an earlier age. 
 
In conclusion, in our preliminary data we have shown that children with antenatal 
ventriculomegaly have increased risk of language, cognitive and attention difficulties at 2 
years of age while there is evidence of a relationship between fine motor scores and 
ventricular size. However, neurodevelopmental follow-up in these children is still on-going 
and the data presented in this chapter are preliminary and require further validation. 
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4. Main discussion 
 
Fetal ventriculomegaly is the most common CNS abnormality and is associated with 
neurodevelopmental impairments in childhood. When isolated, the aetiology of the dilatation 
is usually unknown and the outcome is only partially predicted by the atrial diameter. The 
neurodevelopmental outcome of these children is variable and includes language, cognitive 
and behavioural deficits while the reasons for this variability are not well understood. Much 
of the initial research has focused on outcome prediction and characterisation of the nature of 
deficits whilst classifying the degree of the dilatation according to the atrial diameter. A very 
limited number of studies exist investigating brain development in fetuses with 
ventriculomegaly and these have been unable to detect any brain volumetric differences 
when compared to controls (Grossman et al., 2006; Kazan-Tannus et al., 2007; Pier et al., 
2011; Scott et al., 2012). Ventriculomegaly has been associated with cerebral overgrowth in 
a fetal rat model (Eyles et al., 2003), in children with Soto’s syndrome (Leventopoulos et al., 
2009; Palmen et al., 2005), hemimegalencephaly (Kalifa et al., 1987), and high-functioning 
children with autism (Palmen et al., 2005). Therefore we hypothesise that fetal 
ventriculomegaly is a marker of altered brain development characterised by relative brain 
overgrowth. The main aims and findings of this thesis are summarised in Table 36. 
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Aims Methods Main findings 
To establish whether there is evidence of 
relative overgrowth and/ or aberrant 
development in multiple intracranial 
structures in fetuses with ventriculomegaly 
Manual 
segmentation of 
fetal intracranial 
structures 
Fetuses with ventriculomegaly had 
significantly increased brain volumes and 
enlargement was restricted to the cortical 
gray matter. 
To establish whether volumetric changes 
evident during fetal life persist after birth. 
Automatic 
segmentation of 
neonatal intracranial 
structures 
Ventricular and brain volumes were 
increased in neonates with antenatal 
ventriculomegaly. 
To design a detailed protocol for the 
evaluation of cortical development.                                               
To establish whether ventriculomegaly is 
associated with delayed or abnormal 
cortical maturation. 
Cortical scoring 
system 
There was a delay in the appearance of 
cortical landmarks in fetuses with 
ventriculomegaly. The delay persisted in 
the calcarine sulcus and parieto-occipital 
fissure.The sylvian fissure showed aberrant 
development with an increased opercular 
distance.  
To assess differences in brain metabolite 
ratios between fetuses with isolated 
ventriculomegaly and normal fetuses. 
1
HMRS 
NAA:Cho, MI:Cho and MI:Cr ratios were 
lower whilst Cho:Cr ratios were higher in 
fetuses with ventriculomegaly. 
To assess the white matter development 
in neonates with antenatal 
ventriculomegaly. 
DTI 
FA was decreased in the splenium of the 
corpus callosum, sagittal stratum 
bilaterally and right posterior corona 
radiate in neonates with antenatal 
ventriculomegaly. 
To assess the neurodevelopmental 
outcome of children with antenatal 
isolated ventriculomegaly at 1 and 2 years 
of age and correlate with MR 
measurements. 
Neurodevelopmental 
assessments 
Preliminary data: At 2 years of age, 62.5% 
of children had developmental delay.  32% 
had language delay, 16% cognitive delay 
and 8% delayed motor development. 
Table 36. Main aims and findings of this thesis 
 
This study has longitudinally assessed 60 MR scans of normal control fetuses between 22.4-
38.9 gestational weeks and 65 MR scans of fetuses with isolated ventriculomegaly between 
22-37.3 gestational weeks using volumetric analysis on reconstructed images. We have 
shown that isolated ventriculomegaly in the presence of a normal karyotype and a normal 
infection status is associated with increased supratentorial brain volume which is apparent 
from mid gestation. Volumetric analysis of intracranial structures revealed that brain 
enlargement was restricted to the cortical gray matter while there was no significant 
difference in white matter and central gray matter volumes. An altered relationship was 
present between ventricular size and the developing brain structures in the ventriculomegaly 
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cohort. Our results are in contrast to previous fetal MR volumetric studies that have shown 
no difference in brain tissue or cortical volume in fetuses with isolated ventriculomegaly 
(Grossman et al., 2006; Kazan-Tannus et al., 2007; Pier et al., 2011; Scott et al., 2012). 
However these studies have had several limitations including use of non-homogeneous 
ventriculomegaly populations, inappropriate criteria for selection of normal controls and 
volumetric analysis performed on non-reconstructed MR datasets known to be sensitive to 
fetal motion. These limitations have been taken in to account during the design of this study. 
Our study is in agreement with Gilmore et al. (2008) who showed that neonates with 
antenatally diagnosed isolated ventriculomegaly have increased cortical volumes compared 
to controls. Furthermore, we have followed up a subgroup of these fetuses and quantified 
volumetric changes of brain parenchyma after birth and have shown that brain overgrowth 
persists in neonatal life. Volumetric delineation of cortical gray matter and white matter is 
currently underway to assess whether brain overgrowth is attributed to cortical overgrowth in 
neonatal life. Greater brain parenchyma and cortical gray matter volume may be due to lack 
of normal developmental apoptosis in the developing brain, a process essential for brain 
morphogenesis during gestation and synaptogenesis during the late fetal and postnatal 
period. Several animal knockout studies have shown that alterations in genes regulating 
developmental apoptosis lead to changes in cortical size and shape (Chenn and Walsh, 2002; 
Depaepe et al., 2005; Oppenheim et al., 2001). In previous studies in preterm and IUGR 
infants abnormal neurocognitive outcome has been associated with a reduction in cortical 
volume. However, fetuses with isolated ventriculomegaly are at increased risk of 
neurocognitive delay but according to our study exhibit increased cortical volumes. This 
suggests that it may be the quality of the connections and not the absolute cortical volume 
relating to later neurocognitive outcome. 
 
Due to the neurocognitive nature of deficits reported in children with fetal ventriculomegaly 
and the notion of the neurobiological origin of cognitive impairment within the developing 
cortex we aimed to assess the temporospatial schedule of formation of sulci and gyri. To 
assess cortical development and quantify cortical maturation during fetal life we designed a 
detailed protocol for the evaluation of cortical development similar to the cortical scoring 
system used by van der Knaap et al. (1996) in preterm infants. While previous studies have 
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evaluated cortical folding in large brain areas we have selected individual gyri and sulci 
representative of each brain lobe and performed a detailed assessment of cortical folding. We 
have demonstrated that this was a feasible and reproducible modality to quantify cortical 
development in the fetal brain. The normal control fetuses were assessed to create a 
normative reference dataset which was used for comparison with fetuses with isolated 
ventriculomegaly. We have found regional differences in cortical development between 
fetuses with isolated ventriculomegaly and control fetuses. The gestational age of the early 
form of gyri and sulci was delayed in the ventriculomegaly cohort by approximately 2 weeks 
with delay present in all brain lobes studied. Our results are in agreement with the study by 
Levine and Barnes (1999) that reported a 2-week mean lag in the time of appearance of 
cortical gyrification. While there was evidence of persistent delay throughout gestation in 
several cortical areas, significance was only reached for the calcarine suclus and parieto-
occipital fissure. The data did not withstand Bonferroni correction for multiple comparisons 
except for the calcarine and parieto-occipital landmarks suggesting that changes in cortical 
folding are more prominent in these cortical regions. Our results are in agreement with the 
study by Scott et al. (2012), using curvature analysis, showing reduced cortical folding in the 
parieto-occipital fissure in fetuses with isolated ventriculomegaly. A cortical region that 
could not be assessed with the cortical scoring system, due to its complex formation, was the 
Sylvian fissure. It was included in our analysis because it encompasses regions involved in 
language processing and was evaluated using a different approach. Interestingly we found 
altered development in the Sylvian fissure with an increased opercular distance length with a 
normal insular length. The functional impact of this finding needs further investigation. 
While the underlying mechanisms that drive the formation of cortical undulation are unclear, 
the major hypotheses (Nie et al., 2011; VanEssen, 1997) support that white matter fibre and 
synaptic development are involved in the regulation of cortical gyrification and therefore 
changes in cortical development may reflect aberrant white matter connectivity. 
 
The next component of the study assessed the metabolic profile of the developing brain in 
normal control fetuses and fetuses with isolated ventriculomegaly. In the normal fetal brain it 
was shown that the ratios of metabolites NAA:Cr and  NAA:Cho increased with increasing 
GA at echo times 136ms and 270ms and Cho:Cr  decreased with advancing gestation at echo 
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times 136ms and 42ms. These findings may be attributed to increasing levels of NAA during 
development reflective of increased myelination and synaptic complexity while a decrease in 
choline levels may reflect the high demands for cell membrane formation during this period 
and increased myelination. At echo time 42ms, MI:Cr metabolite ratios decreased with 
advancing GA which may be attributed to stable Cr levels and decreasing myo-inositol levels 
reflecting the high density of glial cells in between 22 and 28 weeks (Girard et al., 2006a). 
When comparing between our cohorts a significant alteration in brain metabolism was 
detected, with fetuses with ventriculomegaly exhibiting lower NAA:Cho levels compared to 
controls. This alteration most likely is attributed to reduced NAA levels and may reflect 
delayed white matter development and alterations in the pre-myelination processes. NAA is 
a neuronal marker, however is also present in oligodendrocytes. A reduction in NAA has 
been deleted in IUGR fetuses and attributed to mitochondrial dysfunction in the absence of 
neuronal loss (Story et al., 2011a). A reduction in NAA has also been reported in autistic 
children and suggested it reflects decreased neuronal density as a consequence of increased 
glial numbers (Aoki et al., 2012). In addition, we detected decreased MI:Cho and MI:Cr 
ratios and increased Cho:Cr levels indicating a reduction in myo-inositol levels and/or 
increase in choline. Myo-inositol is essential for the closure of the neural tube and brain 
morphogenesis and decreased levels may reflect an underlying metabolic process linked to 
altered CNS development. Lastly, choline levels have been shown to decrease in normal 
fetuses as choline molecules are incorporated into myelin lipids. Therefore an increase in 
choline levels in fetuses with ventriculomegaly may reflect higher levels of unbound choline 
molecules present after failure to incorporate into myelin lipids. This may lead to delayed 
white matter development and myelination. In conclusion, these changes in the metabolic 
profile of fetuses with isolated ventriculomegaly may reflect a delay or impairment in white 
matter development. 
 
While there was no difference in white matter volume in fetuses with ventriculomegaly 
during gestation, alterations in cortical development, in volume and maturation, and changes 
in the metabolic profile in the context of increased risk for developmental delay suggested 
delayed or impaired white matter development. In order to assess white matter development 
we used DTI and TBSS to compare white matter microstructure in neonates with antenatal 
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ventriculomegaly (imaged during fetal life) compared to controls. We showed a significant 
reduction in FA in white matter regions including the splenium of the corpus callosum, 
sagittal stratum and right posterior corona radiate. The white matter pathways highlighted in 
our study are involved in the circuitry of  language, attention and cognition. Our results are 
in agreement with Goodlett et al. (2009) that showed a reduction in FA in the splenium of the 
corpus callosum in neonates with isolated ventriculomegaly compared to controls. A 
reduction in FA may reflect a delay in maturation or abnormal development of the specific 
white matter tracts. More specifically a reduction in FA during neonatal life probably reflects 
deficits or delays in pre-myelination including increased axonal thickness, alteration in 
axonal permeability and pre-myelination wrapping of the oligodendrocytes around axons 
(Wimberger et al., 1995). Neurodevelopmental assessments of these children at 2 years of 
age are currently underway with the aim to correlate changes in FA with development scores 
in cognitive, language and motor domains.  
 
Finally, we have assessed the neurodevelopmental outcome in a small number of children 
enrolled in our study however the data presented are preliminary and part of an on-going 
study. We have shown that from the children assessed at 2 years of age, only 37.5% of 
children with isolated antenatal ventriculomegaly had a normal outcome. The deficits 
detected in this preliminary cohort were mostly within language and cognitive domains. 
Only 2 children had delayed motor development. Although not formally assessed but 
observed by the clinical psychologist half of the children had a short attention span and 
difficulty concentrating during the assessment. Our results are in agreement with the current 
literature supporting that children with isolated ventriculomegaly are at increased risk of 
abnormal development with delays in language and cognitive skills, while motor skills were 
the least affected (Bloom et al., 1997; Gomez-Arriaga et al., 2012; Leitner et al., 2009; Sadan 
et al., 2007). While small numbers did not allow for comparison of MR measurements 
between cases with an abnormal outcome and those with normal development we have 
assessed the relationship between developmental scores and ventricular size. Ventricular size 
showed a negative correlation with fine motor scores at 1 and 2 years of age, however these 
results require further verification.  
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In conclusion, we have shown that brain development during fetal and neonatal life is altered 
in the presence of isolated ventriculomegaly. There are macro- and microstructural 
differences associated with isolated ventriculomegaly and including measures of total brain 
size and cortical gray matter, cortical gyrification, metabolite levels and white matter 
connections.  These changes may form the neural basis of later abnormal neurodevelopment 
and further correlation with developmental scores may aid outcome prediction. 
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5. Future work 
5.1 Volumetric segmentation of the cerebellum in fetuses with ventriculomegaly 
While we performed volumetric analysis of supratentorial brain parenchyma and all CSF 
spaces, structures below the tentorium were not included, these comprise the cerebellum and 
brainstem. These structures were not segmented during this study firstly because ventricular 
enlargement was thought to be restricted to the lateral ventricles and therefore hypothesised 
that any alterations in brain development would be restricted to supratentorial structures. 
Secondly, in the study of Gilmore et al. (2008) in neonates with antenatal ventriculomegaly 
there was no difference in cerebellar volume when compared to a control cohort. However 
our results indicate that enlargement of the lateral ventricles is accompanied by enlargement 
of the fourth ventricle therefore cerebellar development may also be altered in the presence 
of ventriculomegaly. In addition, there has been increasing recognition of the role of the 
cerebellum in cognitive processing (Steinlin, 2007) therefore cerebellar development should 
be included in future work. 
 
5.2 Volumetric segmentation of white matter and gray matter in neonates with 
ventriculomegaly 
While we have shown that neonates with antenatal ventriculomegaly have increased 
supratentorial brain tissue volume we have been unable to demonstrate (due to time 
constraints) whether this enlargement was restricted to cortical overgrowth as shown during 
fetal life. While the volumetric algorithm used in chapter 3.2.2 has delineated between white 
matter and cortex, manual editing is required for the correction of mislabelled voxels. 
Segmentation of these structures is currently underway. 
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5.3 Neurodevelopmental follow up in children with antenatal ventriculomegaly  
As mentioned in chapter 3.6, neurodevelopmental follow in children with ventriculomegaly 
is on-going. The future aim of this part of the study is to correlate the developmental scores 
of children with ventriculomegaly with MR measurements including ventricular and brain 
size, cortical gyrification and FA values.  
The assessments currently performed do not include behaviour and attention skills 
evaluation. Therefore as part of our follow-up assessment we aim to use a battery of autism 
tests including the Autism Diagnostic Observation Schedule (ADOS) and Autism Diagnostic 
Interview-Revised (ADI-R) at 3 years in order to formally characterise the behavioural 
phenotype of these children. 
 
5.4 Correlation of neurodevelopmental outcome and white matter development 
Neurodevelopmental data are currently being collected for the 22 neonates with 
ventriculomegaly that had DTI performed. Future work should aim to assess the relationship 
between diffusion parameters and specific neurodevelopmental performance at 2 years of 
age. Previous studies have shown that neurodevelopmental performance can be predicted by 
FA values in white matter on DTI analysed by TBSS (Beaulieu, 2002; Peters et al., 2011; 
Tusor et al., 2012). 
 
5.5 Vitamin D and brain development: a pilot study 
As discussed in the introduction, the aetiology of fetal isolated ventriculomegaly is unknown. 
There has been a newborn rat model of gestational Vitamin D deficiency (Eyles et al., 2003) 
with a brain phenotype of ventriculomegaly and cortical overgrowth similar to the findings 
described in our study in the fetus with ventriculomegaly. These changes were attributed to a 
disruption in the balance between neuronal stem cell proliferation and programmed cell 
death in the offspring (Eyles et al., 2003; Feron et al., 2005). In the recent years there has 
been increasing interest in the role of Vitamin D in the brain, a previously understudied area 
however these is no human study investigating the effect of maternal Vitamin D deficiency 
on the developing fetal brain. We have completed a retrospective pilot study to determine the 
293 
 
feasibility of measuring Vitamin D levels in stored booking bloods obtained at 12 weeks of 
gestation. We have recently received ethics and funding to proceed with a larger prospective 
study to determine the effect of maternal Vitamin D deficiency in normal control fetuses. 
This chapter summarises the background, design and results of the pilot study and concludes 
with the main aims of the larger prospective study on the effect of Vitamin D deficiency on 
brain development. 
 
Background 
The fetus relies on placental transfer of 25(OH)D whilst Vitamin D deficiency in pregnancy 
is of epidemic proportions (Hollis and Wagner, 2006). In of one of the few studies of 
pregnant women from ethnic minorities in the UK more than 50% of women had a plasma 
25(OH)D level in the deficient range (Datta et al., 2002). The consequences for the fetus 
extend beyond the traditional effects on bone development although splaying of the fetal 
femora has now been documented on ultrasound as early as 19 weeks gestation (Mahon et 
al., 2010). Infantile rickets is on the increase, (Holick, 2006; Kreiter et al., 2000) women who 
breast feed placing their infants at the highest risk (Ziegler et al., 2006). In a London study 
1.6 neonates per 1000 deliveries presented with symptomatic vitamin D deficiency such as 
seizures (Sharma et al., 2009). Vitamin
 
D deficiency during pregnancy is also important in 
fetal "imprinting" and may affect immunity (Harvey et al., 2010) and chronic disease
 
susceptibility such as type II diabetes later in life. The relationship between multiple 
sclerosis and latitude and season at birth points strongly to an association with vitamin D 
(Holick, 2006). Neonatal Vitamin D deficiency has also been linked to adult psychiatric 
diseases such as schizophrenia (McGrath et al., 2010). A recent study has also shown that 
maternal Vitamin D insufficiency is associated with offspring language impairments at 5 and 
10 years of age (Whitehouse et al., 2012). 
 
There is to date no information about the effect of maternal vitamin D deficiency on the 
developing human brain however gestational vitamin D deficiency causes permanent 
changes in the developing rat brain. Maternal deficiency alters brain gene and protein 
expression and disrupts the balance between neuronal stem cell proliferation and 
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programmed cell death in the offspring (Levenson and Figueiroa, 2008). Vitamin D receptors 
are particularly concentrated in the subventricular zone and Vitamin D can regulate cell 
proliferation. Recent studies have demonstrated a partially reversible brain phenotype in rat 
pups born to Vitamin D deficient dams (Eyles et al., 2003). Rat pups demonstrated an 
increased brain size and ventriculomegaly. The cortices of deficient pups were also larger 
compared with controls. This brain phenotype was attributed to increased mitosis and a 
decrease in apoptosis in central and cortical gray matter which was confirmed at histology.  
In this study the dam and consequently the rat pups were rendered extremely deficient with 
levels of <10 nmol/L equivalent. In pups that were given Vitamin D from birth 
ventriculomegaly improved but did not normalise. Brain development is recognised to 
involve a fine balance of cell growth and division and cell death and programmed cell death 
is essential for normal brain development. These deficient pups show abnormal behaviour 
with hyperlocomotion. Adult rats with antenatal deficiency show cognitive and memory 
deficits (Becker et al., 2005) and a similar deficient mouse model has shown that the 
offspring of vitamin D deficient dams scored poorly on behavioural tests as adults despite 
being supplemented with Vitamin D from birth (Fernandes de Abreu et al., 2010). There is 
sufficient animal evidence supporting a role for Vitamin D in brain development combined 
with the knowledge that the VDR is present in key regions in the human brain to warrant a 
study to look at the effects of maternal deficiency on fetal brain growth development. 
Vitamin D deficiency is common in our antenatal population, yet treatment is inexpensive.  
 
Retrospective analysis 
Hypothesis 
We hypothesise that fetuses from vitamin D deficient mothers will show altered human brain 
development when compared to normal controls. More specifically we expect the brain 
phenotype of Vitamin D deficient fetuses to be characterised by increased brain tissue and 
cortical gray matter volume and enlarged lateral ventricular volume. 
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Aims of retrospective pilot study 
To measure Vitamin D levels in stored booking bloods. 
Compare maternal Vitamin D levels between normal controls and isolated ventriculomegaly 
fetuses. 
Correlate ventricular and supratentorial brain tissue volumes with Vitamin D levels. 
 
Ethical approval 
Ethical approval for an amendment in the original ethics (07/H0707/105) for retrospective 
measurement of vitamin D levels in the study participants was granted by the West London 
Research Ethics Committee. Contact with participants was made via telephone to provide 
information about the study and invite participation. Consent forms and detailed information 
about the study were posted to all interested participants. Participants who returned signed 
informed consent forms were included in the study. The results were posted to the GPs of all 
participants. 
 
Quantification of Vitamin D levels  
Maternal vitamin D levels were measured retrospectively in stored booking serum samples. 
Serum samples were stored at the Virology department in Charing Cross Hospital at -20C. 
An aliquot of 250l was used for the analysis. Measurements were performed in the Clinical 
Biochemistry department in Charing Cross Hospital according to the standardised protocol 
for measuring Vitamin D levels in clinical samples. The range of storage time was from 6 to 
33 months. Previous studies have shown that Vitamin D is a highly stable molecule at 
temperatures below -20 C and reliable measurements can be obtained on sera samples 
stored up to 40 years. Liquid chromatography mass spectrometry was used for the analysis. 
25(OH)D2 and 25(OH)D3 were measured in all samples. Total Vitamin D levels were 
defined as the sum of 25(OH)D2 and 25(OH)D3. Clinical Vitamin D cut-off levels (on total 
Vitamin D levels) were defined as following: Deficient <40nmol/L, Insufficient 40-
69nmol/L, Replete >70nmol/L.  
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Imaging and volumetric analysis 
Imaging and volumetric analysis of intracranial structures was performed as described in 
chapter 2.3.2. Volumetric measurements of the lateral ventricles and supratentorial brain 
tissue were performed on 3D-reconstructed datasets in the normal control and 
ventriculomegaly cohorts.  
 
Results  
Cohorts 
Normal controls 
The normal control cohort consisted of 10 fetuses with normal brain appearance on fetal MR 
that were already enrolled in the research program. The mean age at scan was 28
+6
 weeks 
and the range was 23 to 36 weeks. 
 
Isolated ventriculomegaly 
The isolated ventriculomegaly cohort consisted of 16 fetuses diagnosed with isolated 
ventriculomegaly on fetal MR and were already enrolled in the research program. The mean 
age at scan was 27
+2
 weeks and the range was 22 to 37 weeks.  
 
Vitamin D levels and ethnicity 
Women were divided according to their ethnicity into two groups including Asian/African 
American (Group A, n=10) and Caucasian (Group B, n=16).  All women from both cohorts 
were included. There was a significant difference between groups A and B (p=0.018) with a 
median of 37 (SD ±18) and 57 (SD ±24) nmol/L respectively (Appendix 6, Figure 1). In 
group A, none of the women had measurements in the replete range, 6/10 were Vitamin D 
deficient while 4/10 were insufficient. In group B, 4/16 were deficient, 7/16 were insufficient 
and 5 had replete levels.   
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Figure 126. Total Vitamin D levels and ethnicity    
 
25(OH)D2 levels obtained through the diet were only detectable in 2 cases. In the rest of the 
cases only the 25(OH)D3 levels contributed to the total Vitamin D levels. 
 
Vitamin D levels and brain development 
Total Vitamin D levels were compared between the control and ventriculomegaly cohorts 
and there was no significant difference in total Vitamin D levels between the cohorts. In both 
the control and ventriculomegaly groups, however, deficient cases (<40nmol/L) had larger 
lateral ventricles and supratentorial brain tissue volumes although this was not statistically 
significant (Appendix 6, Figure 2). There was no significant correlation between vitamin D 
levels and ventricular or supratentorial brain tissue volume adjusted for gestational age.  
298 
 
 
Figure 127. Vitamin D status and intracranial structures in controls and fetuses with ventriculomegaly 
 
Correlation of Vitamin D levels and intracranial structures 
In the control cohort, there was no significant correlation between Vitamin D levels and 
supratentorial brain tissue (Spearman’s r=-0.262, p=0.464) or total ventricular volume 
(Spearman’s r=-0.091, p=0.802) when corrected for GA. Similarly, in the ventriculomegaly 
cohort there was no significant correlation between Vitamin D levels and supratentorial brain 
tissue (Spearman’s r=-0.146, p=0.603) or total ventricular volume (Spearman’s r=-0.275, 
p=0.321) when corrected for GA. 
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Discussion and prospective work 
We have completed a retrospective pilot study to determine the feasibility of measuring 
Vitamin D levels in stored booking bloods obtained at around 12 weeks of gestation. We 
measured the Vitamin D levels in maternal samples of 10 normal fetuses and 16 fetuses with 
isolated ventriculomegaly. Vitamin D levels were successfully measured in all samples and 
we showed that 50% of cases were deficient. Ethnicity was a determining factor. Deficient 
cases had larger lateral ventricles and brain tissue volumes although this was not statistically 
significant, possibly due to the small cohort size. In addition we showed that Vitamin D 
intake through the diet was negligible. 
 
Prospective study 
We have recently received ethics and funding to proceed with a larger prospective study to 
determine the effect of maternal Vitamin D deficiency in normal control fetuses. The 
expectant mothers are currently being recruited from the Queen Charlotte's and Chelsea 
antenatal clinic at the time of their anomaly ultrasound scan at around 20 gestational weeks. 
Eligibility for participation is determined by an uncomplicated pregnancy and a normal brain 
appearance on ultrasound. We are collecting information on ethnicity, practice of skin 
covering, Body Mass Index (BMI), Vitamin D intake and daily sun exposure using detailed 
questionnaires (Appendix 6). All mothers are recruited into the ongoing MR study of fetal 
brain development. The aims of the study are summarised below: 
 
Aims 
1. To prospectively acquire fetal MR imaging from normal control fetuses from 
uncomplicated pregnancies with a normal antenatal ultrasound. 
2. To ascertain the levels of maternal Vitamin D deficiency from the maternal booking 
bloods. 
3. To determine the effect of maternal Vitamin D deficiency at the time of booking on 
the structure and metabolic function of the developing brain and 
4. To assess the effect of any alterations in brain development on later neurocognition 
and behaviour. 
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Appendix 
Appendix 1. Information Sheet for Patients 
 
You will be given a copy of this information sheet 
 
Study Title: 
Quantification of fetal brain development and growth using magnetic resonance imaging 
 
Invitation to take part 
We are inviting you to take part in a research study, which uses a technique called magnet 
resonance to image your baby. Before you decide it is important for you to understand why 
the research is being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with friends, relatives and your GP if you wish.  Ask us 
if there is anything that is not clear or if you would like more information.  Take time to 
decide whether or not you wish to take part. 
 
What is the purpose of this study? 
Magnetic resonance imaging is a method of obtaining pictures of the inside of the body.  
While ultrasound is excellent for showing the anatomy of the normal fetus (baby), magnetic 
resonance is usually better for detecting and assessing both normal structures and 
abnormalities. This is why your obstetrician may have referred you for an MR scan.  We are 
interested in developing the MR technique further to improve our abilities to detect 
abnormalities and to try and understand more about their impact on your child’s later 
development.  
 
We therefore plan to image your baby once or twice prior to delivery.  Where possible we 
also seek your permission to scan your baby after delivery and in the event of a premature 
delivery at term equivalent age. We would also like to assess your child’s development over 
the first few years. 
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We are also keen to understand the effect of maternal illness or complications of pregnancy 
on the developing baby’s brain. In particular we would like to assess the effect of maternal 
Vitamin D. Vitamin D levels are often low in pregnancy, particularly in women who are dark 
skinned or cover their skin when outdoors but the effects, if any, of a low level on the 
developing baby’s brain are not understood. 
 
The MR technique uses a large magnet and radio waves.  It does not involve the use of either 
X-rays or radiation. It is not believed to have any hazard associated with it, although care is 
necessary to keep certain metallic objects away from the magnet and, at the present time, we 
exclude women who are in the first three months of an uncomplicated pregnancy. This is 
only a precaution as there are no reports of any side effects even in the very young fetus. 
However in the first months of pregnancy the fetus is very small and many structures are not 
completely formed therefore we do not feel that, very early MR imaging would be 
particularly useful with current MR techniques. MR can also be used to obtain information 
about the way a tissue is functioning, this is called MR spectroscopy. 
 
Why have I been chosen? 
We seek permission for these studies from: 
Women with complicated pregnancies,  
Women where antenatal ultrasound has shown a possible problem with the fetus,  
Women with normal pregnancies and normal fetuses.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form.  If you decide to 
take part you are still free to withdraw at any time and without giving a reason.  This will not 
affect the standard of care you receive. If you do not wish to take part we will only take those 
images that we consider necessary to help with the management of your pregnancy. We still 
require your permission to do this. 
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What will happen to me if I take part? 
If you have been referred for an MR scan by your doctor this will be performed as usual. 
You will be asked to lie feet first inside a magnet.  Your head will be level with the opening 
of the magnet. We will make you as comfortable as possible. You will hear a knocking noise 
during the procedure. We will give you some headphones and you can listen to some music 
during the scan if you wish. Your partner or a friend or relative may accompany you into the 
scanning room once they have had a safety check. You will be given an alarm bell to sound 
at any time if you are upset or worried during the examination. If the procedure does not suit 
you for any reason, it can be stopped at any time.  
 
For the purposes of this research we wish to collect some extra images from your baby’s 
brain.  We may also collect MR spectroscopy information from your baby’s brain and liver 
and your placenta. We need information on these organs to increase our understanding of 
their role when a baby is not growing well. The total duration of the examination is unlikely 
to be longer than 45 minutes. If you become uncomfortable we can stop the scan. It is 
possible to continue scanning after you have had a break or a change in position.  
 
No extra blood tests will be necessary.  Vitamin D levels will be measured on a small sample 
of your blood that was taken at the time of booking for antenatal care and is stored in the 
hospital.  
 
You may like to go online and watch a short video explaining the MRI procedure in more 
detail and what you can expect when you come for your scan: http://vimeo.com/37368763  
 
What do I have to do? 
For your scans we will ask you to lie as still as possible within a magnetic scanner while the 
machine produces images. 
 
What is the procedure that is being tested? 
The procedures being tested are magnetic resonance imaging and spectroscopy.  We will be 
optimising the scanner’s abilities to obtain the most detailed information possible about the 
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unborn baby. These developments will allow us, for instance, to accurately measure areas of 
a baby’s brain at different gestations and to identify an area of injury soon after it has 
occurred.  
 
What are the side effects of taking part? 
The examination itself is not believed to have any side effects for you or your baby. The 
machine is enclosed and people who cannot travel in a lift because of claustrophobia may 
find it unacceptable. However your head will be level with the opening and not remain deep 
in the scanner. Occasionally we find that the magnet is not wide enough to take women who 
are large e.g. twin pregnancy or women who are nearing term. The machine is noisy when it 
is acquiring images and that is why we give you some headphones whilst you are being 
scanned. We can play music through these and if you want you could bring your own CD.  
 
What are the possible disadvantages and risks of taking part? 
The basic examination is not believed to have hazards associated with it when operated 
within National Radiological Protection Board Guidelines (which we do).  
 
What are the possible benefits of taking part? 
A scan may have been requested by your doctor to help him/her with the management of 
your pregnancy. The further MR images that we take may be of benefit to you in improving 
the diagnostic information of your baby.  Otherwise the benefit is likely to be in improving 
the diagnostic technique for the benefit of others. 
As part of this study we would like to follow your baby’s development. You may find 
information that is produced from these assessments reassuring or it may help plan any 
treatment or extra therapy that your baby may require.  
 
What if new information becomes available? 
MRI may just confirm the findings on your antenatal ultrasound or it may show an 
abnormality that has not been detected previously. This improved detection is why you may 
have been referred for an MRI. All the findings on your scan will be discussed with yourself 
and with your obstetrician. This will allow your obstetrician to advise on the management of 
your pregnancy with all the available information. 
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What happens when the research study stops? 
The present research has been continuing for over 20 years and the results have been 
published regularly.  We intend to continue this. 
 
What if something goes wrong? 
In the unlikely event of you suffering any adverse effects as a consequence of your 
participation in the study you will be compensated through the Imperial College School of 
Medicines "No Fault Compensation Scheme". 
 
Will my taking part in this study be kept confidential? 
The information obtained from your study is covered by the Data Protection Act.  The 
computerised information is protected by a software and hardware barrier and the records are 
handled in the same way as hospital records. We also seek permission to include clinical 
details about your pregnancy in the study, for instance your gestation, ultrasound details of 
your baby. This information would be given to us by your obstetrician and would be handled 
confidentially. Any imaging data that is shared with colleagues in collaborating units will be 
anonymised.   
If we measure Vitamin D levels on your stored blood we will send the result to your doctor 
who if your level is low will be able to discuss with you if any supplementation is necessary.  
 
What will happen to the results of the research study? 
The results are usually published in the medical literature. No patients’ names will be 
included.  
 
Who is organising and funding the research? 
The research is organised and funded by the Medical Research Council, Imperial College 
School of Medicine and charities such as Action for Medical Research. 
 
Who has reviewed the study? 
The study has been reviewed by the Hammersmith Hospitals Research Ethics Committee. 
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Appendix 2. Information Sheet for Healthy Pregnant Volunteers 
 
Study Title: 
Quantification of fetal brain development and growth using magnetic resonance imaging.  
 
Invitation to take part 
You are being invited to take part in a research study.  Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully and discuss it with friends, relatives and your GP 
if you wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. 
 
What is the purpose of this study? 
Magnetic resonance imaging (MRI) is a method of obtaining pictures of the inside of the 
body.  While ultrasound is excellent for showing the anatomy of the normal fetus, MRI is 
usually better for detecting and assessing both normal structures and abnormalities. We are 
interested in developing the MR technique further to improve our abilities to both monitor 
brain growth and development and to detect abnormalities and to try and understand more 
about their impact on a child’s later development. We are therefore asking your permission 
to image your baby prior to delivery and where possible after delivery. We would also like to 
assess your child’s development during the first few years after birth.  
 
We are also keen to understand the effect of maternal illness or complications of pregnancy 
on the developing baby’s brain. In particular we would like to assess the effect of maternal 
Vitamin D. Vitamin D levels are often low in pregnancy, particularly in women who are dark 
skinned or cover their skin when outdoors but the effects, if any, of a low level on the 
developing baby’s brain are not understood 
 
The MRI technique uses a large magnet and radio waves. It does not involve the use of either 
X-rays or radiation.  It is not believed to have any hazard associated with it, although care is 
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necessary to keep certain metallic objects away from the magnet and, at the present time, we 
exclude normal women who are in the first three months of an uncomplicated pregnancy. 
This is only a precaution as there are no reports of any side effects even in the very young 
fetus. However in the first months of pregnancy the fetus is very small and many structures 
are not completely formed therefore we do not feel that very early MR imaging would be 
particularly useful with current techniques. MR can also be used to obtain information about 
the way a tissue is functioning; this is called MR spectroscopy. 
 
Why have I been chosen? 
We seek permission for these studies from normal pregnant volunteers to increase our 
understanding about the normally developing brain and its relationship with the child’s later 
development. The purpose is to obtain information about normal fetuses from uncomplicated 
pregnancies so that deviations from normal can be recognised. We would also plan to 
compare data on the normally growing fetus with that obtained on our population of preterm 
babies. Infants born preterm have a high risk of learning difficulties and we think this is 
because their brains develop differently outside of the womb.  
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. You will also be 
given an information sheet about scanning your baby after delivery. If you decide to take part 
you are still free to withdraw at any time and without giving a reason.   
 
What will happen to me if I take part? 
You will be asked to lie feet first inside a magnet and you will hear a knocking noise during 
the procedure. Your head will be level with the opening of the magnet. We will make you as 
comfortable as possible. Your partner or a friend or relative may accompany you into the 
scanning room once they have had a safety check. You will be given an alarm bell to sound 
at any time if you are upset or worried during the examination. If the procedure does not suit 
you for any reason, it can be stopped at any time.  During the examination we will collect 
imaging data on your baby’s brain. We may also collect MR spectroscopy information from 
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your baby’s brain and liver and your placenta. We need normal information on these organs 
to increase our understanding of their role when a baby is not growing well.  The total 
duration of the examination will be approximately 45 minutes.  If you become uncomfortable 
we can stop the scan. It is possible to continue scanning after you have had a break or a 
change in position. 
We seek your permission to perform two scans during pregnancy several weeks apart to 
allow us to measure growth over time. In addition we would like to be able to follow your 
baby’s development after birth, as this will provide very useful information when 
quantifying our MR scans. The follow up would include a further MRI after delivery. 
Information about this is provided on a separate sheet.  
 
No extra blood tests will be necessary.  Vitamin D levels will be measured on a small sample 
of your blood that was taken at the time of booking for antenatal care and is stored in the 
hospital.  
 
You may like to go online and watch a short video explaining the MRI procedure in more 
detail and what you can expect when you come for your scan: http://vimeo.com/37368763  
 
What do I have to do? 
For the fetal scans we will ask you to lie within a magnetic scanner while the machine 
produces images. 
 
What is the procedure that is being tested? 
The procedures being tested are magnetic resonance imaging and spectroscopy. We will be 
optimising the scanner’s abilities to take the best possible images of your baby. These 
developments will then allow us to accurately measure areas of a baby’s brain at different 
gestations using specially designed computer programmes and also to identify an area of 
injury soon after it has occurred.  
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What are the side effects of taking part? 
The MR examination itself is not believed to have any side effects on you or your baby. The 
machine is enclosed and people who cannot travel in a lift because of claustrophobia may 
find it unacceptable.  However your head will be level with the opening and not remain deep 
in the scanner. Occasionally we find that the magnet is not wide enough to take women who 
are large e.g. twin pregnancy or women who are nearing term. The machine is noisy when it 
is acquiring images and we therefore give you some headphones whilst you are being 
scanned. We can play music through these and if you want you could bring your own CD. 
The noise has not been reported to have any effects on the fetus.  
 
What are the possible disadvantages and risks of taking part? 
The basic examination is not believed to have hazards associated with it when operated 
within National Radiological Protection Board Guidelines (which we do).  
 
What are the possible benefits of taking part? 
The benefit from your examination is likely to be in improving the diagnostic technique for 
the benefit of others. We will however be able to check your baby’s brain development and 
give you a copy of the images on a CD. We would also be able to check your toddler’s 
overall development at 12 and 24 months and hopefully after school entry.  
 
What if new information becomes available? 
Whilst it is unlikely, MRI may detect an abnormality that has not been detected by your 
antenatal ultrasound. If unexpected information of potential clinical importance is found 
during the examination, we will discuss the matter with you and, if you give your 
permission, refer the matter to your GP or any other appropriate doctor. Most often the 
finding will be a normal variation and not clinically significant.  In addition whilst we 
anticipate that your fetal magnetic resonance images will show normal appearances, this 
cannot be considered as a guarantee that your baby will have normal development 
throughout childhood. Some children with significant problems with their development have 
normal appearances on their MRI scans even when performed later in childhood.  
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What happens when the research study stops? 
The present research has been continuing for over 20 years and the results have been 
published regularly.  We intend to continue this. 
 
What if something goes wrong? 
In the unlikely event of you suffering any adverse effects as a consequence of your 
participation in the study you will be compensated through the Imperial College School of 
Medicines "No Fault Compensation Scheme". 
 
Will my taking part in this study be kept confidential? 
The information obtained from your study is covered by the Data Protection Act.  The 
computerised information is protected by a software and hardware barrier and the records are 
handled in the same way as hospital records. We also seek permission to include clinical 
details about your pregnancy in the study, for instance your gestation, ultrasound details of 
your baby. This information would be given to us by your obstetrician and would be handled 
confidentially. Any image information sent out from our unit to colleagues in a collaborating 
unit will be anonomised.  
If we measure Vitamin D levels on your stored blood specifically we will send the result to 
your doctor who if the level is low be able to discuss with you if any supplementation is 
necessary.  
 
What will happen to the results of the research study? 
The results are usually published in the medical literature. No patients’ names will be 
included. 
 
Who is organising and funding the research? 
The research is organised and funded by the Medical Research Council, Imperial College 
School of Medicine and other funding bodies such as Action Medical Research 
 
Who has reviewed the study? 
The study has been reviewed by the Hammersmith Hospitals Research Ethics Committee. 
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Appendix 3. Parental Questionnaire 
                                          
 
 
 
 
 
 
 
 
 
 
 
Dear Parents,  
 
We are trying to improve our clinical and research service and would really value your 
views. It would be helpful if you could answer the following questions for us. The 
completed questionnaire will be anonymous unless you wish to give your name. We 
have given you a stamped addressed envelope to make it easier to let us have your 
replies.  
 
 
Yours faithfully  
 
 
 
 
 
Mary Rutherford 
Professor in Perinatal Imaging  
 
m.rutherford@imperial.ac.uk 
 
            
          
Fetal Imaging Programme 
Parental Questionnaire 
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Please put a circle around your chosen answer i.e.   YES      NO     or tick the box 
 
 
1. Which hospital were you referred from?    
 
Queen Charlottes      Other hospital 
 
 
2. Why were you referred for an MRI scan?  Because there was a problem with my
  
 
Baby’s brain             baby’s body   my pregnancy             other  
 
None of the above I am a volunteer for research  
 
 
 
3. How did you receive your appointment?   
 
Hand/In person   Phone     Mail  
 
4. Were you able to confirm the appointment easily or contact us for more details?    
 
YES     NO 
 
 
5. Did you receive an information sheet about our research?  
   
YES             NO 
 
6. Did you have enough time to read through it?    
 
YES NO 
 
7. Did you understand it?  
 
YES  NO 
 
8. Would you have preferred it to be in a different language from English?  
 
YES  NO  
 
9. If you answered “Yes” which language? _____________________ 
 
           
312 
 
 
10. Did you have the opportunity to ask any questions about the information sheet?   
            
YES  NO 
 
11. Were you clear which aspects of your examination were research and which 
were clinical?   
 
 YES   NO  
 
12. Were the practical details about the scan and safety issues explained to you?  
 
 YES    NO 
 
13. Did you receive (on appointment letter and information sheet) the internet based 
video link showing further details of MR scan? 
 
 YES   NO 
 
14. Did you view it?  
 
 YES   NO 
 
15. Did you find it helpful?  
  
 YES   NO 
 
16. What further information would you have liked to receive prior to the scan? 
 
     YES   NO 
 
 
17.  Was there anything about the scan itself that worried you?  
 
 
 
 
18.  In what ways could the scan have been better for you 
 
 
  
 
 
19. Were you shown the images after the scan?  
 
 YES   NO 
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If you answered NO did you want to see the images?   
 
 YES   NO 
 
20. Did you understand what you were told about the images?  
 
 YES   NO 
 
21. Could the discussion have been improved in anyway?   
 
  YES   NO 
 
22. Did you discuss the scan findings again with one of your doctors?  
 
  YES   NO 
 
23. Did you feel the scan helped you  understand the problems affecting your  
baby or your pregnancy?    
 
  YES   NO 
  
24. Did you feel the scan was a help in making decisions about your  
pregnancy?    
   
  YES     NO 
 
25. As part of the research we have asked your permission to contact you again.  
Were you happy with this?      
 
  YES     NO 
 
26. We may have asked your permission for further scans of your baby.  Did you 
agree?    
 
  YES   NO 
 
If you did not agree for further scans could we ask your reasons for saying no? 
 
 
 
27. We may have asked whether we could follow your baby’s development. Did you 
agree?  
 
  YES              NO   
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If you did not agree for further scans could we ask your reasons for saying no? 
 
            
 
28. Finally on a scale of 1-5, where 1 is not useful at all and 5 is very useful, do you 
feel that having the scan was a useful thing to have done?  
      (Please put a circle around the number.) 
 
    1                  2                      3                      4                       5 
 
 
 
 
Thank you very much indeed for filling this in. We would be very grateful if you could 
put the questionnaire into the pre addressed and stamped envelope 
Also we would welcome,  
 
ANY EXTRA COMMENTS, IDEAS OR SUGGESTIONS:  
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Appendix 4. Ages and Stages Questionnaire 
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Appendix 5. Detailed protocol of cortical development assessment 
 
Central sulcus (Height&Width) 
The height and width of the central sulcus are measured at a sagittal plane at a slice where it 
has the maximum visible height, and when the cerebellum is present. The width is measured 
at the middle and perpendicular to the height measurement. To find the correct place to 
measure as you move laterally towards a midsaggital plane the sulcus appears to make a little 
"jump" and that is where the measurement is performed. 
 
 
 Central sulcus 
 Measurements of the central sulcus included height (blue) and width (red). 
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Precentral and postcentral gyri: (Height&Width) 
Measured at a sagittal plane where the sylvian fissure is not visible and before the 
appearance of the brainstem and spinal cord. Both precentral and postcentral should appear 
in their most mature stage and symmetrical to each other. If either landmark is slightly 
curved the measurement is performed into segments.  
 
Postcentral and precentral and gyri 
(A)Postcentral gyrus (B) Precentral gyrus. Measurements of cortical folding included height 
(blue) and width (red) of gyri and sulci. 
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Parieto-occipital fissure (Height&Width) 
Measured in a transverse plane where the sulcus "dips" inside the atrium. Commonly on the 
same slice as for the measurement for maximum distance from frontal to temporal along the 
insula-temporal cortex. 
 
 
Parieto-occipital fissure 
Measurements of cortical folding of the cortical landmarks included height (blue) and width 
(red). 
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Calcarine sulcus(Height&Width&length) 
Length: measured in a sagittal plane at the slide where it appears longest and before it opens 
fully.  
Height/Width: measured in a transverse plane, on the slide corresponding to the 
measurement performed on the sagittal. On the sagittal the cursor is positioned at the most 
posterior part in the centre of the loop formed. Commonly at eye level. 
 
 
Calcarine sulcus 
Cortical development of the calcarine sulcus was assessed using (A) the length of the 
cingulate sulcus in a sagittal plane (green) and (B) the height (blue) and width (red) on a 
transverse plane. 
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Sylvian fissure (2 linear measurements and their ratio) 
Opercular distance= minimum distance from frontal to temporal of the operculum. Insular 
distance = maximum distance from frontal to temporal aslong the insula-temporal cortex.  
Ratio =    insular distance 
               opercular distance 
 
 
Sylvian fissure 
Sylvian fissure development was assessed using the ratio of (A) the maximum distance from 
frontal to temporal boundaries along the insula-temporal cortex to (B) the minimum distance 
from frontal to temporal borders of the operculum. 
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Cingulate sulcus 
In a sagittal plane length of the sulcus is measured at the slice where it has maximum length. 
If the cingulate appears in segments that might appear in slightly different slices then the 
segments are measured individually and added together. The paracingulate is not included in 
the measurement as it is not present in all fetuses. 
 
 
Cingulate sulcus 
Cortical development of the cingulate sulcus was assessed using the length of the cingulate 
sulcus (blue) on a sagittal plane. 
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Frontal lobe 
Superior frontal gyrus and sulcus/ middle frontal gyrus/ inferior frontal gyrus and 
sulcus: All measurements are made in a coronal plane on a slice where the anterior temporal 
lobes are present but not the brainstem. To locate the correct slice, the frontal sulcus is 
visualised in a transverse plane and the cursor is placed at 1/3 distance along the sulcal 
length from the anterior, in order to locate the corresponding coronal slice. 
 
 
Frontal lobe 
(1) superior frontal gyrus (2) superior frontal sulcus (3) middle frontal gyrus (4) inferior 
frontal sulcus (5) inferior frontal gyrus (B) precentral gyrus. Measurements of cortical 
folding included height (blue) and width (red) of gyri and sulci. 
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Temporal lobe 
Superior temporal gyrus and sulcus/Middle temporal gyrus/ Inferior temporal gyrus: 
All measurements are made in a coronal plane before the appearance of the brainstem and 
spinal cord. Measurements are taken where the brainstem appears as a square. Late in 
gestation it is more clear to take the measurements a few slices more frontal just as the 
brainstem starts to appear.  
 
 
Temporal lobe 
(1) Superior temporal gyrus (2) superior temporal sulcus (3) middle temporal gyrus (4) 
inferior temporal gyrus. Measurements of cortical folding included height (blue) and width 
(red) of gyri and sulci. 
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Appendix 6. Cortical development: Mean and standard deviation of GA for different development scores 
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Appendix 7. Vitamin D Questionnaire 
 
Do you know your vitamin D levels? Yes              No  
If yes: Date last measured (mm/yy) and level _______________________ 
 
Do you take multivitamins?      Yes              No  
 
If so which product do you use?        ______________________ 
When did you start taking the multivitamins?    ____________________ 
 
Do you take Vitamin D supplements or calcium with Vitamin D?    
Yes              No           
 
If so, how many IU (units) per day?   ______________________ 
When did you start taking Vitamin D?  _______________________ 
 
Do you take cod liver oil?    Yes              No  
 
How much and how often?   ________________________ 
When did you start taking cod liver oil?    ____________________ 
 
Are you vegetarian/vegan?   Yes              No 
 
How many times per week do you eat oily fish?   _____________________ 
 
What is your ethnic background?   _____________________ 
 
What is your clothing style? (please circle) 
Skin fully covered   /   only face uncovered   /   no traditional clothing 
 
What is your occupation?  ___________________ 
 
Have you received a suntan in the past 12 months?  Yes              No 
 
Have you used a tanning booth in the past 12 months?  Yes              No 
 
On average, how much sun exposure have you had during your pregnancy?  (please circle) 
<5minutes per day  /  5-15 minutes per day  /  15-30 minutes per day  /  >30 minutes per day 
 
Do you use sunscreen?   Yes              No 
 
Do you suffer from any renal conditions? Yes             No         _____________ 
 
Have you got any family history of rickets, bone diseases or previous children affected?     
 
Yes              No             ___________________________________
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